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The Convention of Stereochemical Descriptors 
Throughout this thesis, the stereochernical descriptors shown in I and 11 have been 
used to represent the stereochernistry of single enantiorners and the stereochernistry 
of racernates respectively, as proposed by Maehr. 
Br Br 
1-ýOH 
OH OH 
Single Enantiorner, I Racernate, II 
Reference: Maehr, H. J. Chem. Educ., 1985,62,114-120. 
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Abstract 
Chapter One provides a review of the literature relating to the isolation, structure 
elucidation and biological activity of ficellomycin, a natural product with antibiotic 
activity. This chapter also provides an overview of published synthetic routes 
towards ficellomycin and 1-azabicyclo[3.1.0]hexanes. 
Chapter Two describes our synthetic efforts to the I -azabicyclo[3.1.0]hexane core of 
ficellomycin. Initially, a model system developed in the group with a double 
cyclisation as key step was optimised. This involved the reduction of a 1,2-azido 
alcohol, using a solid-supported triphenylphosphine reagent, to an aziridine that 
undergoes conjugate addition onto a tethered dehydroamino acid in situ. Under these 
conditions, azido alcohol 94 led to the formation of the four stereoisomeric bicycles 
45 a/b, 142 a/b, in 45% overall yield in a 3: 1: 5: 1 ratio. 
A second approach towards the natural product is also described. This involved the 
development of a system wherein the C-5 amino substituent is incorporated. Two 
open chain y-aldehydes 212 and 232, were made in 8 and 10 steps respectively from 
168 using a sequence that involved anti- 1,4-addition of azide onto 168, formation of 
Weinreb amides 211 and 231 and their chemoselective reduction as key steps. 
Reaction of these aldehydes with phosphonate 99 using DBN, produced alkenes 214 
and 230 respectively, and exclusively, as the (Z)-isomers. Further stereocontrolled 
cyclisation to piperidines 220 and 235 possessing the required 3S, 5S, 6R- 
stereochernistry was achieved in good yields by hydrogenation using Lindlar's 
catalyst. We anticipate that these intermediates could be further advanced to the 
natural product. 
Chapter Three draws conclusions from the work to date, and discusses future options 
with respect to the completion of the synthesis to the natural product. 
Chapter Four contains detailed experimental procedures for the novel compounds 
described within this thesis. 
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Abbreviations 
Ac Acetyl 
Alloc Allyloxycarbonyl 
ax Axial 
AZT Azidothymidine 
Bn Benzyl 
Boc tert-Butyloxycarbonyl 
b. p. Boiling point 
Bu Butyl 
CAN Ammonium cerium(IV) nitrate 
cat. Catalyst/catalytic 
Cbz Benzyloxycarbonyl 
CDI Carbonyl-NX-di-imidazole 
COLOC Long range 'H- 13C correlation spectrum 
C1 Chemical ionisation 
COSY Correlation spectroscopy 
CSA Camphor sulfonic acid 
DABCO 1,4-Diazabicyclo [2.2.2] octane 
DBN 1,5-Diazabicyclo[4.3.0]non-5-ene 
DCC NN-dicyclohexylcarbodiimide 
de. Diastereomeric excess 
DIBAL-H Di-iso-butylaluminium hydride 
DIPT Di-iso-propyl tartrate 
DMAP 4-Dimethylaminopyridine 
DME 1,2-Dimethoxyethane 
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Abbreviations Maria Garcia 
DMF N, N-Dimethylformamide 
DMP 2,2-dimethoxypropane 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dr. Diastereomeric, ratio 
E. Escherichia 
ee enantiomeric excess 
EDTA Ethylenediaminetetraacetic acid 
EI Electron ionisation 
ES Electrospray 
Et Ethyl 
eq. Equivalent/equatorial 
FAB Fast atom bombardment 
gem Geminal 
HPLC High performance liquid chromatography 
HRMS High resolution mass spectrometry 
IC50 Mean Inhibition Concentration 
Imid Imidazole 
IR Infra red 
LCMS Liquid Chromatography Mass Spectrometry 
LD50 Mean Lethal Dose 
LDA Lithium diisopropyl amide 
LRMS Low resolution mass spectrometry 
m-CPBA meta-Chloroperoxybenzoic acid 
Me Methyl 
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Abbreviations Maria Garcia 
MHz Mega-Hertz 
mmTr monomethoxytrityl 
M. P. Melting point 
Ms methanesulfonyl 
MS Mass SPectrometry 
MWt Molecular weight 
NBS N-Bromosuccinimide 
NMO 4-Methylmorpholine N-oxide 
NMR Nuclear magnetic resonance 
nOe Nuclear Overhauser effect 
NVoc Nitroveratryl 
P. Penicillium 
PCC Pyridinium chlorochromate 
pH potential of Hydronium ions 
pKý, -log K,, (acidity constant) 
PMB para-Methoxybenzyl 
PPM parts per million 
PPTS Pyridinium-p-toluenesulfonate 
RT Room Temperature 
SN2 Substitution Nucleophilic Bimolecular 
SNib Internal backside nucleophilic substitution 
TBAF Tetra-n-butylammonium fluoride 
TBDMS tert-Butyldimethylsilyl 
TBDPS tert-Butyldiphenylsilyl 
TBS Tributylsilyl 
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TCA Trichloroacetic acid 
TEMPO 2,2,6,6-Tetramethylpiperidine N-oxide 
TES Triethylsilyl 
Teoc Triethylsilyloxycarbonyl 
TFA Trifluoroacetic acid 
THIF Tetrahydrofuran 
TIPS Triisopropylsilyl 
TLC Thin layer chromatography 
TMEDA NNNN-Tetramethylethylene diamine 
TMS Trimethylsilyl 
TMSE Trimethylsilylethyl 
TMSI Trimethylsilyl iodide 
TPAP Tetra-n-propylammonium perruthenate 
Ts para-Toluenesulfonyl 
pTSA para-Toluenesulfonic acid 
PTSCI para-Toluenesulfonyl chloride 
UV Ultra violet 
Vic Vicinal 
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Chapter One: Introduction Maria Garcia 
1. Introduction to Ficellomycin 
1.1. Background 
The isolation of ficellomycin (U-47,929) was first described in 1976 by Argoudelis 
et al. at the Upjohn Company. ' It was one of three natural products, displaying 
antibacterial activity, produced by and isolated from a culture broth of Streptomyces 
ficellus (UC05438). In 1989, Kuo and co-workers proposed structure 1 for 
ficellomycin as represented in Figure 1, through a combination of NMR, MS, 
chemical degradation and derivatisation studies, which revealed the presence of a 
highly strained I -azabicyclo [3. I. O]hexane ring system 2.2 
H 
'1ý4ý N"'rNH2 
IIN C02H 0 
>=NH 
H2N 
Figure 1 
The unusual structural features and prominent biological activity have attracted the 
attention of the synthetic chemistry community. To date, there have been several 
efforts directed towards its synthesis by the groups of Armstrong, 3 Yudin, 4 and our 
own, 5 but no reported total synthesis. 
In this Chapter, the isolation and biological properties of ficellomycin 1, its structural 
elucidation and the stereochernical ambiguities that surround this natural product are 
described. General synthetic routes to the skeleton of this and related natural 
products are discussed. Synthetic efforts towards the total synthesis of ficellomycin 
1 in our and other groups are also described. 
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Although the natural product is most likely a zwitterion at neutral or physiological 
pH, we represent it in the neutral fonn throughout this thesis, in the same way as it is 
represented in the literature. 
1.2. Isolation 
Ficellomycin 1 was produced by and isolated from the culture broth of Streptomyces 
ficellus (UC105438) together with two other natural products displaying antibiotic 
activity; one of them, was designated feldamycin 3, and the other, was later 
identified as nojirimycin 4, which had been isolated and described in 1967 by Ishida 
and Kumagai (Figure 2). 6 
0 q02H OH H 
NN 
OH 
N --eN"'ý 
C :e11 H 
\> -J 
HNý e CO, 
ýH 
N Me 2H N HO" OH 
HH OH 4 
Figure 2 
The production and isolation of the three antibiotics were guided using bioassays. 
For ficellomycin 1, the process was followed by assaying against Staphylococcus 
aureus and Penicillium oxalicum, as well as by paper or thin layer chromatography 
developed with ninhydrin. 
The isolation of ficellomycin has been achieved on a large (5,000 L) scale. For the 
isolation of the natural product, the broth was filtered through diatomaceous earth. 
Acid washed florisil chromatography separated feldamycin 3 from ficellomycin 1 
(eluting system, water then 50% aqueous acetone), and Amberlite XAD-4 
chromatography separated nojirimycin 4 from ficellomycin 1 (PH 10, eluting system 
water then 20% methanol/water). 
13 
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From this, 20 g of ficellomycin preparation were dissolved in water (pH found 10.4) 
and purified by ion-exchange column chromatography with Dowex-I (X-4) in the 
hydroxide form, eluting with water. 
Fractions active to ninhydrin staining in TLC and bioautography on S. aureus were 
combined and freeze-dried to afford 8.3 g of pure ficellomycin, isolated as an 
amorphous colourless material ffa]" + 39 (c 1, water)}, soluble in water and D 
lower alcohols and stable at pH 8-10. 
1.3. Biological Properties 
Ficellomycin 1, at pH 8-10, displays high in vitro activity against S aureus including 
strains resistant to penicillin, streptomycin, neomycin, macrolides and lincosaminide 
antibiotics. It is moderately effective in the treatment of experimental S. aureus 
infections in mice (subcutaneously, CD50 ca 7.6 mg/kg) and strains resistant to either 
streptomycin or erythromycin (subcutaneously, CD50 of 10 and II mg/kg, 
respectively). It is inactive against Gram negative bacteria, viruses and a variety of 
fungi, except Penicilium oxallcum. The acute LD50 values in mice are approximately 
of 800 mg/kg via intraperitoneal or intravenous administration. 
For the other co-isolated metabolites, feldamycin 3 displays high activity against 
Sarcina lutea, slight activity against S. aureus and inactivity against P. oxalicum; it 
has also been tested as an inhibitor of depigmentation of S. bikiniensis and B16 
melanoma cells. 7 Nojirimycin 4 is active against Gram positive and negative 
bacteria (including S. aureus and Escherichia coli) and inactive against P. oxalicum. 
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It seems likely that the aziridine is the structural feature responsible for the antibiotic 
activity of ficellomycin. A plausible mode of action could involve the inhibition of 
DNA synthesis, since the aziridine ring is often an effective alkylating agent, and is a 
key detenninant in the antitumoral activity of structurally related natural products. 5 
Reusser established that both ficellomycin 1 and feldamycin 3 target the DNA 
replication process; they impair serniconservative DNA replication, but not DNA 
8 
repair synthesis in bacteria. Approximately 50% inhibition was observed in the 
presence of 0.5-1 mM of ficellomycin when assayed in vitro against whole bacterial 
E. coli cells. Greater potency (100-200 ýtg/mL concentration) was observed towards 
inhibition in DNA replication in toluenised cells at 100-200 [tg/mL concentration. 
Reusser has suggested that ficellomycin does not inhibit the initial steps of 
replication including the polymerases, but causes the accumulation of a DNA 
population with a mean size of 34 S, formed in the presence of the antibiotic, which 
must be deficient in some function and lack the ability of being integrated into larger 
DNA fragments, and consequently into the whole bacterial chromosome! 
Ficellomycin 1 and feldamycin 3 do not stabilise double-stranded DNA against heat 
denaturation, but increase the melting point of synthetic polydeoxynucleotide 
poly[d(A-T)] by 1-3 'C, which was put forward as evidence for them being weak 
DNA alkylators. No evidence of base pair intercalation was found by UV difference 
spectroscopy or circular dichroism. 8 
15 
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Although it has been widely speculated that the antimicrobial activity of ficellomycin 
is due to its aziridine functionality, 2 this has not been verified (vide supra). In fact, 
some or all of its biological activity may be associated with the free guanidine group 
in its structure. It has been suggested that its "aziridine ring system may be stabilised 
by the neighbouring guanidino group". 2 The potential important role of ficellomycin 
and/or its analogues incorporated as the active ingredients in antibiotic and antifungal 
pharmaceutical compositions has made them, amongst other guanidine-containing 
compounds, the subject of a recently published patent application. 9 
The outermost bacterial cell surface is usually negatively charged overall, rendering 
bacteria susceptible to cationic species, such as protonated guanidines. 9 
Due to their strongly basic character, guanidines are fully protonated at physiological 
pH and this may be the basis for the specificity of these compounds as they provide 
the molecule with cationic and hydrophobic domains which can orient themselves 
via hydrogen bonding and electrostatic van der Waals interactions with the bacterial 
cell wall. " 
1.4. Structure Elucidation 
In the original isolation paper, Argoudelis determined some structural and chemical 
features of ficellomycin through preliminary analytical and chemical studies! The 
formation of a penta-trimethylsilyl derivative subjected to fast atom bombardment 
mass spectroscopy determined that ficellomycin has a molecular formula of 
C13H24N503 (MWt 312); NMR, mass spectrometry and acid and base hydrolysis 
provided evidence for the presence of an L-Valine residue, bound to the rest of the 
16 
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molecule via a peptide bond. The presence of a free amino group was supported by 
the positive response of ficellomycin to ninhydrin. 1 The basic character and 
behaviour of ficellomycin, along with a positive Sakaguchi test revealed the presence 
of a primary guanidino group. 
In 1989, Kuo determined the identity of the heterocyclic core of ficellomycin and its 
substitution pattern, through NMR studies. 2 Moreover, treatment with MeOH/HCI 
produced a methyl ester, which revealed the presence of a carboxylic acid, which 
was not identified in the original paper. This acid group completed the count for 
exchangeable protons observed in the 1H NMR spectrum. 
'H-1H COSY identified the L-valine and an additional 8 hydrogen spin system. The 
observation of a characteristic methylene group with characteristic small geminal 
coupling constants (2.1 Hz) and vicinal coupling constants (5.3 and 3.5 Hz) 
suggested the presence of an aziridine ring (Figure 3). Two additional methylene 
hydrogens with large gerninal coupling constants (13.4 Hz) was indicative of a six- 
membered ring. The location of the guanidine and the dipeptide substituents at C-3 
and C-5 was readily achieved, the bicyclic structure of the core being confirmed by 
use of a long range 'H- 13C correlation (COLOC) spectrum. The complete structure 
proposed by Kuo was valyl-2-[4-guanidyl-l-azabicyclo[3.1.0]hexane-2-yl]glycine 1. 
HH 
3H 
H6N NH2 
HN C02H 0 
>=NH 
H2N 
Selected 1H NMR homonuclear coupling 
constants (300 MHz, D20) 
Jge,,, (7. -7e , q) 
2.1 Hz 
J, ic (6-7, q) 5.5 Hz 
J, i. (6-7.,, ) 3.5 Hz 
Jg,,,, (4.4, q) 13.4 Hz 
Figure 3 
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Although Kuo provided details of the homonuclear coupling constants, no further 
support was provided for the formulated stereochernical assignment. For example, 
no nOe difference studies were reported. These were subsequently performed by 
Armstrong, who revised the stereochernistry and assigned the I- 
azabicyclo[3.1.0]hexane conformation to a boat 6 (Figure 4). 3 Crucially, nOe 
enhancements were seen between H-7, H-4 and H-2. These results indicate that the 
dipeptide substituent, the aziridine and the guanidine group are all on the same face 
of the molecule. Furthermore, H-3 and H-5 showed reciprocal nOe enhancements, 
demonstrating they are syn to one another. No nOe enhancements were observed 
between H-7., and H-5. 
H 
N., 2H H2N) H. H 
7 
Co 2" 
03 
HN 
HNzzýN 56 
-l' 
NH2 5 
HH HO2C N irNH2 
0 
N- H N 
H2N 6 
Figure 4 
Additionally, Armstrong supported his findings using the work of Shustov et al., who 
had studied the solution conformations of I-azabicyclo- and diazabicyclo- 
[3.1.0]hexanes. 11 These studies had established that such systems prefer a boat 
conformation unless geminal substituents are introduced simultaneously at C-6 or C- 
3. This manifests itself in upfield chemical shifts of the C-3 and C-6 signals in the 
13 C NMR spectrum due to steric compression. Indeed, these signals occur at 27.9 
and 22.3 ppm in ficellomycin, whereas they might be expected at > 30 and > 40 ppm, 
respectively, in the corresponding chair form. 
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Hence, Armstrong proposed structure 5 as shown in Figure 4 with the absolute 
stereochernistry as displayed. However, he stated, it could also be its diastereomer 6 
(Figure 3). The stereochemistry of the amino centre at C-2 is not known, Armstrong 
suggested that it is most likely the S-configuration as illustrated if it is assumed to 
derive biogenetically from the L-amino acid. 
1.5. Chemical Stability of Ficellomycin 
During the isolation of ficellomycin, it was determined that the natural product 
displayed its antibiotic activity in a narrow pH range (8-10) within which it is stable. 
At pH < 8, a new fonn of the natural product was produced, designated "inactive 
ficellomycin" by Argoudelis, which did not display biological activity. Further 
analysis determined that it has the same molecular formula, indicating an 
"intramolecular change"! Armstrong, subsequently proposed that "inactive 
ficellomycin" 7 arises from ficellomycin 5 by intramolecular nucleophilic opening of 
the aziridine ring by the guanidine (Scheme 1). 
HH 
N C02H N C02H 
H2N H2 N 
0 E) pH <80 N4- H No HN -N-H 
HN rN 
HN H 
NH 
H2N_) 
7 
Scheme 1 
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1.6. Structurally Related Natural Products 
1.6.1 Other Aziridine Containing Systems 
The most closely related natural products to ficellomycin are those isolated from 
Streptomyces griseofuscus, namely azinomycins A (8) and B (9) (Azinomycin B, 
also known as carzinophilin, has also been isolated from Streptomyces sahachiroi), 
respectively (Figure 5). 12,13 
These compounds contain an unsaturated 1-azabicyclo[3.1.0]hexane-2-ylidene core. 
They are active against Gram positive and negative bacteria, and inactive against 
yeast and fungi. These natural products have anticancer properties, with azinomycin 
A8 being more cytotoxic in in vitro tests against the L5178Y turnour cell line (IC5o = 
0.07 gg/mL for 8; 0.11 gg/mL for 9)12 and azinomycin B9 being more potent in vivo 
against P388 leukemia, B-16 melanoma, and Ehrlich carcinoma. 14 Work performed 
by Shipman and co-workers on structurally related synthetic compounds have 
highlighted the role of the epoxide and the aziridine in the antiturnoural activities of 
these natural products through inter-strand crosslinking of DNA. 15 This proceeds 
most likely via a two step process by alkylation of the adenosine (N-7) by the 
aziridine (C- 10) followed by alkylation of the guanine (N-7) by the epoxide (C-2 1). 16 
Like ficellomycin 5, the azinomycins are stable at alkaline pH 6-9 but acid labile and 
biologically inactive when the pH is lowered to 5.12,13 
8 
Figure 5 
HO 
0N 
N 
0 
HI 
0 )y 
0H0 
I 
AcO-1, N 
Me 
HO 
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Other natural products containing aziridine rings or precursors and to aziridinium 
cations, are also known to impair DNA replication. These include mitomycin C 10,17 
Antibiotic 593A 11,18 Streptolutin 1219 and Nitrogen mustards e. g. 13 20 (Figure 6). 
H21j 
cl 
0 
NH2 0 
HO-ý 
e 
0 12 0 10 0 
ý, 7"4-ýNH 
H2N 
. 
0me N cl M, H 
Me#N NH 0 Me-N 
10 11 13 
I-Nb 
Figure 6 
Mitomycin C 10, after bioreduction, forms inter-strand cross-links between C-1 and 
C-10 with Guanine residues on the opposite DNA strands. 17 
Antibiotic 593 A 11 displays a high antibiotic and antineoplastic activity. 18 This 
natural product, isolated from Streptomyces griseoluteus as the hydrochloride salt, 
closely resembles the structure of the synthetic nitrogen mustards, such as N-methyl- 
bis-(2-chloroethyl)amine (mechlorethamine) (13)21 and accordingly, a similar mode 
of action has been proposed. 19 
Based on the studies on the behaviour of I -azabicyclo[3.1.0]hexane 2 in the presence 
of acids, 22 Armstrong suggested that antibiotic 593 A 11 may in fact be an 1- 
azabicyclo[3. I. O]hexane 2 in its natural form with the isolation of 11 being an artifact 
of the isolation procedure which involved treatment with hydrochloric acid. Even if 
11 is the true form for the natural product, the I-azabicyclo[3.1.0]hexane 2 may be 
the biologically relevant DNA-alkylating species in cellS. 23 
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1.6.2 Guanidine Containing Natural Products 
Although not the main topic of this thesis, it is appropriate to briefly discuss the 
biological importance of the guanidine functional group in medicinally important 
natural and synthetic compounds. 
There are many examples of natural products that contain a free guanidine group. 
Extensive reviews have been compiled by Berlinck and Hannon et al. 24 
Examples include Eulicin 14,25 isolated from a Streptomyces strain, which is a potent 
antibiotic against a broad spectrum of Gram-positive and negative bacteria and a 
dose dependent HIV infection inhibitor; 26 Segetalin H 15,27 isolated from a member 
of the Caryophyllaceae plant family which has an estrogen-like activity. GE20372 
factor A 16 '28 isolated from Streptomyces sp. 
ATCC 55925, is a new HIV-1 protease 
inhibitor; and Nazurnamide A 17,29 obtained from the sponge Theonella sp. which 
interacts with human thrombin. The most potent inhibitor of the influenza virus, 
sialidase inhibitor (GG167) 18 is a guanidine containing compound (Figure 7). 30 In 
addition, several mono- and bis-guanidine salts, have been recently disclosed as an 
effective water treatment to control protozoa and protozoan cysts that host Legionella 
pneumophila, a bacterium that causes Legionnaire's disease, and which may be 
responsible for its growth. 31 
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One of the most commonly used guanidine containing drugs is chlorhexidine 19, an 
antiseptic with both bacteriostatic and bacteriocidal activity against gram positive 
and negative bacteria, viruses, bacterial spores and fungi. 32 It is frequently 
incorporated as the active ingredient in mouth wash. 33 
Other therapeutic applications of substituted guanidine containing compounds 
include antihypertensives, cardiotonics, H2 antagonist/agonists and anti-turnour 
agents. 34 
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1.7. Synthesis of 1-azabicyclo[3.1.0]hexanes 
Although ficellomycin 5 and the azinomycins 8,9 are the only natural products 
containing I-azabicyclo[3.1.0]hexane 2 ring systems, this heterocyclic system has 
been known for over fifty years and various synthetic routes have been devised for 
its assembly (Scheme 2). They will be briefly surveyed herein, according to the 
general strategies depicted in Scheme 2. 
Ring contraction 
(*ýNH 
(LG 
H 
LG 
Formation from preformed pyrrolidine 
Scheme 2 
1.7.1. Formation by Ring Contraction 
Simultaneous formation of both rings 
CN 
(LG 
; NH 
Pyrrolidine ring forination 
The I-azabicyclo[3.1.0]hexane system was first reported, although not isolated, by 
Fuson in 1948 . 
35 It was proposed that the alkali-mediated rearrangement of I-ethyl- 
2-chloromethylpyrrolidine hydrochloride 20 to I-ethyl-3-chloropiperidine 21 
proceeded via a bicyclic intermediate 22 (Scheme 3). 
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cl 
cl H 
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Et Et cl Et 
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Scheme 3 
Related bicycles were subsequently isolated as crystalline perchlorate salts 23 in the 
synthesis of a fl-benzomorphan after treating an epimeric mixture of 
tetrahydropyridine dibromide 24 with sodium bicarbonate. It was proposed that the 
ring contraction took place through backside displacement of the bromine at C-3 by 
the tertiary amine (Scheme 4). 36 
Me 
I C104 
I 
Ph 
N- HBr NaHC03 --N- HC104 
Ph__; 
Br 
Br Br Ph 'Br 
Br 
24 23 
Scheme 4 
Gassman performed a similar ring contraction of a piperidine to the parent 1- 
azabicyclo[3.1.0]hexane 2. This was achieved by conversion of 3-hydroxypiperidine 
25, to its sulfuric acid ester 26 by treatment with sulfuric acid. 37 Treatment of this 
ester with sodium hydroxide and subsequent steam distillation afforded (5S)- 
azabicyclo[3.1.0]hexane 27 in low yield. The alternative ring closure from a 
preformed pyrrolidine was therefore explored. Using the same methodology, L- 
25 
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prolinol 28 was converted to I-azabicyclo[3.1.0]hexane 27 in an improved 54% yield 
(Scheme 5). 
- 
OH OSO3- 
H2So4 NaOH 
NN 
10% 
HHH 
25 26 
H 
27 
4J-ýý OH H2S04 
Co ýI.. 
/ 
OSC)i NaOH 
NN 
HSO 75% t% 54% li 'H 4HH 
28 
Scheme 5 
The reactivity of bicycle 27 was examined by these authors. It was observed that 27 
was stable for several months stored at 5 OC over potassium hydroxide, while 
treatment with methyl iodide afforded a violent reaction which resulted in the 
formation of an opaque white solid. Reduction of 27 with H2/Pd-C afforded two 
products formed in a 2: 1 ratio, namely, 2-methylpyrrolidine (29) and piperidine (30) 
(Scheme 6). 37 
H2 (3.4 atm) 
N Pd/C IP HNO 
+ 
ft 
27 29 30 
2: 1 
Scheme 6 
In 1972, Hammer et al. reported mechanistic studies on the rearrangement reactions 
of I-alkyl-3-chloro piperidines 31 . 
38 These workers provided synthetic, kinetic and 
stereochernical evidence that suggested that their rearrangement proceeded via a two- 
step process involving neighbouring group participation in which the bicyclic 
26 
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aziridiniurn ion intermediate 22 was formed. The first and rate-determining step 
involved displacement of chloride by nitrogen in what was designated as an "internal 
backside nucleophilic substitution" (SNib) mechanism. The second step involved 
nucleophilic attack on the intermediate by chloride ion, via an SN2 displacement to 
give the observed pyrrolidine 32 and piperidine 21 products (Scheme 7). 38 
cl base 
cl 
N N 
II - HCI Et Et 
31 
cl 
77'-ý 
ICA 
ED ý Cl Et 
22 
Scheme 7 
+ 
cl 
N 
I Et 
21 
1.7.2. Formation from preformed pyrrolidine 
Intrarnolecular haloarnination of pentenylarnine derivatives was used by Homing et 
al. in 1974, to assemble I-azabicyclo[3.1.0]hexanes. 39 A series of 2,2-diphenyl-4- 
pentenylamines 33 were reacted with bromine to afford pyrrolidinium salts 34 that 
upon treatment with sodium hydride in DMF resulted in the formation of I- 
azabicyclo[3.1.0]hexane derivatives 35. These products could be further converted to 
the corresponding piperidinium salts 36 on treatment with anhydrous hydrogen 
bromide. Regeneration of 35 from 36 could be accomplished by treatment with 
39 sodium hydride (Scheme 8). 
Cýý cl N I Et 
32 
27 
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33 L 34 -1 Ph Ph 
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RI -- NH 
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Br--I HBr 
36 
Scheme 8 
The formation of 1-azabicyclo[3.1.0]hexanes from aldonitrones and ylids has been 
reported by Breuer el al. 40 Reactions of pyrrolidone N-oxide 37 and diethyl 
cyanomethylphosphonate and dialkyl alkoxycarbonylphosphonates 38 using sodium 
hydride in 1,2-dimethoxyethane favoured aziridine formation (Scheme 9). Enamine 
39 formed preferentially using metal alkoxides in protic solvents. Since aziridine 40 
and enamine 39 do not interconvert under the reaction conditions, the authors 
suggested two different mechanistic pathways (Scheme 9) 
aprolic 7?, -r 
solvent N 
C02Et 
(%k-, 
H -A b is 0-; Eý-M N 
(D, N(ý 37 0 ý, 
EtO to H 
Et02C 
Hey 40 
rC02Et 
EtO- 
,P Cj' b 
B H 4N 
C02Et C02Et 
4 ýý 
Et protic N E) 
38 solvent 0-; Pý'O& 
EtO OH 11 
--ýNýýC02Et 
H 
39 
Scheme 9 
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1.7.3. Formation from preformed aziridine 
The synthesis of I-azabicyclo[3.1.0]hexanes through cyclisation of preformed 
aziridines was first reported by Laurent and co-workers, who studied the 
hydroboration of ethylenic aziridines. 41 Addition of allyl magnesium bromide to 41, 
followed by hydroboration furnished aziridino alcohol 42. Upon addition of 
triphenylphosphine and bromine, the alcohol was transformed to the corresponding 
bromide which spontaneously cyclised to I-azabicyclo[3.1.0]hexane 43 (Scheme 
10). 42 
Ph e _, 
MgBr 
Ph- 
Me 
me 
88% N Me 
H 
41 
B2H6 then 
H202/NaOH 
62% 
. 
Ph PPh3, Br2 HO'-(ý 3 
me Et3N, CH Ph 
Me 3CN 
Me 64% N Me 
H 
43 42 
Scheme 10 
More recently, Yudin has examined an oxidative cycloamination reaction of olefins 
tethered to aziridines for the construction of substituted pyrrolidines and piperidines. 
Aziridine precursors are converted into I-azabicyclo[3.1.0]hexanes and I- 
azabicyclo[4.1.0]heptanes upon treatment with N-bromosuccinimide in 
DME/water. 43 Precursor 44 containing a terminal double bond preferentially formed 
45 whereas aryl-substituted substrate 46 favoured 47 (Scheme 11). Bicycle 45 can 
be converted into exo-methylene bicyclic aziridines 48 through dehydrobromination 
in quantitative yields, and 47 can be converted into 49 under hydrazinolysis 
conditions. 
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1.7.4. Simultaneous Formation of Both Rings 
The simultaneous formation of both rings of I-azabicyclo[3.1.0]hexanes was first 
reported by Logothetis, in 1965, in a study of the thermal decomposition of olefinic 
azides in refluxing hydrocarbon solvents. 44 Using 5, c-unsaturated azide 50, 
intramolecular addition to the double bond takes place in a [3+2]-cycloaddition, to 
afford a stable triazoline 51. Further opening to a diazonium. intermediate 52, and 
subsequent loss of molecular nitrogen gives a mixture of bicycle 53 and cyclic imine 
54 (Scheme 12). 
'Hex, 80 TN slow step < 
(Dý N Nj 8 h, 80% 
50 51 52 
+ 
N 
54 53 
2.2 :I 
Scheme 12 
J-- 
- 
N2 
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In 1987, Schultz and co-workers reported related intramolecular azide-olefin 
cycloadditions. 45 Thermolysis of azido diene 55, formed through 
photorearrangement of 2,4-cyclohexadienone 56 via ketene 57, in refluxing xylenes 
yielded vinyl aziridine 58 as a mixture of diastereomers (Scheme 13). 
0 C02Me -10 
N3 
hv 
(365 wn) C02Me 
N3 
56 L 57 
1 
MeOH 
98%, 2: 1 
Hrl N3 
N 
CO2Me Me02C 
N 
140 'C 
79% C02Me H 
CO2Me 
58 55 
Scheme 13 
Hudlicky et al. determined that when stereocentres were present on the linking tether 
of the azido diene 59, high levels of diastereocontrol can be achieved using bulky 
ether substituents in the formation of the vinyl I-azabicyclo[3.1.0]hexane products 
60 and 61 (Scheme 14). 46 
H RO H 
e , ýý]H 
HN RO N E) 
RO N-N-: N PhMe H 
'ýIll 
H, 
I ý\' 110 OC II C02Me 60 C02Me 61 C02Me 
59a R=H 64: 36 (50%) 
59b R= TDS 100: 00 (70%) 
Scheme 14 
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A related strategy for the syntheses of pyrrolizidines and indolizidines was used by 
Pearson et al., which involved intramolecular cycloaddition of azides onto electron- 
rich 1,3-dienes. 47 The presence of an electron-donating sulfur, selenium or oxygen 
containing substituent on diene 62 led to 5-endo-trig cyclisation to 63, rather than 
formation of I -azabicyclo[3.1.0]hexane species 64 (Scheme 15). 
X: 
CNT 
r. d. s. 63 CNr 
N3 
62 :X 
X= SH, SeH, OH 
CHN 
64 
Scheme 15 
1.7.5. Formation of the 1-AzabicycIo-[3.1.0]hex-2-ylidine skeleton of the 
Azinomycins 
Synthetic routes to these natural products are discussed in this section. In these 
compounds, the exocyclic double bond presents an additional synthetic challenge, 
hence the chemistry is discussed separately from the general strategies described 
above. 
1.7.5. a. Formation from preformed aziridine 
The heterocyclic core of azinomycin A8 was achieved by Armstrong et al. in 1996 
48 using a cyclisation that formed the pyrrolidine ring. This convergent synthesis 
involved the reaction of protected aziridine-aldehyde 65 derived from D-arabinose, 
and a suitably substituted glycine phosphonate, to produce alkene 66 by means of a 
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Homer-Wadsworth-Emmons olefination. Further bromination of the double bond of 
66 afforded 67, which upon deprotection of the aziridine underwent addition- 
elimination to yield bicycle 68 in 91% yield (Scheme 16). 
PMBOO-, 
H 
PMBOO 
NmmTr 
65 
0 
PhOCHIN 
(0 E 
PMBO.,, N N 
PMBO 68 
PhOCHN 
PMBO. " H 
iii-iv 
it 
IMBO"'ý4 mmTr 
0 
PhOCHN 
OEt 
0', 
11 
: IMBO.,, 
13ý Br 
12 
NmmTr 
? MBO 
67 
Scheme 16. Reagents and conditions: i) PhCONHCH(PO(OEt)2)CO2Et, LDA, THF -78 T, 
70% (3.7: 1 Z: E); ii) NBS, CHC13,76%; iii) CC13CO2H, CD3CN, RT; iv) Et3N, 50 T, 16 h, 
91%. 
The monomethoxytrityl protecting group (mmTr) in the aziridine proved essential. 
Different protecting groups for the C-12/C-13 alcohols (azinomycin numbering) 
were evaluated, although replacement of p-methoxybenzyl groups for triethylsilyl 
ethers was not fruitful. 49 
Subsequently, Coleman et al. achieved the first asymmetric total synthesis of 
50 Azinomycin A8 using a similar synthetic approach but different protecting groups. 
In this approach, they installed the required acetate at C-13 in aldehyde 69 prior to 
olefination and cyclisation. This greatly reduced the number of protecting group 
manipulations once bicycle 70 was assembled. The proximity of the C-13 acetate 
proved problematic during olefination, resulting in low 40% yield for the required E 
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isomer 71 but this was offset by the simplicity of the route and reduction in the 
number of steps. The aziridine was protected as a benzyl carbamate, which could be 
deprotected by a palladium-catalyzed, silane-mediated process to afford the free 
aziridine. Further displacement of the bromide in the presence of Dowex anion 
exchange resin (C03 2- form) afforded the I-azabicyclo[3.1.0]hex-2-ylidene core 70. 
The stability of 70 to basic conditions was exploited to cleave the C-12 triethylsilyl 
ether as the last step of the synthesis (Scheme 17). 
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Scheme 17. Reagents and conditions: RHC(PO(OMe)2)CONliR', KO'Bu, CH202 or THF, 
75%; H) excess NBS, DABCO, CH2C12 then 'BuOK, CH202,40%; iii) PdC12, Et3SiH, 
2- CH2CI2,50%; iv) Dowex (C03 ), CH2CI29 64%; v)"Bu4NF/fIF, 95%. 
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1.7.5. b. Formation from a preformed pyrrolidine 
Terashima et al. have adopted an approach whereby the bicycle is assembled from a 
preformed pyrrolidine ring in their route to fully protected azinomycin B 9.51 
Thiolactarn 72 is accessible from 2,3,5-tri-o-benzyl-fl-D-arabinofuranose (73) in 
several steps. This thiolactarn was then S-methylated and reacted with 2-Ph-A2-5- 
oxazolinone to furnish 74 in 89% yield over 2 steps. Cleavage of the silyl ether, and 
conversion of the resulting alcohol to a mesylate gave 75. Several steps were 
required to produce a precursor 76 for the cyclisation to the 1- 
azabicyclo[3.1.0]hexane. After deprotection of the N-alloc group, treatment with 
TBAF induced intramolecular displacement of the mesylate, to form I- 
azabicyclo[3.1.0]hex-2-ylidene 77 in 73% yield (Scheme 18). 
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Scheme 18. Reagents and conditions: i) Mel, CH2Cl2 then 2-Ph_A2 -5-oxazolinone, toluene, 80 *C, 81% over two steps; ii) TBAF, THF then iii) MsCl, Et3N, CH2CI2,89% over two 
steps; iv) Pd(Ph3P)4, dimedone, THF, 97%; v) TBAF, 4A MS, THF, 73%. 
35 
Chapter One: Introduction Maria Garcia. 
This type of cyclisation has proven rather versatile and has been adopted by other 
groups, 52 including our own. 15,53 
1.7.6. Formation of the 1-azabicyclo[3.1.0]hexane of ficellomycin 
In this section, the synthetic efforts performed by our and other groups towards the 
natural product are detailed. 
1.7.6. a. Formation from preformed aziridine 
The first recorded approach to the total synthesis of ficellomycin 5 was performed by 
Dr Zuchun Zhao, in his PhD thesis, supervised by R. W. Armstrong, whose work on 
3 the azinomycins 8 has already been discussed (vide supra). Unsurprisingly, their 
first synthetic approach was based on the nucleophilic addition of an aziridine onto a 
dehydroamino acid. 
The requisite substrate was made from aziridine 2-carboxaldehyde 78, made from L- 
serine ethyl ester 79 via ester 80.54 The monomethoxytrityl (mmTr) group was 
chosen to protect the aziridine nitrogen. Aldehyde 78 was converted to the 
corresponding oxime ether, then treated with allyl magnesium bromide to give amine 
81 as a single diastereomer. Reduction of the N-0 bond in 81 with lithium 
aluminium. hydride and protection of the resulting amine as the trifluoroacetamide 
proceeded in 69% yield over the two steps. Direct ozonolysis of the terminal alkene 
proved problematic, however, treatment of the terminal olefin using OS04/NMO 
followed by cleavage of the resulting diol 82 with lead acetate afforded aldehyde 83 
in 54% over the four steps. 
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Scheme 19. Reagents and conditions: i) SOC12, EtOH, 0 "C-RT, 2h; ii) mmTrCl, Et3N, 
CH202) -78 *C; iii) TsCl, Et3N; iv) Et3N, THF, reflux, 12h; v) LiAIH4, THF, -78 T, 90%; 
vi) Swern oxidation, 95%; vii) MeONH3CI, Et3N, CH202,15 h, 94%; viii) allylMgBr, THF, 
- 78 *C, 10 min, 92%; ix) UA1114, THF, - 78 IC, 14h, 86%; x) CF3CO2Et, Et3N, THF, 13h, 
90%; Xi) OS04, NMO, (CH3)2CO/H20 (1: 1, v/v), 74%; xii) Pb(OAC)4, EtOAc, Et3N, 0 IC, 10 
min, 94%. 
LDA-mediated olefination of 84 with 85 produced dehydroamino acid as a separable 
8: 1 mixture of E-86 with Z-86 in 86% combined yield (Scheme 20) with E-86 being 
the major adduct. Careful cleavage of the amino protecting group from 86 was 
achieved using TCA, with the reaction being quenched by addition of Et3N. 
Attempts to isolate the free aziridine on preparative TLC resulted in cyclisation to a 
mixture of I-azabicyclo[3.1.0]hexanes along with uncyclised aziridine. It was 
proposed that the cyclisation was catalysed by the weak acid in a polar environment. 
Interestingly, the diastereorneric ratio of products was dependent on the acidity of the 
silica used; untreated silica afforded a 1: 1 ratio, whereas pre-treated with Et3N, 
afforded a 3: 1 ratio. 
FmocHN 
H 
NHFmoc 
mmTrN 
N C02Et 
CO Et 
zo 
2+ CHO 0 "YýAýPO(OE02 
TFAHf4 
NmmTr 
TFAHN 
84 85 Z-86 and E-86 
Scheme 20. Reagents and conditions: i) LDA, THF, -78 *C to -10 *C, 86% (E: Z; 8: 1) 
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Cyclisation of Z-86 and separation by preparative TLC yielded three of the expected 
four aziridine diastereomers (Scheme 21). Only one diastereomer 87a or 87b, with 
an all syn-stereochemical relationship was isolated in a 23% yield, its syn- 
configuration being determined by nOe difference studies. Both diastereomers with 
an anti-relationship between C-3 and C-5,88a and 88b, epimeric at the (x-position, 
were isolated as an inseparable 1: 1 mixture in 24% yield. 
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Scheme 21. Reagents and conditions: i) TCA, CH2CI2, then Et3N, Si02- 
When E-86 was subjected to the cyclisation conditions, 87a and 87b differing in C-2 
stereochemistry, were isolated in 14 and 9% yield, respectively, while 88a and 88b 
were obtained as an inseparable 1: 1 mixture in 24% yield (Scheme 21). The authors 
predicted that introducing a bulkier group than TFA as the amino protecting group at 
C-5 might help favour the formation of the desired syn-diastereomers. While the 
stereochernistry at C-3 is dictated by the preferred confonnation during the transition 
state for cyclisation, that of C-2 is determined by the approach of a proton either 
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from an external source or alternatively, intramolecular syn-protonation from 
produced aziridinium ion resulting from conjugate addition. 
Work in our group has focused on the synthesis of the I-azabicyclo[3.1.0]hexane 
core of ficellomycin via a triphenylphosphine promoted double cyclisation of an 
55 
azido alcohol. In this route, the bicycle is assembled in one step from acyclic 
precursors by the cyclisation of an aziridine, generated in situ, onto a suitably 
substituted dehydroamino acid derivative, the aziridine being produced through the 
well-known Staudinger reaction of an azido alcohol with triphenylphosphine. 56 At 
the time the authors began their studies they were unaware of the work of Armstrong 
and Zhao. 3 
To test the viability of this approach, a model system was devised devoid of the C-5 
5 amino substituent and the L-valine residue. Diene 89 was assembled through 
olefination of 4-pentenal 90 with a commercially available phosphonate 91. On a 
large scale, this phosphonate can be conveniently synthesised according to the 
57,58 procedures of Ben-Ishai and Schmidt (Scheme 22). The formation of diene 89 
was accomplished using a two step procedure from 4-penten-l-ol 92 by oxidation 
with PCC and further reaction with phosphonate 91 and DBN. Only one geometrical 
isomer was isolated, which was determined by nOe analysis of 93 to be the expected 
Z-isomer 89.58 
Stereo- and regioselective epoxidation of the terminal olefin of 89 with 3- 
chloroperoxybenzoic acid afforded exclusively terminal epoxide 93.59 Ring opening 
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of 93 with sodium azide and ammonium chloride in a regioselective manner 
provided the required 1,2-azido alcohol precursor 94. 
i Eý 92 R= HOCH2 
+ 
90 R= CHO 00 
00 IN HCbz MeO 
NHCbz MeO 
MCbz 
NHCbz ii b- 
MeO IV 
MeO -ly 
(MeO)20P 
N3 1 
91 89 93 94 H 
Scheme 22. Reagents and conditions: i) PCC, CH202; ii) DBN, CH2CI2,79% over two 
steps; iii) 3-chloroperoxybenzoic acid, CH2CI2.88%; iv) NaN3, N114CI, EtOH, 3 d, 65%. 
The key cyclisation reaction was perfonned under several conditions, the best 
conditions involved heating 94 in the presence of triphenylphosphine (1.4 
equivalents) in acetonitrile at 70 'C (Scheme 23). Repeated column chromatography 
was required to remove the triphenylphosphine oxide by-product, which eluted at 
nearly the same Rf as one of the aziridine components. In this way, 95a and 95b, 
epimers at C-2, were isolated as an inseparable mixture in 30% yield. Integration of 
the signals in the 1H NMR spectrum revealed that they were formed in a 1: 1.2 ratio. 
NOe experiments indicated that these compounds had an anti relationship between 
the aziridine ring and C-3, resembling the stereochernistry proposed by Kuo for 
ficellomycin, i. e. 1. 
0H C02Me 0 
)QNHCbz HINHCbz NHCbz 
MeO 
+ 94 + MeO 
NN 
dN 
Z2ý 
m 
95a 95b 95c 
Scheme 23. Reagents and conditions: i) PPh3, CH3CN, 3 5%. 
Further elution provided a more polar diastereomer 95c isolated in just 5% yield. 
The 1H NMR was rather broad, but nOe studies indicated a syn relationship between 
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the aziridine ring and the C-3 centre. This stereochernistry is consistent with 
Armstrong's structural proposal for ficellomycin, i. e. 5. A further fraction was 
isolated from the column, displaying the right molecular mass (mlz = 305). It was 
postulated that this might be the epimer of 95c at the C-2 position, although due to an 
inexplicable broadness of the 1H NMR signals, this compound was not properly 
characterised. 
Two possible mechanisms were proposed to account for the double cyclisation 
(Scheme 24). Imino phosphorane 96, formed by nucleophilic attack of 
triphenylphosphine on the azide, might add onto the dehydroarnino acid to form 
piperidine 97. Subsequent migration of the triphenylphosphine group to oxygen, ring 
contraction and release of triphenylphosphine oxide would lead to 95a-95c (Scheme 
24). Another perhaps more likely possibility is that aziridine 98 is produced in situ, 
and this then adds to the double bond to produce the same products. 
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Hence, a rapid method for the assembly of the 1-azabicyclo[3.1.0]hexanes was 
developed, with the modest combined yield (35%) for the cyclisation products being 
offset by the brevity and convenience of the approach. In addition, since the absolute 
stereochernistry at C-2 and C-3 of the natural product is unknown, access to all 
possible diastereorners was viewed as a possible advantage, at least in the first 
instance. 
Efforts to extend this approach to "ficcllomycin-like" structures was investigated, by 
introducing the second amino acid residue and the amino substituent at C-S. 
Phosphonate 99 was synthesised in a 5-step sequence in 26% overall yield using a 
Rh2(OAC)4 catalysed condensation6o of amide 100 with diazo phosphonate 101.55 
The two key building blocks for this coupling were assembled in the following way. 
Commercially available (S)-valine methyl ester 102 was N-protected with as a 
trimethylsilyloxycarbarnate (Teoc) to give 103.61 Saponification of this ester with 
potassium hydroxide gave 104 which was transformed into amide 100 via the mixed 
anhydride (Scheme 25). 
62 
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Scheme 25. Reagents and conditions: i) Teoc-OSuc, 1,4-dioxane, H20, Et3N, 89%; ii) 2M 
KOH, THF, 100%; iii) EtOCOCI, NH3 aq., Et3N, THF, 57%; Teoc = -CO(CH2)2Si(CH3)3- 
Diazo phosphonate 101 was made in two steps from commercially available starting 
materials. Protection of (diethoxyphosphono)acetic acid (105) as its 
trimethylsilylethyl ester gave 106, which was treated with the diazo transfer agent I- 
acetamido-4-benzenesulfonyl azide in the presence of cesium carbonate to give 101 
in 83% yield over the two steps (Scheme 26). 63 
00 
Ho TMSEO 
1ý 
(EtO)20P (EtO)20P 
105 
0 
TMSEOlLyN2 
(EtO)20P 
106 101 
Scheme 26. Reagents and conditions: i) DCC, DMAP cat., 2-trimethylsilylethanol, THF, 
90%; H) CS2C032 I -acetamido-4-benzenesulfonyl azide, THF, 92%. 
Coupling of 100 and 101 was performed by refluxing 100 and 101 together with 
rhodium(II) acetate in toluene for 48 hours. 62 Phosphonate 99 was isolated after 
column chromatography as a single diastereomer in 55% yield (Scheme 27). 
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Scheme 27. Reagents and conditions: i) Rh2[OCOCH3]4, PhCH3. I 10 "C, 48h, 5 5%. 
Olefination of 99 with benzaldehyde was undertaken using DBN (Scheme 28). The 
NMR spectrum in the presence of (R)-(-)-2,2,2-trifluoro-1-(9-anthryl)ethanoI of the 
resulting Z-olefin 107 was compared against that obtained using (±)_99.64 This 
established that no racernisation had occurred during the synthesis of (S)-107 (ee 
>90%). 
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Scheme 28. Reagents and conditions: D CACHO, DBN, CH2CI2.5 *C-RT, 16 h, 88%. 
To explore the impact of the C-5 amino substituent on the double cyclisation, 
aldehyde 108 was synthesised via 4-vinyl-azetidin-2-one (109), following a 
procedure described by Goebel et al . 
65 The P-lactarn 109 was made by cycloaddition 
between 1,3-butadiene (110) and chlorosulfonyl isocyanate (111). 109 was ring 
opened with acidic ethanol, 66 and the resulting amine 112 protected as its p- 
toluenesulfonamide to give 113. Reduction of 113 to alcohol 114 with lithium 
aluminium hydride followed by Swern oxidation provided aldehyde 108 in a very 
modest 8% yield over the 5 steps. 67 
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Scheme 29. Reagents and conditions: i) Et20,70 h, 16%; ii) HCI (g), EtOH, 100%; iii) TsCl, 
Et3N, 80%; iv) LiAlH4, THF, 86%; v) oxalyl chloride, DMSO, CH2CI2, Et3N, 74%. 
Aldehyde 108 was subjected to the same olefination conditions as those employed 
previously to give analogously, Z-alkene 115. The epoxidation step was 
problematic, both in terms of conversion and selectivity, and finally, a procedure 
68 described by Yang et al. using methyl(trifluoromethyl)dioxirane was used. A 
mixture 71: 29 of 116a: 116b was obtained in 65% yield. The stereochemistry of the 
major diastereomer was assigned tentatively as that indicated. Regioselective ring 
opening of epoxide 116a with sodium azide provided azido alcohol 117a in 54% 
yield, while minor diasteromer 116b led to just 27% of 117b. Due to constraints in 
the availability of starting material, cyclisation of small amounts of these azido 
alcohols was performed using tributylphosphine to ease isolation and purification of 
the products. Two fractions were obtained, displaying the expected molecular ion 
(mlz= 474) for the double cyclisation product, but unfortunately the rest of the 
analytical data did not provide convincing evidence of product formation. 
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Scheme 30. Reagents and conditions: i) DBN, CH2CI2.0 *C-RT, 57%; H) CF3COCH3. 
NaHC03, oxoneg, CH3CN, Na2. EDTA aq., 0 IC, 65%, (116a: 116b; 71: 29); iii) NaN3. 
NH4CI, MeOH, 50 'C, 6 h, (1 17a, 54%; 117b, 27%). 
More recently, Chcn et al. working under the supervision of Professor Andrei K. 
Yudin at the University of Toronto, reported a novel synthetic approach employing 
an oxidative cyclisation of olefin-containing aziridines. 4,69 Two related synthetic 
routes have been devised. 
Hydroxyl directed epoxidation of allylic alcohol 118 gave epoxide 119 in 86% yield 
(Scheme 3 1). Stepwise oxidation to the acid followed by esterification with 
azidotrimethylsilane afforded epoxy ester 120 in 70% over the three steps. The 
aziridine 121 was assembled by ring opening of the epoxide with azide followed by 
Staudinger reaction. Oxidative cycloarnination with N-bromosuccinimide provided 
three bicycles in 85% combined yield. 122 was isolated as a single diastereomer in 
30% yield, along with 123 and 124 (one of them, being epi-122), which were 
obtained as an inseparable mixture in 55% yield. 
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Scheme 31. Reagents and conditions: i) VO(acaC)2, TBHP, DCM, 86%; H) Swern; iii) 
NaC102, NaH2PO4; iv) TMSCHN2, DCM, 70% over three steps; v) NaN3, NH4CI, vi) PPh3, 
CH3CN, 40% over two steps; vii) NBS, DCM, 85%. 
It was proposed that 122, after acid-catalysed aziridine opening with sodium azide 
could provide a 1-azabicyclo[3.1.0]hexane 125 consistent with Kuo's proposal for 
the natural product 1. However, it is unclear how the stereochernistry could be 
preserved at C-5 during the introduction of the guanidine group (Scheme 32). 
H 
TBDPSO TBDPSO W02C. ýN3 H H' (cat), NaN 'H 3C C02Me ------------- NNN 
Br H3 
OTBDPS 
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Scheme 32 
An improved route using a Sharpless asymmetric epoxidation of the terminal olefin 
has also been described. 70 In this approach, 126 was converted into secondary 
alcohol 127, which underwent kinetic resolution under Sharpless asymmetric 
epoxidation to give 128 in 40% yield. Further manipulation gave 129 which was 
again subjected to the oxidative cyclisation protocol. Using N-bromosuccinimide, 
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two diastereorners 130a and 130b were isolated in 57% yield in a diastereorneric 
41: 59 ratio (Scheme 33). 
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Scheme 33. Reagents and conditions: i) PMBCI, Bu4NI, NaH, THF, 92%; ii) TBAF, THF, 
80%; iii) L-(+)-DIPT, Ti(O'Pr)4, TBHP, DCM, -20 IC, 3 days, 45%; iv) PMBCI, Bu4NI, 
NaH, THF, 86%; v) NaN3, NH4CI, MeOH/H20, VO PPh3, CH3CN, 50%; vii) NBS, DCM, 
57%. 
Bromide 130a was treated with sodium azide to give azide 131, which the authors 
intend to advance towards the natural product, bearing the same stereochernistry as 
that proposed by Armstrong. 3 Again, the introduction of the guanidine will require 
two inversions to preserve the stereochernistry at C-5 (Scheme 34). 
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1.7.6. b. Formation from a preformed pyrrolidine 
An approach to ficellomycin from a preformed pyrrolidine has been devised by 
Armstrong and Zhao. 3 It was intended that this route would provide a cyclisation 
precursor where the stereochernistry of all chiral centres would be known. It was 
assembled from aldehyde 132, itself derived from D-xylose (133) in six steps. These 
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involved conversion of 133 to dithioacetal 134, followed by abstraction of the C-1 
hydrogen using 'BuOK and elimination of acetone to furnish 135 .71 Reduction with 
lithium aluminiurn hydride, protection of the free alcohol as a TBS silyl ether, 
followed by selective cleavage of the dithioacetal gave aldehyde 132 in 30% overall 
yield (Scheme 35). 
EtS-ýSEt 
OH OH 0 
H0 ryy 0 
OH OH 0 1)-f-- 
133 134 
iv-vi 0 
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Scheme 35. Reagents and conditions: i) EtSH, HCI; H) (CH3)2CO, H3PO4,75% over 2 steps; 
iii) KO'Bu, DMSO: THF, 1: 3,82%; iv) LiAlH4, THF, 80%; v) TBSCI, Imid., DMF, 92%; vi) 
HgO/HgCI2, (CH3)2CO/H20,66%. 
Treatment of 132 with benzylamine afforded imine 136 which was further reacted 
with homochiral ketene 137 via a [2+2] cycloaddition to produce a mixture of 
azetidinones. Purification by column chromatography provided the required cis 
isomer as the major product 138.72 Dissolving metal reduction cleaved the chiral 
auxiliary, which was re-protected as a tert-butyl carbarnate. Additional simple 
functional group interconversions yielded 139 in 13% overall yield over seven steps 
from aldehyde 132 (Scheme 36). 
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Scheme 36. Reagents and conditions: i) Et20, Na2SO4.0 *C, 2h, quant.; ii) Toluene, 60 *C, 
3h, 41%; iii) Li, NH3, THF: BuOH, 10: 1, -78 *C, 10 min then BOC20, THF/H20,81%; 
TBAF, THF, RT, lh, 95%; iv) MsCl, Et3N, CH202, RT, 30 min, 90%; v) NaN3, DMF, 90- 
100 'C, 13 h, 76%; vi) pTSA, MeOH, RT, 15 h then PTSCI, Imid., DMF, RT, 2h, 70%; vii) 
MsCl. Et3N, CF12CI2, RT, 30 min, 90%. 
Treatment of lactam 139 with hydrochloric acid in methanol induced simultaneous 
tert-butyl carbarnate and silyl ether cleavage, and opening of the azetidinone ring. 
Addition of Et3N induced closure to pyrrolidine in a regiocontrolled manner, which 
was isolated as 140 after further Boc protection. In this manner, all the 
stereochernistry around the pyrrolidine ring was set, along with that at C-2. 
Mesylation of the pendant alcohol followed by cleavage of the tert-butyl carbarnate 
protecting group and base induced cyclisation gave I-azabicyclo[3.1.0]hexane 141 
albeit in a modest 31% yield (Scheme 37). No further advances from 141 to 
ficellomycin have been described. 
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Scheme 37. Reagents and conditions: i) HCI, MeOH, 0 *C, 35 min then Et3N, BOC20, RT, 
Ih, 75%; ii) MsCl, Et3N, CH202, RT, 2h, 95%; iii) HCI, MeOH, then Na2C03,0 *C, 30 min, 
31%. 
1.8. Conclusions 
Ficellomycin is a structurally complex natural product with important antibiotic 
activity. Routes to I-azabicyclo[3.1.0]hexanes are known involving a variety of 
disconnections, some key examples being highlighted herein. Several innovative 
methods have been applied to synthesis of "ficellomycin-like" structures although 
none have yet delivered the natural product. My thesis work has been concerned 
with further developing and extending work already undertaken by Dr David 
Paurnier, with a view to achieving the first total synthesis of this intriguing natural 
product. 
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2.1. Assembly of the 1-azabicyclo-[3.1.01hexane system 
In seeking the most expedient route to ficellomycin, Dr David Paumier, another PhD 
student in the Shipman group, developed a route to a model compound namely 95a-c 
whereby an NH aziridine 98 generated in situ from the corresponding 1,2-azido 
alcohol 94 by a Staudinger-type reaction, undergoes spontaneous closure onto a 
suitably activated double bond in a Michael-type reaction (Scheme 38). 
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Scheme 38 
The route to the 1,2-azido alcohol precursor 94 undertaken by Dr David Paurnier was 
discussed previously (Scheme 22). 
The cyclisation was initially performed, by David Paumier, in the presence of 
triphenylphosphine (1.4 equivalents) in acetonitrile at 70 T. Purification of the 
aziridines 95a-c was hampered by the presence of excess triphenylphosphine and 
triphenylphosphine oxide, which eluted at nearly the same Rf as one of the products. 
A total of three bicycles 95a-c were isolated and characterised. Two of them, 
epimeric at C-2 (dr 1: 1.2) were obtained as an inseparable mixture in 3 0% yield. On 
the basis of nOe difference studies, both of them were tentatively assigned as having 
an anti relationship between the aziridine ring and C-3. 
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Further elution provided a more polar diastereomer in 5% yield, displaying a syn 
relationship between the aziridine ring and the C-3 centre. A further fraction was 
obtained from the column, displaying the correct molecular mass (mlz = 305), but no 
characterisation data for this compound was obtained. 
To overcome the problems encountered with isolation and purification of the 
bicycles generated in the Staudinger-type reaction, David Paumier tested 
tributylphosphine as an alternative. However, no improvement in yield was 
forthcoming. 
At the start of my PhD studies, I was tasked with examining alternative methods for 
achieving this transformation, in an effort to improve this chemistry. 
The resynthesis of azido alcohol 94 was readily achieved in accordance with the 
reported method (Scheme 22). 
Several alternative phosphine sources and purification methods are known. For 
example, triphenylphosphine and triphenylphosphine oxide can be removed through 
addition of a metal salt to form a complex with the oxide. Alternatively, a high- 
loading chloromethylated polystyrene modified in situ with sodium iodide, can be 
used as a scavenger resin. 73 Aqueous work-up to remove water soluble phosphines is 
also an option. However, all these methods require further manipulation of the 
reaction mixture, which we viewed as undesirable because of the potential sensitivity 
of 95.74 
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We attempted using a more polar 4-dimethylaminophenyl diphenylphosphine, but 
this resulted in a rise in impurities and failed to improve yields. Having considered 
the alternatives, we elected to examine the use of a polymer-supported variant of 
triphenylphosphine. The conventional use of synthetic polymers was introduced by 
Merrifield who, in the 1960s was the first to use them as reagents in synthetic 
organic chemistry. 75 The general advantage of solid-phase synthesis is the simplicity 
of work up which usually involves just a simple filtration. 76 
Some disadvantages with supported substrates and reagents are apparent, such as the 
steric bulk of the polymer. 77 The extent of swelling or solvation, porosity and 
mechanical stability of the polymer can also affect the diffusion of reagents into the 
reactive sites. Changes in reactivity in comparison to solution phase reactions are 
frequently encountered, but these may be overcome by suitable modification of the 
reaction conditions. 
Poly-triphenylphosphine (poly-TPP) is commercially available (Fluka) and has been 
used as a precursor to form Wittig reagents in THF and benzene. 78 It has been used 
successfully in Mitsunobu79 and Staudinger/Aza-Wittig8o reactions, and several total 
syntheses have been reported with/on polymer supported reagents/resins. 81 
Encouraged by these reports, we decided to explore the use poly-TPP (ca 3 mmol/g, 
polystyrene cross-linked with 2% divinylbenzene, Fluka) in the cyclisation of azido 
alcohol 94. As far as we are aware, polymer supported phosphines have not been 
previously used for aziridine formation from 1,2-azido alcohols. 
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In the original study, acetonitrile was used as the solvent. However, polyTPP is 
reported to swell poorly in this solvent. 82 Therefore, toluene was selected, as it had 
been used successfully by Dr David Paurnier using TPP. 
Swelling of poly-TPP (I. I. eq. ) was performed by gentle stirring in toluene for 30 
minutes before the start of the reaction. Subsequent addition of 1,2-azido alcohol 94 
and heating for 16 hours at 70 "C provided 95a, b and 142a, b devoid of phosphine 
oxide contamination after filtration and washing with dichloromethane and 
evaporation (Scheme 39). 
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Scheme 39 
Gratifyingly, analysis of the crude reaction mixture by 1H NMR revealed full 
conversion of the starting material to products, indicating efficient reactivity of the 
supported phosphine. However, a relatively low mass recovery was witnessed (ca 
70%), which did not improve after repeated washing of the resin with 
dichloromethane. We cannot account for this low mass recovery, but suggest that 
these relatively small substrates/products may become trapped within resin cavities. 
The distinctive pattern of the aziridine hydrogens was readily discerned in the 1H 
NMR spectrum. Integration of these signals indicated the presence of all four 
possible diastereomers with modest diastereoselectivity (crude dr 
95a: 95b: 142a: 142b = ca 3: 1: 5: 1). These products proved quite stable and could be 
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purified by chromatography on silica gel pre-treated with triethylamine. The 
chromatography was performed on silica (Merck Kieselgel 60 GF254) using a 
moderately polar eluting solvent (20 -> 100% ethyl acetate in petroleum ether, 1% 
triethylamine), which allowed separation of three different components (95a/b, 142a 
and 142b). 
The use of methanol as co-solvent resulted in low yields and poor product purity. 
Although not isolated, the most likely degradation product is that arising from ring 
opening of the aziridine by methanol, which may occur even in triethylamine pre- 
treated silica. No product was collected using neutral alumina as support, and the 
use of a less acidic type of silica (GF254) yielded no separation of the different 
diastereomers and only modest yield of products (68%). 
The anti-diastereomers 95a and 95b, epimeric at C-2, were isolated as an inseparable 
3: 1 mixture in 21% yield, this is in contrast to the 1: 1.2 diastereomeric ratio observed 
when the reaction is performed in solution phase. The more polar syn-diastereomers 
142a and 142b, also epimeric at C-2, were isolated as separate components in 20 and 
4% yields, respectively. 
Overall, the reaction shows a very modest preference for the production of the syn- 
diastereorners (symanti; 1.2: 1). The stereochernical assigrunents of all the products 
was confirmed by nOe studies conducted in benzene. Both anti-diastereomers 95a 
and 95b showed strong reciprocal nOe enhancements (2.8-3.2%) between H-3 and 
H-7,, d,,. In contrast, syn-diastereomers 142a and 142b showed nOe enhancements 
(2.7-3.5%) between H-2 and H-7,, d,. At this point in time, it has not been possible to 
determine the relative stereochernistry at C-2 in either syn- or anti-diastereomers. 
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In collaboration with my CASE supervisor at AstraZeneca, the biological activity of 
95a/b and 142a and 142b was tested against a variety of common pathogens (See 
Appendix Three). However in the screens used, 95a/b and 142a and 142b had no 
biological activity. This may indicate that other portions of the natural product (e. g. 
guanidine, valine residue, free C02H) are important for antibiotic activity. 
Alternatively, the high lipophilicity of these compounds may limit their 
bioavailability. 
Whilst little stereoselectivity was observed in this model system, it does provide 
access to ficellomycin-like molecules in a very concise manner. In fact, the lack of 
stereocontrol may be viewed as an advantage since there is some doubt over the 
stereochernistry at C-3, and the stereochernistry at C-2 is not known (vide supra). 
The use of poly-TPP represents a significant advance over the original method 
developed by Paurnier. The overall yield is improved (45% qf 35%), isolation is 
greatly simplified and all the diastereomers were successfully isolated and 
characterised. 
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At this point in our own studies, we became aware of the work performed by 
Armstrong and Zhao and their revision to the stereochemistry of ficellomycin 5. 
To apply this chemistry to the synthesis of the natural product, the synthesis of an 
1,2-azido alcohol precursor bearing the C-5 amino substituent was needed. 
Significant problems had been encountered by Dr David Paumier attempting to 
achieve this goal (vide supra). 
In view of the poor stereoselectivity witnessed herein, and the difficulties 
encountered by David Paurnier in building/cyclising substrates bearing C-5 amino 
substituents, we decided to abandon this strategy and explore a more stereoselective 
approach to ficellomycin. 
2.2. Towards a C-5 Amino Substituted System 
Since it is highly likely that either 5 or its diastereomer 6 is the correct sterechernistry 
for ficellomycin, it seemed desirable to develop an enantioselective route to the 
lower half of the natural product that would enable access to 5 or 6. Thus, aldehyde 
143 would, after olefination with 99, provide a cyclisation precursor 144 with the 
correct stereochernistry to access 5 (Scheme 40). 
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Analogously, its enantiomer 145 would provide a suitable starting material to access 
6, using the same route. (Scheme 41). 
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In this chapter, we describe our synthetic efforts to develop an enantioselective 
synthesis of aldehydes 143 and 145 and its further manipulation to set the 
stereochemistry and structure needed to complete the natural product. 
In our attempt to design the most expedient route to aldehydes 143 and 145, we were 
drawn to the idea of exploiting the well-known equilibrium between lactols and y- 
hydroxy-aldehydes. 
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Thus, olefination of phosphonate 99 with a suitably substituted lactol 146 would 
yield in one step 1,2-azido alcohol 144, the precursor for the double cyclisation. 
Although the lactol 146 would be more thermodynamically stable than aldehyde 143, 
the olefination of the aldehyde would drive the reaction to completion on the basis of 
Le Chatelier's principle (Scheme 42). 
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The remaining question to be addressed in the synthesis design relates to when to 
introduce the C-5 guanidine moiety. Several strategies can be envisaged of which 
the most practical are: (i) introducing it early in the synthesis in a protected form, 
with mild deprotection late in the synthesis (i. e. after installation of the I -azabicyclo- 
[3.1.0]hexane ring); (ii) introducing the guanidine late in the synthesis from the 
corresponding C-5 protected amine. We opted for the latter option, and decided to 
first establish a synthesis of 144 bearing a protected C-5 amino substituent. 
With respect to olefination of y-lactols, a number of examples are known. Two are 
briefly highlighted herein. Rapoport showed that lactol 147 can be used in 
olefinations employing the Wittig or HWE reagents. 83 For example, under 
Masamune Roush conditions, 84 reaction with methyl diethylphosphonoacetate 
afforded unsaturated ester 148 in 71% yield. The modest yields observed were due 
to intramolecular Michael addition of the alcohol onto the olefin to form 
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tetrahydrofuran 149. This was confirmed by treatment of 148 with sodium hydride, 
which resulted in clean formation of this tetrahydrofuran in 89% yield (Scheme 43). 
OH 
H-, >[jo 
i 
3, 
TsHN'o 
147 
C02Me 
H., 
TsHN 
H 148 
C02Me 
TsHN 
149 
Scheme 43. Reagents and conditions: i) (EtO)2P(O)CH2CO2CH3, LiCl, 'Pr2NEt, CH3CN, 
71%; H) NaH, 89%. 
Several examples of Wittig olefinations of ylides with lactols containing azide 
groups were uncovered (Scheme 44). 85 These encouraged us to think that the 
chemistry outlined in Scheme 42 would be viable. 
OH OH 
0 ll' OH HO w, -, ) 
ýý 
C13H27 
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N3 
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MeO2C 
fý 
N3 
'-OH 
N3 
152 153 
OTBDMS 
Scheme 44. Reagents and conditions: i) n-tetradecylphosphonium bromide (3.2 equiv. ), n- 
BuLi (2.8 equiv. ), THF, cis-151 24.4%; trans-151 6%; ii) Ph3P=CHC02Me, PhH, 90 T, 
60% (1: 1, E: Z). 
This led us to design the route to the lactols using D-mannitol (154) and L-ascorbic 
(155) acid as starting materials. The route begins with the formation of lactones (S)- 
156 and (R)-157 via the D-(R)- and L-(S)-glyceraldehyde acetonide building blocks 
(S)-158 and (R)-159, respectively. 86,87,88 These lactones are commercially available 
albeit at a prohibitive price (Aldrich, L27.20,250 mg and Fluka, E65.60,100 mg, for 
S and R, respectively). Since the absolute stereochernistry of the ring carbons in 
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ficellomycin is unresolved, it was important that access to either enantiomeric series 
could be realised in a predictable way. 
Further manipulation of 156 into lactol substrates for olefination reactions is detailed 
in the following section. 
OH OH 2 steps 
X' 
lý 
HO, 
_, 
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Ome 
OH OH 
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0 
go 
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0 HO--'. ' 0 HO Z000 Ome 
Cl> 
0 
H 
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155 (S)-159 (R)-161 (R)-157 
Scheme 45 
The synthesis of enone (S)-156 is reported to be straightforward. D-Glyceraldehyde 
acetonide (R)-158 can be obtained from D-mannitol (154) in two synthetic steps 
namely, protection of the sugar and oxidative cleavage using sodium periodate 
(Scheme 45). The synthesis of the enantiomer (R)-157 from L-ascorbic acid (155) is 
one step longer, since it requires the hydrogenation of L-ascorbic acid over palladium 
on carbon under high pressure followed by protection and oxidative cleavage to form 
L-glyceraldehyde acetonide (S)-159 . 
87 Other alternative synthetic routes to L- 
glyceraldehyde acetonide include using erythrulose as starting material and 
performing the oxidative cleavage using lead(IV) acetate 89 or sodium periodate. 90 
By use of a sterically hindered protecting group for the primary alcohol in (S)-156, 
we hoped to direct conjugate addition of an amine nucleophile to the Si-face to give 
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162 (Scheme 46). Subsequent reduction of the lactone to the lactol 163 would 
provide the anticipated dynamic equilibrium between the lactol and the desired 
aldehyde 164. An identical approach could be adopted starting from (R)-157. 
HO--NCO\ý_C; 
... 
RO--N 0 
0. 
RO--N o 
OH "" 
PGN 0 
/_ -- - RO 
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162 163 164 
o RO", 0 
RO"-, 0 
c; 10 ;0- 
->O-- 
OH Cl> 
PGN 
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PGN 
(R)-157 165 166 
(where R and PG = protecting group) 
Scheme 46 
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Since the absolute stereochernistry in the natural product is unknown, we decided to 
develop the synthesis from D-mannitol (154) as it is slightly shorter in the first 
instance (vide infra). 
2.3. Stereo controlled Synthesis of Aldehyde and Attempted Olefinations 
The synthesis of enone (S)-156 proved straightforward and it allowed us to obtain 73 
g of D-glyceraldehyde acetonide (R)-158 from 100 g of 154 in one day. However, 
(R)-158 is highly unstable and prone to polymerisation. It is reported that the 
polymer can be cracked and subsequently used, but in our hands we found that 
cracking the polymer was not efficient with only about 60% of aldehyde being 
recovered. 
Thus, D-glyceraldehyde acetonide (R)-158 was freshly made and subjected to the 
olefination reaction immediately after distillation. In this way, aldehyde (R)-158 was 
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prepared in a reproducible 70-73% yield. The olefination was uneventful giving (S)- 
160 as an 8: 1 mixture of isomers in favour of the required (Z)-form. Subsequent 
cyclisation to enone (S)-156 was achieved using Dowex 5OW-X8 according to the 
method developed by Sugisaki et aL (Scheme 47). 88 
OH QH 
X0 
OZ 
HO ýOH 
7H 
OH OH 
0 
154 (R)-158 
HO'N, 0 iv) 
- /=O OMe 
(S)-156 (S)-160 
Scheme 47. Reagents and conditions: 2,2-DMP, 1,2-DME, SnC12. pyr., quant.; n) Na104, 
NaHC03, CH2CI2,0 *C -> RT, 73%; iii) (CH3)3P=CHC02CH3, MeOH, -10 T, 86% (8: 1, 
Z: E); iv) Dowex 5OW-X8. EtOH, RT, 99%. 
Perlmutter had shown that lactone (S)-156, after protection of the primary alcohol as 
a tert-butyldiphenylsilyl ether 168, reacts with benzylamine in methanol, to give 
169.91 They reported that lactone 169 was obtained in a disappointingly 43% yield 
over the 2 steps. 
We re-examined this procedure on a small scale, but a similarly low 39% yield was 
obtained for 169 which was inconvenient at this early stage in the synthesis. Further 
reduction of this lactone to lactol 170 using DIBAL-H in THF at -78 "C proceeded in 
a modest 41% yield (Scheme 48). 
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Scheme 48. Reagents and conditions: i) BnNH2, MeOH, 0 'C; (ii) 'BuPh2SiCl, Imid., DMF, 
48 h, 39% over two steps (lit. yield 43%); iii) DIBAL-H, THF, -78 C, 41%. 
Next, we were drawn to the idea of using a trityl-protected lactone in this 
transformation. This might help block the top face of the enone and add crystallinity 
to the product, aiding product purification. The crystalline trityl-protected lactone 
171 was prepared in 74% yield using a published method. 92 Addition of 
benzylamine to a solution of 171 in methanol at 0 'C did not show consumption of 
starting material even after three days (Scheme 49). Use of 4 equivalents of 
benzylamine and subjecting the mixture to reflux overnight led to a complicated 
mixture of products none of whom, as judged by TLC and 'H-NMR, appeared to be 
172. 
TrON0\. 
= 
Tro-ý 
ý, 0 \0 
00 )c- 
BnHN' 
(S)-156 171 172 
Scheme 49. Reagents and conditions: i) TrCl, Pyr., 70 'C, 96%; ii) BnNH2. MeOH, 0 'C. 
We postulate that there are two possibilities why this reaction failed. The first being 
that benzylamine is too large to add to the conjugated double bond adjacent to a 
highly sterically hindered centre; the second possibility may be that the enone is a 
poor Michael acceptor. This problem might be surmounted by activation of the 
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carbonyl through use of a protic or Lewis acid. Unfortunately, benzylarnine would 
protonate or coordinate to the Lewis acid under these conditions. Hence, we sought 
alternative nitrogen nucleophiles for this transformation. The use of a protic acid 
seemed inappropriate if the trityl group were to be maintained as the alcohol 
protecting group. However, Chu, in the synthesis of anti-HIV nucleosides based on 
3'-azido-3'-deoxythymidine (AZT) '93 had shown that TBDPS-protected lactone 168, 
reacted with sodium azide (10 equiv. ) and acetic acid (30 equiv. ) in THF-water to 
give azido lactone 173 in 71% yield (Scheme 50). In this procedure, the acetic acid 
has a double function: since it has a pK. of approximately 4.5 comparable to that of 
hydrazoic acid (pKa 4.7), it generates hydrazoic acid in situ, in addition it activates 
the carbonyl group of the lactone via protonation. Although Chu reported that the 
reaction proceeded through an anti- 1,4-addition, no further evidence was provided. 
For safety reasons, we modified the procedure slightly, and sodium azide (30 equiv. ) 
was added in small batches to avoid evolution of the hazardous hydrazoic acid in 
high concentrations. To this end, sodium azide was added portionwise over four days 
every twelve hours. The reaction was maintained under a slow flow of nitrogen 
which was purged through a potassium hydroxide scrubber. In this way, azido 
lactone 173 was obtained in 79% yield in crystalline form as a single diastereomer 
after column chromatography (Scheme 50). X-ray crystallography of a single crystal 
of 173 grown from diethyl ether confirmed that anti- 1,4-addition had occurred 
(Figure 9). 
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(S)-156 173 
Scheme 50. Reagents and conditions: i) TBDPSCI, Imid., DMF, 96%; ii) NaN3, CH3CO2H, 
THF: H20 (1: 1.3), 5d, 79% (lit. 71 %). 
Using trityl-protected lactone 171, the corresponding azido lactone 174 was isolated 
in a reduced 52%, presumably due to the acid lability of the trityl group (Scheme 5 1). 
The azide in 173 was reduced to the amine 175 
C14 
C21 by hydrogenation and protected as the 
C20 C22 
benzyloxycarbamate in 88% yield to give 176 
C19 
Cle 
C23 over two steps. Reduction of lactone 176 to 
Cle 
-- 
f 
C26 
cis I 
C16 
i ýC ý17 
N2 
NI 
N3 
C13 
C24 
lactol 177 proceeded smoothly using DIBAL-H 
5.11 (1.5 equiv. ) in THF at - 78 'C. This lactol was 010 C25 CS 
07 
C27 stable and could be purified by column 
C8 
C6 06 chromatography, after which it was isolated in C4 
CS 
89% yield as a 1.5: 1 anomeric mixture. No peaks 
corresponding to the aldehyde tautomer were 
Figure 9 
observed in the 'H-NMR spectrum. 
TrO TrO - -0 
0 
11ý 
-), ýýO Ni 171 174 
Scheme 51. Reagents and conditions: i) NAN3. CH3C02H, THF: H20(1: 1.3), 5d, 52% 
The Cbz protecting group was chosen as it resembles more closely the structure of 
photocleavable protecting groups which we intended to ultimately use in the total 
synthesis. Also, it was possible that the Cbz protecting group could itself be cleaved 
under UV irradiation. 94 
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Scheme 52. Reagents and conditions: i) H2. Pd-C, EtOAc, 90%; ii) CbzCl, Na2CO3. 
THF: H20 (1: 1)) 98%; iii) DIBAL-H, THF, -78 T, 89%. 
Use of a photocleavable protecting group at this amino centre was investigated 
briefly. It was assumed that if the guanidine was introduced late in the synthesis 
after assembly of the bicyclic core, it would be essential to further manipulate the 
system under neutral or slightly basic conditions. It was imagined that a 
photocleavable protecting group might be ideal, as it could be cleaved under very 
mild conditions. 
Therefore, we attempted the introduction of 6-nitroveratryloxycarbonyl (NVoc) 
95 
amino protecting group at the lactone stage 175 (Scheme 53). Standard procedures 
involved treatment of 6-nitroveratryl alcohol (178) with phosgene gas but we opted 
to alternative means such as triphosgene 96 or 1,1'-carbonyl-di-imidazole. 97 
However, these attempts met with failure and 179 was not formed in the reaction. 
This may be due to lower reactivity of these reagents compared to phosgene. Since 
using commercially available nitroveratryl chloroformate would be expensive at this 
stage and the increased sensitivity of intermediates would hinder the development of 
a route to the aldehyde, we decided to revisit this issue at a later time, if required. 
69 
Chapter Two: Results and Discussion Maria Garcia 
Me0 
OH 
Me0 N02 
178 
i 
-142 IN- then 
TBDPSO "*"*. 0 
., %ý 
0 
H2N 175 
TBDPSO"**. " 0 
., %r 
0 
NVocHN' 
179 
Scheme 53. Reagents and conditions: 0 (Cl3CO)2CO or CDI, Et3N, 
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Lactol 177 was subjected to olefination with phosphonate 99, prepared according to 
the method of Paumier and reproduced in similar yields (Scheme 54). 
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Scheme 54. Reagents and conditions: i) Teoc-OSuc, 1,4-dioxane, H20, Et3N; R) 2M KOH, 
THF; iii) EtOCOCI, NH3 aq., Et3N, THF, 58% over the three steps; iv) DCC, DMAP cat., 2- 
trimethylsilylethanol, THF; V)CS2CO3. I-acetamido-4-benzensulfonyl azide, THF, 91% over 
two steps; vi) RhAOCO(CHACH314, PhCH3.110 *C, 48h, 79%. 
The olefinations were conducted under Masamune Roush conditions, 84 and also 
using DBN/DCM, for comparison. Similar results were obtained in both cases. 
Although a UV active spot was observed by TLC, perhaps indicative of enone 
formation, a series of other spots developed as the reaction progressed. The major 
product, tentatively assigned as 180, was isolated in 52% yield. The 'H-NMR 
spectrum was complex, perhaps indicating the formation of diastereomers. No 
olefinic signals were seen in the NMR spectrum, but it did possess the correct 
molecular weight for 181 (mlz = 693) (Scheme 55). When this product was 
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subjected to mesylation (MsCl, 1.3 eq.; Et3N, 1.4 eq. ) or to hydrogenation (H2 latm, 
10% Pd/C, 10 wt%, EtOAc), no change occurred as indicated by NMR, reaffirming 
the absence of the free alcohol, or olefin. Similar cyclisation to tetrahydrofurans was 
reported by Rapoport (Scheme 43). 83 
0 HI 99 
TMSEO NHTeoc 
+0 
TBDPSO 177 
OH 181 
0 
HH 
TMSEO NHTeoc 
0 
0 
TBDPSO . NHCbz 
180 
Scheme 55. Reagents and conditions: LiCl, Et3N, CH3CN, RT; or DBN, CH2CI2,10 "C-RT. 
The fact that both, TBDPS and Cbz protecting groups were bulky led us to consider 
whether they might force the secondary alcohol to adopt a spatial orientation that 
would favour cyclisation to the tetrahydrofuran. Both substituents are locked in a 
favourable anti disposition upon cyclisation. To explore this idea further, three 
additional lactols were synthesised and evaluated in the Homer-Wadsworth-Emmons 
reaction. The compounds made were 182,183 and 184 (Schemes 56 to 58). Azido 
lactol 182 being made by simple DIBAL-H reduction of lactone 173 (Scheme 56) 
0 
TBDPSO--'ý 
N3 173 
DIBAL-H 
DCM, -78 T 
IN 
80% 
0 OH 
TBDPSO"'ýC 
ýj3 182 
Scheme 56 
Boc-protected lactol 183 was conveniently made by hydrogenolysis of 176 and in 
situ protection with Boc anhydride (Scheme 57). 
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Azido lactol 184 was prepared uneventfully in five steps from 173 in 54% overall 
yield (Scheme 58). These involved reduction of azide 173 and Boc protection of the 
resulting free amine in situ, cleavage of the silyl ether to alcohol 185, mesylation and 
displacement with azide. The resulting lactone 186 was then reduced to the 
corresponding lactol 184 using the same conditions as previously described. 
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Scheme 58. Reagents and conditions: i) BOC20, H2s 10% Pd/C, EtOAc, 72%; ii) TBAF, 
THF, 0 T, 91%; iii) MsCl, Et3N, CH202,0 T --> RT; iv) NaN3, DMF, 70 T, 84% over 
two steps; v) DIBAL-H, CH202. -78 T, 98%. 
Unfortunately, Homer-Wadsworth-Emmons; reactions with 182-184 were 
disappointing. Olefination of lactols 182-184 and phosphonate 99, using DBN in 
dichloromethane or alternatively potassium carbonate in DMF led to complex 
mixtures. LC-MS analysis of olefination of 184 and 99 indicated the presence of 
components having the correct mass (mlz = 658) for the alkene or cyclised 
tetrahydrofuran, however, during the reaction, the concentration of UV-active 
species, which are presumed to be alkene, decreased while the concentration of four 
UV-inactive species, which could correspond to the four possible tetrahydrofuran 
diastereomers, appeared to increase with time. 
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The bases employed i. e. DBN and HUnig's base, are weak, and we were initially 
surprised that spontaneous cyclisation occurred. Of course, under Masamune Roush 
conditions, the lithium cation forms a tight complex with the fl-ketophosphonate 
facilitating deprotonation of the phosphonate using a weak base. Such a mechanism 
might explain the observed propensity for THF formation, as the lithium cation 
might act as a simple Lewis acid, activating the acceptor for Michael addition 
(Scheme 59). 
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To test this idea, we subjected azido alcohol 94 to the olefination conditions. Again, 
a complicated mixture of products was observed (mlz = 348), which we attribute to 
the tetrahydrofuran 188 formation (Scheme 60). At this point, it seemed preferable 
to lengthen the route and arrive at the olefination step with an open chain aldehyde in 
which the C-4 hydroxyl group is protected. 
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Scheme 60 
At this juncture, we tested the replacement of the C-5 amino substituent of 86 by a 
protected guanidine. This can be readily realised at the lactone stage using 
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Goodman's reagent in good yield to the guanidine containing lactone 189 (Scheme 
61). 8 
0 
N3 
SI 
BocHN 
186 
i)-ii) 
00 
N3"*" 
BocN "H 
BOCHN 189 
Scheme 61. Reagents and conditions: i) TFA, CH202.0 ýýC; H) Goodman's reagent, Et3N, 
CH2C12, RT, 16 h, 91% over two steps. 
Initially, we attempted to form terminal olefin 190 by reaction of lactol 176 with 
triphenylphosphonium bromide in the presence of n-butyllithium. We envisaged that 
190 could be transformed into aldehyde 191 by subsequent protection and ozonolysis 
(Scheme 62) Unfortunately, the Wittig reaction did not afford the expected terminal 
olefin, but an oxazolidinone 192 albeit in low purity, as a result of the formed 
alkoxide ion 193 attacking the carbonyl centre of the carbarnate. Using NaH in THF, 
it was possible to synthesise 192 in 45% isolated yield. Related cyclisations have 
98 been observed . 
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Whilst oxazolidinones can, after N-Boc protection, be ring opened using cesium 
carbonate, 99 the increased number of steps that would be required meant this 
approach was not investigated further. 
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To overcome oxazolidinone formation, we explored the use of azido lactol 182. In 
this case, the aldehyde group could be observed by 'H-NMR spectroscopy as a minor 
component (aldehyde: lactol; 1: 26). Upon subjection of lactol 182 to Wittig 
olefination, (1,3Z)-diene 194 was isolated as the major product (30%) (Scheme 63). 
The stereochernistry was assigned on the basis Of J2,3 coupling constant V2,3 ý 10.8 
Hz). Clearly, the basicity of the reaction mixture had promoted elimination of the 
azide to form the diene. Alkene 195 was also recovered, however in a very low 1.4% 
yield. A third compound was also isolated in 18% yield, although its structure was 
not elucidated. 
=PSO-ý 
TBD 
N3 
OH 110 
Pso"" 
07 
ýH 
+ TBDPSO---ý-', 
N 182 194 OH 195 
Scheme 63. Reagents and conditions: i) Ph3PCH3Br, "BuLi, toluene, 0 'C, 194 (30%), 195 
(1.4%). 
To overcome these problems, we decided to examine an alternative route to the open 
chain aldehyde 196 required for the Homer-Wadsworth-Emmons reaction. Ring 
opening of the lactone 197 to the y-hydroxy ester 198, and protection of the resultant 
hydroxyl group prior to reduction was expected to allow access to the required 
aldehyde 196 (Scheme 64). 
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Scheme 64 
Several examples of opening of lactones to y-hydroxy esters are known. This can be 
achieved by hydrolysis to the y-hydroxy acid and subsequent esterification with 
diazomethane derivativesloo or alkylation with an alkyl halide. 101 Altematively, 
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transesterification. using an alcohol in combination with a Lewis acid'02 can be used 
which exploits the difference in reactivity between lactones and the corresponding 
open chain esters. 
With this in mind, the transesterification of 199, formed as an intermediate in the 
synthesis of 185 (Scheme 58), was attempted by stirring it in methanol in the 
presence of boron trifluoride etherate (-20 T -> RT). Analysis of the crude mixture 
by 1H NMR revealed a 2: 1 mixture of 199 and 200, respectively (Scheme 65). 
Similar results were obtained when 199 was treated with acetyl chloride in methanol, 
or triethylamine in methanol. We were also unsuccessful in driving the reaction to 
compIction using potassium hydroxidc (rcflux, 4 h) and mcthyl iodidc (RT, 24 h) 
(Schemc 65). 
NHBoc 
TBDPSO 
00 
Sol"", -,, "ýCOA TBDP 
BocHN .12: 1 
6H 
199 200 
Scheme 65. Reagents and conditions: a) MeOH, BF3-OEt2, -20 *C -> RT, 3 h; b) AcCl, MeOH, overnight; c) MeOH, Et3N, RT, overnight. 
Next, we decided to explore the difference in reactivity of amides relative to esters. 
This is exploited in the efficient procedure developed by Weinreb for transforming 
esters into N-methoxy-N-methylamides. 103 Since amides are typically more stable 
than the corresponding esters, their formation should be essentially irreversible. y- 
Lactones have been opened using N-methoxy-N-methyl amine in good yields, to the 
corresponding y-hydroxy amides. 104 When lactone 199 was treated with 
trimethylaluminium. and N-methoxy-N-methyl amine, amide 201 was produced in an 
encouraging 67% yield after column chromatography (Scheme 66). 
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Next, protection of the resulting alcohol was examined. In considering suitable 
protecting groups, we needed to take into account their stability to DIBAL-H 
reduction and Homer-Wadsworth-Emmons olefination conditions, prior to 
deprotection and transformation to an azide. Triethylsilyl or p-methoxybenzyl ethers 
seemed appropriate choices since they can be cleaved under mildly acidic or 
oxidative conditions, respectively, and would be expected to be stable under the 
reaction conditions required for the reduction/Homer-Wadsworth-Emmons reaction. 
Protection of the secondary alcohol of 201 was attempted using triethylsilyl chloride 
and imidazole in DMF, 105 and alternatively, by subjecting the alcohol to 
methoxybenzyl iodide, formed in situ by reacting p-methoxybenzyl bromide, sodium 
hydride and tetra-n-butyl ammonium iodide (Scheme 66). 106 In both cases, only the 
y4actone 199 was observed with none of the required ethers (202 or 203) being 
observed. In the case of the silyl protection, the silyl chloride presumably acts as a 
Lewis acid activating the carbonyl group and making it susceptible to nucleophilic 
attack by the alcohol. In the case of the etherification with PMBI, the deprotonated 
alcohol is sufficiently nucleophilic to add to the carbonyl group, yielding the 
unwanted lactone after ejection of NaNMe(OMe). 
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Clearly, milder conditions were required. Moreover, since protection of alcohol 
would add steps to the synthesis, we were drawn to the idea of converting it to the 
azide via the corresponding mesylate. Gratifyingly, mesylation of alcohol 201 
BocHN 0 
not TMPSO"ýWO"'I 
OPG 
202 (PG = TES) 
203 (PG = PMB) 
proceeded uneventfully providing 204 in 90% yield (Scheme 68). 
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204 
Mesylate 204 was stirred in DMF with sodium azide at 50 'C overnight, however the 
reaction was very slow so the temperature was raised to 95 T. After 4 hours at this 
elevated temperature, all the starting material was consumed. Unfortunately, the 
major product obtained after column chromatography had a molecular weight (m/z = 
457) inconsistent with simple SN2 displacement of the mesylate by azide to form 
205. In addition, no signals attributable to the tert-butyl carbarnate group could be 
seen in the lH NMR spectrum, and no azide stretch was witnessed by IR 
spectroscopy. Based on these data, we propose that 204 undergoes an intramolecular 
reaction leading to oxazolidinone 206. Indeed, when 204 was stirred in neat DMF at 
95 'C, the same oxazolidinone was formed, confirming no involvement of sodium 
azide in the reaction (Scheme 69). 
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As we had lactone 186 to hand, we subjected it to the same sequence of reactions. 
Thus treatment of lactone 186 with trimethyl aluminium. and N-methoxy-N-methyl 
amine gave Weinreb amide 207 in an excellent 92% yield (Scheme 70). As an aside 
it is noteworthy that Weinreb amide 207 can be obtained in a good state of purity 
after filtration through a short pad of silica following workup. This is convenient and 
desirable, since on a large scale, purification by conventional silica gel 
chromatography gives rise to significant amounts of lactone 186, decreasing the 
isolated yield. 
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At this point, we again were confronted with the problem of protecting the C-4 
hydroxyl group. A series of protecting groups were tested, in the hope this system 
would be less prone to re-lactonisation. Under many conditions tested (PMBCI, NaH, 
TBAI, THF; PMBCI, NaH, DMF; PMBBr, NaH, DMF; TESCI, Imid., DMF; TESCI, 
Et3N, DMAP, DCM; TESOTf, Pyr., MeCN/Et2O) the lactone 186 was again 
produced as the sole product. Attempted tritylation (TrCl, Et3N, DMAP, DCM) led 
NaN3, DMF 
-142' 10- 
-tBu 0 NH 0 
TBDPSO-ýýýN 
(oms 
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to complete recovery of starting materials whereas efforts to introduce a THP ether at 
C-4 (DMP, p-TSA) led to a complex mixture of products. 
Since the search for a protecting group was not fruitful, mesylation was attempted. 
Gratifyingly, mesylation of alcohol 207 afforded 208 in 75% yield. Further 
reduction of 208 to the aldehyde 209 proceeded in a reproducible 55% yield (Scheme 
71). This reduction was found to be very sluggish with starting material (ca. 40%) 
recovered. Whilst inconvenient, this could then be recycled, increasing the yield to 
95% based on recovered starting material. It is remarkable that total 
chemoselectivity is observed during this reaction, the mesylate does not undergo 
reduction to the corresponding alkane. 
BocHN 0 BocHN 0 BocHN 0 
NjrýN IOIN 
1 
01 N "-ýN 1011,11 -10- N "-"'ýH 
6H 11 6ms 6ms 
207 208 209 
Scheme 71. Reagents and conditions: i) MeNHOMe, AlMe3, CH2CI2,0 *C--)ýRT, 92%; H) 
MsCl, Et3N, DMAP, CH2CI2,75%; iii) DIBAL-H, THF, -78 *C, 55%. 
With aldehyde 209 in hand, we could finally attempt the olefination reaction with 
phosphonate 99. During the reaction of 209 with phosphonate 99 in DMF using 
K2C03 as base, the aldehyde was consumed, as judged by thin layer chromatography. 
However, although 1: 1 stoichiometry of phosphonate to aldehyde was used, it was 
clear that phosphonate 99 had not been completely consumed. Disappointingly, 
aldehyde 209 had undergone an intramolecular reaction to form dihydrofuran 210 in 
26% yield (Scheme 72). The formation of this material was readily apparent from 
the distinctive alkene signals in the 1H NMR spectra (8 = 6.42-6.40 and 4.92 ppm 
with J=3.0 Hz) and 13C (8 = 146.7; 100.5 ppm). Presumably it arises from 
displacement of the mesylate group by the carbonyl oxygen with inversion at C-4 
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followed by loss of a proton by the base to neutralise the charge. Treatment of 
aldehyde 209 in a suspension of potassium carbonate (I eq. ) in DMF in the absence 
of the phosphonate afforded the same product. Since the driving force for this 
elimination is the neutralisation of the oxonium. cation, the use of weaker bases in 
this process was not expected to radically change the outcome. 
BocHN 0 
Nj H 
oms 
K2CO3 
DNT 
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Scheme 72 
Eventually, a satisfactory solution to these problems was forthcoming. In spite of all 
the difficulties encountered in the protection of amide 207 (vide supra), we finally 
established that an acetate group could be successfully introduced at C-4. 
Weinreb amide 207 could be acylated to 211 in 94% yield under basic conditions 
using acetic anhydride and pyridine and a catalytic amount of 4- 
dimethylaminopyridine (Scheme 73). We cannot readily explain why this 
transformation, and indeed the mesylation to form 208, are successful in light of all 
our earlier failures with seemingly similar reagents. 
We were concerned that it would not prove possible to selectively reduce the 
Weinreb amide group of 207 in the presence of the acetate group. One can argue that 
the amide 207 will coordinate more strongly to DIBAL-H since it is more Lewis 
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basic, leading to the requisite chemoselectivity. Some experimental precedent in 
support of this hypothesis can be found in the literature. 107 We were greatly relieved 
that the reduction of 211 to aldehyde 212 proceeded in a very respectable 79% yield. 
i 
BocHN 0H BocHN 0 
207 Ol N'---'ýN' Nr"ýýH 3 
OAc 211 OAc 212 
Scheme 73. Reagents and conditions: i) AC20, Pyr., 4-DMAP, CH2CI2.0 'C -> RT, 94%; ii) 
DIBAL-H, TBF, - 78 *C, 79%. 
In summary, we achieved the synthesis of a stable aldehyde 212 in 38% overall yield 
and 7 steps from azido lactone 173. Although olefination reactions with earlier 
substrates (eg. 177,182-184) had not been successful, we were optimistic that similar 
problems could not be encountered with 212. As we will see in the following 
section, this optimism was well founded. 
2.4. Olefination Reactions 
Having developed a 7-step enantioselective route to a fully protected aldehyde 212 
from lactone 173 (Section 2.3), we were now in a position to explore olefination 
conditions that would lead to the desired Z-alkene 144. 
2.4.1. Preliminary Studies 
Before utilising aldehyde 212, some preliminary experiments were conducted with 
phosphonate 99 with n-butyraldehyde (Scheme 74). Two sets of conditions were 
examined, namely DBN in dichloromethane and LiCl/'. Pr2NEt in acetonitrile. When 
the reaction was performed under Masamune-Roush conditions both geometrical 
isomers were produced in a ca. 4: 1 ratio as judged by 1H NMR spectroscopy. After 
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column chromatography, (Z)- and (E)-213 were isolated in 59 and 15% yields, 
respectively. 
0 
O, 
IL"T, H 
TMSE 
N )rNHTeoc 
(EtO)20P 0 
99 
0H 
N 
TMSEO )T"'ýNHTeoc 
0 
213 
Scheme 74. Reagents and conditions: i) "PrCHO, LiCl, 'Pr2EtN, CH3CN, Z-213 59% and E- 
21315%. 
The geometries of the two olefins were established by nOe experiments. (E)-213 
shows a reciprocal enhancement (1.8-2.0%) between H-3 and the adjacent NH of the 
peptide chain. No such enhancement is observed in (Z)-213, but instead a reciprocal 
enhancement (2.8-3.6%) between H-4 and this NH is observed (Figure 10). 
00 'ýýNHTeoc 
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H 
ýý 
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H 2.8-3.6% 
(Z)-213 
Figure 10 
Using DBN in dichloromethane, only (Z)-213, was obtained in 76% yield after 
column chromatography (Scheme 75). The presence of the other geometrical isomer 
could not be detected in the crude reaction mixture. 
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N ýrNHTeoc 
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Scheme 75 
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We anticipated that using a fully protected aldehyde in the olefination, the problems 
seen using lactols 176 and 182-184 would no longer arise (Section 2.2). This 
hypothesis proved correct and when aldehyde 212 was reacted with phosphonate 99 
using DBN in dichloromethane, only the Z-isomer was formed and after column 
chromatography, it was isolated in 81% yield (Scheme 76). 
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Jty H N,, ýý 
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TMSEO 
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NH 3 OAc 
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Scheme 76 
To confirm the Z-selectivity of this reaction, this olefination was repeated using the 
less stereoselective Masamune-Roush conditions. Under these conditions, both 
geometrical isomers were obtained in 5: 1 Z: E ratio and isolated in 51% and I I% 
yields, respectively, after column chromatography (Scheme 77). 
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Scheme 77. Reagents and conditions: i)LiCl, 'Pr2EtN, CH3CN, Z-214 51% and E-214 11%. 
With both isomers in hand, it was possible to confirm the stereochernistry of (Z)-214 
using nOe difference experiments. The alkene hydrogen at H-3 was well resolved as 
an apparent triplet at 6.5 ppm with J=7.8 Hz for E-214, and at 6.6 ppm with J=7.0 
Hz for Z-214. Moreover, the carbarnate NH was easily discerned as a singlet at 8.74 
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and 8.47 ppm, respectively. Strong reciprocal nOe enhancements (1.4-2.5%) 
between these two signals were witnessed for the E-isomer, but not for Z-214. 
Instead, a strong reciprocal enhancement (1.2-1.7%) between NH and the allylic 
methylene group (H-4) was observed. 
(Z)-214 was now just two steps away from the key cyclisation. The C-5 amino 
substituent had to be exchanged for the photo-cleavable protecting group and the 
cleavage of the acetate was also required. In the literature, the orthogonal cleavage of 
a tert-butyl carbamate in the presence of trimethylsilylethyl carbarnate is reported. 108 
We adopted essentially the same procedure using para-toluenesulfonic acid, but used 
dichloromethane as the solvent rather than ethanol. The reaction was run at room 
temperature, rather than at 60-65 'C to more carefully control the deprotection. 
0 H 
TMSEO N NHTeoc 
0 
N NHR 
7 
OAc 
pTSA 
214 R= Boc Z: 
215 R=H 
Scheme 78 
After five hours, an aliquot was analysed by 
electrospray mass spectrometry. Alkene 214 (mlz = 
701) was still present and no formation of the free 
amine 215 could be observed (Scheme 78). The 
reaction was left to stir overnight at which point ES- 
MS indicated that 214 had been consumed. The 
desired molecular ion at 601 [M+H+] was observed, but analysis by 1H NMR was not 
encouraging. In the case of 214, we have three acid labile protecting groups, and 
competitive cleavage of the Boc and TMSE protecting groups is conceivable. 
Unable to cleave the Boc group at this juncture, we elected to advance the synthesis 
to explore the cyclisation with the Boc group retained. If successful, we reasoned 
that this protecting group might be removed at a subsequent step. Alternatively, the 
use of a different phosphonate in the Homer-Wadsworth-Emmons reaction would 
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allow the introduction of alternative protecting groups in the "Northern" half of this 
substrate, potentially circumventing the need for a chemoselective deprotection. 
Treatment of Z-214 in methanol in the presence of potassium carbonate led to 
cleavage of the trimethylsilylethyl ester to the free acid 216 rather than the required 
acetate 217 as judged by 1H NMR. The same result was observed when the 
saponification was performed with lithium hydroxide (1 eq. ) in aqueous THE No 
cleavage of the acetate group was observed (Scheme 79). 
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With respect to achieving the double cyclisation, an azido alcohol is essential. Up 
until this point, the synthesis of this material has not been possible. Indeed, even if 
selective removal of the acetate could be achieved, closure to the corresponding 
tetrahydrofuran 206 seems likely based upon our earlier findings (Scheme 80). 
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Scheme 80 
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Due to these concerns, we decided to explore the formation of the bicycle in two 
steps, via ring contraction of the corresponding piperidine, formed by an initial ring 
closure, to form a piperidine. 
2.4.2. Preliminary synthetic attempts towards a piperidine 
The plan was to chemoselectively reduce the azide group of 214 to the corresponding 
amine 219, which we expected to undergo spontaneous ring closure to the piperidine 
220 via a Michael addition. Moreover, we hoped that the substituents on the chain 
would guide the stereochernical outcome of this addition process (vide infra). 
We decided to exploit the low reactivity of trisubstituted alkenes to hydrogenation at 
atmospheric pressure. Alternatively, reduction via the Staudinger reaction, is 
possible although purification problems associated with the triphenylphosphine oxide 
by-product formation might arise. 55 By using a protic solvent or a weak base, in situ 
cyclisation to the piperidine could be anticipated. 
To achieve the required reduction, the hydrogenation of Z-214 was undertaken using 
10% Pd/C in ethanol, and alternatively in ethyl acetate. Gratifyingly, we observed 
the formation of the piperidine 220 with no additional base being necessary. Similar 
results were obtained in both solvents although slightly higher yields being achieved 
in EtOAc (69% vs 60%). Of the four possible diastereomers that could be produced 
from this reaction, only two could be detected by 1H NMR. Piperidine 220 was 
obtained as an inseparable mixture of epimers, with the exact ratio being dependent 
on the choice of solvent (EtOAc 1: 3; EtOH 1: 1.5) (Scheme 8 1). 
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Assignment of the stereochemistry of piperidine 220 was very difficult, in part due to 
the broadness of some of the 1H NMR signals. Bearing this in mind, we were 
expecting to see three clear reciprocal nOe enhancements upon irradiation of the 
axial hydrogens at C-3, C-5 and C-7 (ficellomycin numbering). However, the NMR 
spectrum for the epimeric mixture of piperidines was not clear and the peaks could 
only be tentatively assigned. We believe that apart from signal overlap, the ring 
could be flipping on the NMR time scale leading to broadness. At this juncture, we 
could not confirm that the piperidine 220 had the stereochernistry we anticipated. 
Later studies revealed that in fact, the two diastereomers produced are indeed 
epimeric at C-2 and that the C-3 centre has been completely controlled in this 
cyclisation. A rationale for these observations will be detailed later (Section 2.3.3. ). 
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Scheme 81. Reagents and conditions: i) Pd/C (10%), EtOH, 60% (1: 3); or Pd/C (10%), 
EtOAc, 69% (1: 1.5). 
2.4.3. Synthesis and piperidine formation using related substrates 
Knapp has undertaken some closely analogous cyclisations as part of work directed 
towards the synthesis of (+)-tetrahydropseudodistomin. 109 These workers used a 
'large' protecting group, namely a dibenzyltriazone (DBT) group to encourage this 
substituent to adopt a pseudo equatorial orientation in the cyclisation transition 
state! 10 
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Using trans or a cis and trans mixture of 221, cyclisation produced a single 
piperidine 222 in good yield (Scheme 82). The stereochernistry in the cyclisation 
reaction was rationalised in terms of the conformation of the transition state. If both 
the alkene and the silyl ether adopted a pseudo axial conformation in the transition 
state, there would exist an unfavoured 1,3-diaxial interaction between the alkene and 
the silyl ether group, whereas this would not occur in a transition state where the 
alkene assumed an equatorial conformation. 
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We imagined that a DBT protected C-5 amino group might be a useful alternative for 
the Boc group used in our original cyclisation (219 -+ 220). To explore this idea, we 
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Figure 11 
set about the synthesis of olefin 223. It was 
envisaged that the introduction of the DBT could be 
accomplished at the Weinreb amide stage. The 
cleavage of the Boc group from 211 using a solution 
of TFA in dichloromethane proceeded smoothly. 
However, the introduction of the DBT protecting 
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group onto the resulting free amine ('Pr2EtN, aq. HCHO then dibenzylurea, EtOAc, 
A) led to a complicated mixture of products. 
Due to these complications, the introduction of the protecting group was attempted at 
an earlier point in the synthesis. Thus, lactone 186 was treated with TFA in 
dichloromethane to afford the deprotected lactone. Initial attempts to isolate the free 
amine by dissolving the TFA salt in water and extracting with ether resulted in low 
yields. 
To circumvent these problems, the reaction was repeated and the solution 
concentrated to afford the TFA salt of this amine. Introduction of the DBT group 
was performed by treating this TFA salt with an excess of HUnig's base followed by 
addition of an aqueous solution of formaldehyde. This mixture was azeotroped with 
toluene, then treated with dibenzylurea in ethyl acetate at reflux to afford protected 
lactone 224 in a satisfactory 47% yield after column chromatography (Scheme 83). 
Further conversion to amide 225 via 224 was achieved in 86% yield in an identical 
way to that used earlier. 
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Scheme 83. Reagents and conditions: i) TFA, CH2CI2,0 IC then 'Pr2EtN, HCHO (aq. ) then 
(BnNH)2CO, EtOAc, 70 'C, 47%; H) AlMe3, MeONHMe, CH2CI2.0 *C -* RT; iii) 
AC200 
Pyr., CH2CI2,86% over two steps. 
The next stage of the synthesis was the reduction of the Weinreb amide; this proved 
problematic. Initially, amide 226 was treated with DIBAL-H (1.5 eq. ) for 4 hours at 
-78 "C. After work up, 50% conversion to aldehyde was witnessed as estimated by 
1H NMR analysis. However, aldehyde 227 was only isolated in 28% yield after 
column chromatography. 
We attempted to optimise this transformation by increasing the reaction temperature 
from -78 T to -40 T. In a separate experiment conducted at -40 T we lengthened 
the reaction time from 4 to 16 hours. Neither of these attempts led to an increase in 
product formation. Concerned about the potentially instability of 227 during column 
chromatography, we decided to use triethylamine pretreated silica for product 
isolation. This led to the formation of a further by-product which was not identified. 
Over-reduction of the amide to the corresponding alcohol was also attempted. Using 
3 equivalents of DIBAL-H resulted in a mixture of aldehyde 227 (28%) and lactol 
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228 (48%) were produced. The latter compound arising from cleavage of the acetate 
and subsequent addition to the aldehyde (Scheme 84). 
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Undeterred, the crude mixture of Weinreb amide/aldehyde was subjected to the 
olefination conditions. A 3: 1 mixture of aldehyde 227 and amide 228 produced by 
treatment with DIBAL-H (1.5 eq., 4 hours) was subjected to Horner-Wadsworth- 
Emmons olefination with phosphonate 99 (Scheme 85). A complicated mixture of 
products was observed, among which, we isolated a,, 8-unsaturated aldehyde 229 (mlz 
= 389 [M+Na]+) in 18% yield. Clearly, under the basic reaction conditions, 
elimination of the DBT group had occurred leading to the formation of 229. 
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The low yields witnessed for the introduction of the DBT group into lactone 186, 
coupled with problems associated with its smooth conversion to aldehyde 227 and 
complications seen in initial Homer-Wadsworth-Emmons reactions led us to 
abandon further efforts to use this protecting group. 
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Concurrent to these studies, we were also exploring the preparation and cyclisation 
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N3 NBOC2 
OAc 230 
Figure 12 
reactions of another substrate bearing a larger C-5 
substituent, namely alkene 230. The introduction 
of a second tert-butyl carbarnate group usually 
requires relatively forcing conditions, for example 
use of a stoichiornetric amount of 4- 
dimethylarninopyridine and di-tert-butyldicarbonate. 111 Gratifyingly, when Weinreb 
amide 211 was subjected to these conditions, we obtained the di-Boc arnine 231 in 
93% yield. Reduction of this compound to the corresponding aldehyde 232 
proceeded in a very high 93% yield after column chromatography (Scheme 86). This 
reduction is better than the corresponding conversion of 211 to 212 (Scheme 73), 
suggesting that removal of the carbarnate NH is advantageous. 
BocHN 0 B0C2N 0 
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Nry'j"ýN'Oý" N ýýN'0'*' 3 
ÖAc ÖAc 
211 231 
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Nj""""ýH 
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Scheme 86. Reagents and conditions: i) BOC20, DMAP, CH3CN, 60 T, 93%; ii) DIBAL-H, 
THF, - 78 T, 93%. 
This NN-di-Boc protected aldehyde 232 was then subjected to both sets of 
olefination conditions (Scheme 87). The DBN mediated olefination conditions 
produced Z-230 in 72% yield, whilst the Masamune-Roush conditions formed Z-230 
in 54% yield along with the unwanted E-olefin in 5% yield. The assigrunent of the 
stereochernistry was performed by analogy to 214. 
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Scheme 87. Reagents and conditions: i) DBN, CH2C12.10 'C, 72% (Z)-230; or H) iPr2EtN, 
LiCl, CH3CN, 10 T, 54% (Z)-230,5% (E)-230. 
Interestingly, when the olefination reaction was conducted at room temperature, 
elimination of bis-tert-butyl imidate was observed 
H 
NHTeoc (ca. 10%) giving 233 (3 J3,4 -= II Hz, 
3J4,5 
= 15 Hz) 
This material could be derived from 230, or from 
6Ac 232 followed by subsequent olefination with 99. 
233 
This problem was overcome by reducing the Figure 13 
internal temperature of the olefination to 0 *C. 
With quantities of 230 in hand, our attention turned to the reduction/cyclisation 
sequence. By analogy with the conversion of 214 -> 220, the hydrogenation was 
initially performed using I atmosphere of hydrogen with 10% Pd/C as catalyst in 
ethyl acetate (Scheme 88). No chemoselectivity was achieved, and the major 
product of the reaction was amino alkane 234, obtained in 41% yield, resulting from 
the reduction of both the azide and the double bond; piperidine 235 was not isolated. 
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Scheme 88 
Using 3% Pd/C as catalyst, the reaction was very sluggish, and after 48 hours only a 
small amount (5%) of amino alkane 234 was observed in the crude reaction mixture 
as judged by 1H NMR. When this reaction was repeated in a microwave CEM 
Discovery (100 W, T= 35 'C), the formation of amino alkane 234 was observed 
after just 10 minutes. To attempt to overcome these problems, we switched to using 
palladium hydroxide (10 wt%, H2 I atm., EtOAc) as catalyst although this was also 
unsuccessful. 
Next, reduction of the azide was attempted using a Staudinger reaction. Stirring 
alkene 230 and triphenylphosphine in aqueous THF (1: 50 v/v) at 50 "C overnight, 112 
led to complete consumption of starting material. By ES-MS, a molecular ion of 556 
was observed, and 1H NMR analysis of the complex mixture indicated that the olefin 
remained .3 
1P NMR suggested the presence of the iminophosphorane (26 ppm) 
rather than triphenylphosphine oxide (30 ppm). Presuming the reaction mixture to 
contain iminophosphorane 236, we attempted to promote cyclisation by stirring the 
crude mixture in water at 80 'C for 3 hours. However, no change was observed 
(Scheme 89). 
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Next, we tested the use of poisoned palladium catalysts. Corey 113 has reported the 
chemoselective reduction of azides using Lindlar's catalyst. 114 For example, 237 was 
obtained after reduction of 238 in 95% yield (Scheme 90). 
0 H2, Lindlar's cat. 
EtOH 
N3 
CA 
95% 
IN 
238 
Scheme 90 
CAI 
237 
Gratifyingly, when we tested this procedure, piperidine 235 was isolated in 80% 
yield after column chromatography, as an inseparable 6: 1 mixture of epimers at C-2. 
0 H HH 
N 
NHTeoc 
H2, Lindlar's cat. TMSEO,, 
ý-ýN 
NHTeoc TMSEO 
EtOH 
lr, 17ý 
80% HN 
0 
"'NBOC2 (D/" N3 
- NBOC2 
6Ac 6Ac 
230 235 
Scheme 91 
In the light of these positive results, we re-subjected alkene 214 to the reaction 
conditions and gratifyingly found that this method yielded piperidine 220 in 89% 
yield, as a mixture of 5: 1 epimers at C-2 (cf. 60% and 1: 1.5 epimeric mixture using 
10% Pd/C) (Scheme 81). Thus, efficient cyclisation can be achieved using either 
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substrate. Moreover, only one Boc group is needed to exert complete control over 
the stereochernistry at C-3. 
2.4.4. Stereochemical Assignments 
The stereochernical elucidation of 235 was deduced by NMR, using a combination of 
nOe studies and analysis of gerninal coupling constants (Figure 14). Clear reciprocal 
enhancements between H-5, and H-7,,, and H-3 were observed suggesting that these 
three hydrogens were axial. Furthermore, we could clearly observe large coupling 
constants consistent with the presence of di-axially disposed hydrogens. Thus, H-5 
was observed as a double doublet of doublets with one large coupling (3 J5,4,, ý = 12.8 
Hz) and two smaller couplings 05,4eq = 2.4 and 3J5,6 = 2.0 Hz) consistent with axial- 
equatorial couplings and one axial-axial coupling. For H-7,,,,, one large geminal 
coupling constant value (2 Aix, 7eq = 14 Hz) was observed, along with a smaller (3J7,,,, 6 
= 3Hz) assigned as an axial-equatorial coupling to H-6; H-6 was observed as a broad 
singlet, characteristic of small (equatorial-equatorial and axial-equatorial) coupling 
constants. Both minor and major diastereorners display the same characteristics in 
terms of nOe and coupling constants, confirming that they are epimeric at C-2, i. e. 
they have the same relative configuration at C-3. Whilst we have been able to 
confidently deduce the stereochemistry at C-3 using this analysis, the configuration 
at C-2 in the major isomer remains undetermined. 
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Analysis of the homonuclear coupling constants indicated that piperidine 220 also 
had the same conformation as that of 235, showing clearly 1,3-diaxial couplings in 
the case of H-5 and H-7a, Thus, H-5 is observed as a double triplet (3JS, 4 -ý 13 Hz; 
3 ýý 3 J5,4eq , J5,6 ý 1.5-2 Hz). For H-7,,,, only the geminal coupling constant 
is large 
07ax, 
7eq = 14 Hz, 
2J7ax, 6 =2 Hz). H-6 is again observed as a broad singlet, 
characteristic of a series of small coupling constants (equatorial-equatorial and axial- 
equatorial). Furthermore, nOe difference studies indicated that H-3, H-5 and H-7. x 
are all axial due to the existence of reciprocal nOe enhancements (Figure 15). 
4.9% dd, 2J = 14.0 Hz 
4.4% 
-- 
3J = 2.0 Hz 
/6.1 91'6ý dt, 3J = 13.0 Hz 
HH 3J = 1.5-2.0 Hz , 
I, 
a4t Rl HN 3HH5H H/ 
32C 7 
tH 
NHBoc R'HN A Fj H5 
NHBoc RO tC Hý 
Ac H-N 
220 HH OAc 
br. s 
Figure 15 
2.4.5. Stereochemical rationale of cyclisations to 220 and 235 
It has been reported that the intramolecular 1,4-Michael type addition of primary 
amino olefins into piperidines is kinetically controlled, and the stereochernistry is 
independent of the olefin geometry. 115 Knouzi et al. explain this as a result of a chair 
transition state where the substituents; are arranged to minimise steric interactions. 
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Knapp used similar transition states to rationalise the stereochernical course of the 
cyclisation of 222 to 221 (Scheme 82). 
The conformational and stereochernical outcome of these intramolecular reaction can 
be rationalised. At least four possible transition states can be imagined for this 
cyclisation. Since the stereochernistry at C-5 and C-6 is set from that within 
aldehydes 212 and 232, these centres must be syn in the product. The 
stereochernistry of the valine amino acid residue, is also fixed and of L- 
stereochernistry. Based upon the work of Knapp, we believe that the alkene of 217 
and 233 adopts a pseudo equatorial conformation in the transition state. Assuming 
the reaction proceeds via a lower energy chair conformation, two competing 
transition states are accessible (Scheme 92). In (I) the NHBoc or NBOC2 group 
adopts a pseudo equatorial orientation with the acetate axial, whereas in (II) their 
orientations are reversed. 
-t HH 
H 217 35 
or IN NZBoc HNO 
233 YN 
H OAc NZBoc H L -i 6Ac 220Z=H 
235 Z= Boc 
VS. 
x 
217 
1 r. --OAc 
or x 
rH ' 
b. - HN 
233 
1 V'ZBoc 
'5 
LH NZBoc 
OAc 
not observed X= C02TMSE 
Y= NHC02VaINHTeoc 
Z=H or Boc 
Scheme 92 
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Our results using 220 and 235, are consistent with transition state (1) being the 
preferred pathway. 
The preference of a substituent in a cyclohexane ring to adopt an equatorial position 
over an axial one is reflected by its A value, with larger substituents possessing 
larger A values (e. g. A (Bu) > 4.5 kcal/mol). ' 16 Our results are supported by 
measurements of A-values. The A value for an acetate group is 0.6-0.79 kcal/mol. 
Whilst we have not been able to obtain a literature value for NHBoc, the A value for 
NH2 is 1.2-1.7 kcal/mol. 1 17 We reason that NHBoc and N(BOC)2 must have A values 
at least as large as this ý: 1.7 kcal/mol, supporting the notion that the amino group is 
larger than acetate will prefer to be orientated equatorial in the transition state. 
The fact that both epimers at C-2 are observed would indicate that the protonation 
step is not fully selective. 
2.5. Further Work to Ficellomycin 
To make further progress towards ficellomycin, we anticipated that cleavage of the 
acetate group and conversion to a leaving group would set the stage for a second 
cyclisation to the I -azabicyclo-[3.1.0]hexane. 
Acetate cleavage is often carried out using potassium carbonate in methanol. This 
produces the corresponding alcohol and methyl acetate, which is easily removed in 
vacuo. However, we faced another problem, the presence of two esters in 234 
suggested that these conditions would, most probably, cause transesterification of the 
trimethylsilylethyl ester. To overcome this problem, we decided to use 
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trimethylsilylethanol as the solvent, this alcohol, although greasy, is a liquid (bp = 
71-73 'Q. When we treated piperidine 234 with a suspension of potassium 
carbonate in this solvent, at room temperature or at 50 'C, no reaction was observed. 
However, heating the reaction at 70 'C overnight brought major changes as judged 
by ES-MS, with the molecular ion for acetate cleavage (mlz = 633) being observed. 
However, since the 'H-NMR remained almost the same, we inferred that a small 
quantity of the hydrolysed acetate had been formed, which ionises more readily in 
the MS source. Adding water to the reaction mixture to increase the solubility of 
potassium carbonate in trimethylsilyl ethanol had no beneficial effect. Treatment of 
235 with potassium carbonate in methanol for I hour followed by purification by 
column chromatography using 1% ammonia in the eluting solvent provided 
carboxylic acid 239 as a white solid in 74% yield. This occurred with concomitant 
cleavage of one Boc group. This result suggested that water was present in the 
methanol, as hydrolysis of the TMSE ester occurred and no transesterification was 
observed. Using freshly purchased dry methanol, some carboxylic acid could still be 
observed (10%). To obviate these problems, it seemed prudent to use wet methanol 
and subsequently re-esterify the resulting carboxylic acid. 
0 
0,4 
HH 
TMSE 
N 
NHTeoc K2CO3 H04 
N )r N NHTeoc 
- MeOH 
HNý) 
0 
74% HN 
0 
NBOC2 NHBoc 
OAc 6H 
235 239 
Scheme 93 
Similar results were observed when 220 was treated with potassium carbonate in 
methanol. We attempted the mesylation of the crude alcohol 240 obtained from this 
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reaction. An analysis of the crude reaction mixture revealed the presence of a 
mixture of free alcohol and mesylate by ES-MS (mlz = 710) but IH NMR failed to 
yield convincing evidence regarding this transformation, so we can only tentatively 
propose that the cyclisation precursor 241 was formed. 
00 
HH HH 
TMSEO NHTeoc 
MsCl, Et3N 
TMSEO 
N 
NHTeoc CH2C12 
HN 
0 
HN 
0 
ES-MS (D"'NHBoc 
NHBoc 
OH 6ms 
mlz7lO 
240 241 
Scheme 94 
Next, we decided to examine if we could find conditions under which the Boc and 
Teoc carbarnates could be removed orthogonally. Since earlier attempts to cleave the 
Boc of 214 (Scheme 78) in the presence of the Teoc group using para- 
toluenesulfonic acid had met with failure, other options were explored. Thermal 
conditions have been used to cleave Boc groups especially in acid sensitive 
molecules. 118 Other reported methods include using a catalytic amount of ceric 
ammonium nitrate, 
119 
or TMSI. 
120 
When we subjected piperidine 220 to the reported CAN-based conditions, no change 
was observed after three days at 80 'C (Scheme 95). 
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220 
Ce(NH4)2(NO3)6 
7, m<- I, 
CH3CN, 80 IC 
Scheme 95 
0 
HH 
TMSEO ZN 
11"'ýýNHTeoc 
HN 
0 
/ 
: NH2 
ÖAc 
242 
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Using trimethylsilyl iodide, deprotection of the amine and cleavage of the TMSE was 
observed after 1 hour at 0 'C, as judged by ES-MS. Attempts to isolate 242 after 
derivatisation with 3,5-dinitrobenzoyl chloride were unsuccessful. A complicated 
mixture developed and attempted purification resulted in the isolation of a crude 
solid with the correct mass for the formation of one amide (mlz = 525), which was 
not crystalline and judging by 1H NMR, corresponded to a mixture of amide 
products. 
0 H 
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JýN 
NHTeoc 
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02N 
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Scheme 96 
At this juncture, time constraints prevented further development of the chemistry. 
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To summarise, we have optimised an existing procedure to form the I- 
azabicyclo[3.1.0]hexane core of ficellomycin that had already been developed in the 
group. Treatment of azido alcohol 94 with poly-triphenylphosphine as the reagent, 
formed an NH aziridine in situ which underwent subsequent intramolecular 
conjugate addition onto a dehydroarnino, ester. This procedure gave access to all four 
possible diastereomers, epimeric at C-2 and C-3. In relation to the earlier solution 
phase method, it gave an increase in the overall yield, simplified isolation and 
purification. The anti-diastereomers 95a and 95b were isolated as a 3: 1 mixture in 
21% yield, and the syn-diastereomers 142a and 142b were isolated in 20 and 4% 
yield, respectively. 
Me02C NHCbz 
()-PPh2 C02Me 
PhMe, 70 'C 
IN 
+ 
CbzHN 
CbzHN N N3 C02Me 
H 95a and 95b (21%) 142a (20%) 
94 142b (4%) 
Scheme 97 
Moreover, we have established an enantioselective route to aldehyde 212, suitable 
for application to the total synthesis, in 28% yield over eight steps from enone (S)- 
156, itself commercially available or accessible in 4 steps from D-mannitol. Key to 
the success of this sequence were stereocontrolled azide addition to 173, controlled 
opening of lactone 186 using MeONHMe and chemoselective reduction of 211. 
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Scheme 98. Reagents and conditions: i) TBDPSCI, Imid., DMF, 96%; H) NaN3. CH3CO2H, 
THF: H20 (1: 1.3), 5 d, 79%; iii) H2) 10 % Pd/C, EtOAc, 90%; iv) TBAF, THF, 0 T, 91%; v) 
MsCl, Et3N, CH2CI2.0 T -> RT; then NaN3, DMF, 70 T, 84% over two steps; vi) 
MeONHMe, AlMe3, CH2CI2.0 T -* RT, 71%; vii) AC20, Pyr., 4-DMAP, CH2CI2,94%; viii) 
DIBAL-H, TFIF, -78 T, 79%. 
It is expected that starting from the known enantiomeric lactone (R)-157, the 
antipode of aldehyde 212 could be obtained. Aldehyde 244 should lead to the 
stereochernistry proposed by Armstrong for ficellomycin, whereas aldehyde 212 
should lead to its diastereomer. 
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We have established that aldehyde 212 participates readily in olefination reactions 
with phosphonate 99, prepared according to the protocol of David Paurnier, to form 
preferentially the Z-olefin. Moderate selectivity was achieved with Masamune 
Roush conditions (Z: E; 5: 1) which could be improved using DBN as base. Further 
cyclisation of (Z)-214 by chemoselective reduction of the azide group using Lindlar's 
catalyst produced piperidine 220 in which the stereochernistry at C-3 is fully 
controlled. Crucially, this piperidine possesses all syn stereochernistry at C-3, C-5 
and C-6, as determined by the homonuclear coupling constants and nOe difference 
studies. This stereochernical outcome is rationalised by cyclisation through a 
transition state in which the NHBoc group preferentially occupies a pseudo 
equatorial orientation. This stereochemistry is that anticipated to be needed to 
produce ficellomycin upon further ring closure. 
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NHTeoc 
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N )rNHTeoc 
-0 
N' "'ý' -'NHBoc 3 
6Ac (Z)-214 
I 
ii 
H02C NHBoc TMSE02C NHBoc 
NN H iýý H NH OH 4 NH OAc 0 =ý 
I I.. 
( 239 0=ý11. < 220 
TeocHN TeocHN 
Scheme 100. Reagents and conditions: i) DBN, CH2CI2.10 "C -+ RT, 81%; ii) H2P Pd/CaC03. Pb(OAC)4, EtOH, 89%; iii) K2CO3. MeOH, 74%. 
Time constraints prevented us making much further progress towards the natural 
product. It was demonstrated that hydrolysis of the acetate occurred concurrent with 
the saponification of the trimethylsilyl ethyl ester. This precursor, is potentially two 
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steps away from the ring-contraction to form a I-azabicyclo[3.1.0]hexane with the 
same stereochernistry as 6. This would require re-introduction of the trimethylsilyl 
ethyl ester, mesylation of the alcohol and base-mediated ring closure. Examples of 
similar ring closures, albeit in simpler systems are known. 
121 If TBAF were used in this last step, both protecting groups in the dipeptide 
segment would also be cleaved concomitantly. 
'11ý 
H02C NHBoc HH H02C N lr; ý NH2 N Hi 
ýý 
3 steps NH OH ------------- IN- 0 N- H o 
lIX 
INH 
TeocHN 239 6 H2N 
Scheme 101 
At this point in time it is unclear whether 239 possesses the required orthogonality in 
protecting groups to further the synthesis to the natural product. The protecting 
groups for the phosphonate unit were chosen with a double cyclisation strategy in 
mind. Future work might be best undertaken with alternative protecting groups on 
this part of the molecule. 
The introduction of the guanidine group is currently an unsolved challenge. Whilst it 
is conceivable that this group could be introduced prior to piperidine formation, it is 
perhaps more prudent to introduce this polar substituent late in the synthesis. 
Another unresolved problem is the separation of the C-2 epimers. This may be 
possible once some rigidity is conferred to the system, probably after the I- 
azabicyclo[3.1.0]hexane is assembled, at which point rigorous assignment of their 
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relative stereochernistry could be undertaken. Work to resolve these challenges and 
complete the synthesis is ongoing in the group. 
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4.1. General Experimental 
Solvents and reagents were used as supplied or purified using standard procedures. 
122 Dry solvents were obtained from Aldrich Tm as anhydrous in Sure/SealTm bottles. 
Petroleum ether refers to the fraction of petroleum ether having a boiling point between 
40-60 T. All reactions were carried out under an atmosphere of nitrogen unless 
otherwise stated. Commercially available compounds were generally used without 
purification. Analytical thin layer chromatography was carried out using aluminium 
backed plates coated with Merck Kieselgel 60 F254. Plates were visualised under UV 
light and developed with potassium permanganate or cerium ammonium molybdate 
followed by heating. Column chromatography was carried out using Matrex silica 60 
unless otherwise stated. 
Infrared spectra were recorded in the range of 4000 - 600 cm'l using a Perkin Elmer 
Spectrum One FT-IR spectrometer with internal calibration. 
1H and 13 C NMR spectra were recorded using the Bruker DPX 300, Bruker Advance 
DPX 400 or Bruker DRX 500 spectrometers at operating frequencies 300,400 and 500 
MHz respectively for 1H NMR and 75,100 and 125 MHz, respectively for the 13 C NMR 
using deuterated solvents as quoted. Chemical shifts are quoted in ppm relative to 
tetramethyls i lane as reference with coupling constants being given to the nearest 0.5 Hz, 
assignments derived from COSY (1H-1H correlation), HMQC ('H_13C correlation) and 
PENDANT editing. The abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; quin, 
quintet; sext, sextet; sept, septet; m, multiplet; br, broad and app, apparent are used. 
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Low resolution mass spectra were recorded on a Kratos Profile HV3 or an Esquire 2000 
platform with electrospray ionisation. High resolution mass spectra were obtained using 
a Kratos analytical MS80 RFAO spectrometer and a Micromass Quattro 11 instrument 
(EPSRC Mass Spectrometry Service, Swansea). Compounds characterised by high- 
resolution mass spectrometry were chromatographically homogeneous. 
Elemental analysis was performed in a Carlo Erba 1160 apparatus (Warwick Analytical 
Service Ltd. ) 
Melting points were determined using the Gallenkamp MPD350 apparatus and are 
reported uncorrected. 
Optical rotations were measured on an Optical Activity Ltd. AA-1000 polarimeter, 
values are quoted in lo-ICM2g-1. 
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4.2. Experimental 
Methyl-(2Z)-7-azido-2-(benzyloxycarbonylam ino)-6-hyd roxy-hept-2-en-I -oate 
55 (94). 
H 
N 0, 
__-, 
Ph y 
0 
0H 
INS Oý, ýPh 0y 
30 
7 
N3 
I 
OH 
94 
To a stirred solution of methyl (2Z)-2-(benzyloxycarbonylamino)-6-epoxyhept-2-en-l- 
oate (1.30 g, 4.30 mmol) in dry ethanol (43 mL) at room temperature were added 
sodium azide (I. IIg, 17.00 mmol) and ammonium chloride (682 mg, 12.80 mmol) and 
the resulting solution was stirred for 9 days. Ethanol was removed in vacuo and the 
residue dissolved in water and extracted with ethyl acetate (3 x 40 mL), the combined 
organic fractions were dried over MgS04, filtered and concentrated in vacuo. Silica gel 
column chromatography (5-ý 30% ethyl acetate in petroleum ether) provided 94 (765 
mg, 52%) as a colourless oil; Rf 0.07 (ethyl acetate/petroleum ether, 30%); Vrnax 
(neat)/cm" 3421,3330,2953,2097,1719,1509; 8H (400 MHz, CA) 7.18-7.02 (5H, 
ArH), 6.49 (1 H, aPP. t, J3-4 = 7.5 Hz, H-3), 6.40 (1 H, hr. s, NH), 4.97 (2H, s, CHA 3.41 
(IH, d, JOH-6 = 2.3 Hz, OH), 3.56 (IH, app. d, J6-5 = 6.8 Hz, H-6), 3.32 QH, s, CH3), 
2.6 8 (1 H, dd, J7-7' --= 12.7, J7-6 = 6.5 Hz, H-7), 2.62 (2H, dd, J7-7' = 12.7, J7-6 = 3.9 Hz, H- 
T), 2.17 (IH, app. sextet, J44, = 14.0, J4-5 = 7.6, J4-3 = 7.5 Hz, H-4), 2.03 (IH, app. 
sextet, J4, -4 = 14.0, J4-5 = 7.6, J4'-3 = 7.5 Hz, H-4'), 1.30-1.23 (IH, m, H-5), 1.11-1.01 
(IH, m, H-5'), 8c (100 MHz, C6D6) 164.9 (CH30CO), 154.8 (NHCO), 137.0 (C-3), 
136.6 (ArC) 128.7 (2 x ArCH), 128.5 (ArCH), 127.8 (2 x ArCH), 116.3 (C-2), 70.0 (C- 
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6), 67.6 (CH2), 56.7 (C-7), 51.9 (CH30)2 32.7 (C-5), 24.5 (C-4). Spectroscopic data 
were in accordance with the reported values of Paurnier. 55 
Methyl 2-(I-azabicyclo[3.1.0]hex-2-yl)-2-(benzyloxycarbonylamino)acetate (95a 
and b 
55; 142a and b) 
0H7 
NyO, _ýPh C02CH3 ý-N 
0 
1ý 
CbzHN- 
17 
CbzHN-21\ 3 _N 
N3 C02CH3 I 
OH 
95a, b 142a and b 
Diphenylphosphino-polystyrene (732 mg, 2.19 mmol) was gently stirred in dry toluene 
(10 mL) for 30 min. To this 94 was added (696 mg, 1.99 mmol) in dry toluene (30 mL) 
and the resulting solution was stirred for 20 min at room temperature, then warmed to 70 
'C and heated overnight. It was then allowed to cool down to room temperature, filtered 
through celite and rinsed with dichloromethane (3 x 30 mL). The filtrate was 
concentrated in vacuo. Silica gel column chromatography (20 - 100% ethyl acetate in 
petroleum ether; 1% triethylamine) yielded methyl-2-(I-azabicyclo[I. 3.0]hexan-2-yl)-2- 
(benzyloxycarbonylamino)acetate derivatives (278 mg, 45%) as a mixture of four 
diastereomers as white foams: 
142a (123 mg, 20%); Rf 0.05 (20% ethyl acetate in petroleum ether); Vinax (neat) cm" 
3319,3172,2947,1712,1708,1527,1435; 8H (400 MHz, C6D6) 7.22-7.18 (2H, m, 
ArH), 7.11-7.01 (3 H, m, ArH), 5.99 (1 H, d, J=9.0 Hz, NH), 5.09 (1 H, d, J= 12.3 Hz, 
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CHHPh), 5.01 (1H, d, J= 12.3 Hz, CHHPh), 4.54 (IH, t, J=8.4 Hz, H-2), 3.33 (3H, s, 
CH30)5 3.21-3.14 (1H, m, H-3), 2.07-2.02 (IH, m, H-6), 1.59-1.52 (IH, m, H-5), 1.43- 
1.3 3 (1 H, m, H-5'), 1.26 (1 H, d, J=4.8 Hz, H-7. ), 1.20-1.05 (2H, m, H-4), 0.99 (1 H, 
d, J=2.0 Hz, H-7endo); 8c 0 00 MHz, C6D6) 172.2 (CH30CO)) 156.2 (NHCOO), 137.2 
(ArC), 128.4-128.3 (ArCH), 67.0 (CH2Ph), 65.4 (C-3)5 56.8 (C-2), 51.7 (CH30)9 38.7 
(C-6), 26.0 (C-5), 23.1 (C-7)5 22.2 (C-4); NIS (ES) m1z 327 [M+Ne] (30), 305 [M+H+] 
(100), 91 (100%); HRMS (ESý calculated for C16H21N204 305.1496 [M+H+]; found 
3051492. Anal. calcd. for C16H20NO4: C, 63.14; H, 6.62; N, 9.20 %. Found: C, 63.10; H, 
6.65; N, 8.80%. 
142b (26 mg, 4%), Rf 0.13 (ethyl acetate/petroleum ether, 20%); vma,, (neat)/cm" 3368, 
3181,2948,1710,1499; 8H (400 MHz, C6D6) 7.22-7.16 (3H, m, ArH and NH), 7.11 - 
6.99 (3H, m, ArH), 5.08 (IH, d, J= 12.0 Hz, CHHPh), 5.03 (IH, d, J= 12.0 Hz, 
CHHPh), 4.3 3 (1 H, dd, J=8.8,6.6 Hz, H-2), 3.3 8-3.29 (4H, m, CH30 and H-3), 2.15- 
2.09 (1 H, m, H-6), 1.51 (1 H, dd, J= 13.0,8.0 Hz, H-5), 1.44-1.34 (1 H, m, H-5'), 1.22 
(I H, d, J=5.0 Hz, H-7. ), 1.18-1.09 (IH, m, H-4), 1.05-0.96 (IH, m, H-4'), 0.93 (IH, 
m, H-7endo); 8C (100 MHz, C6D6) 172.0 (CH30CO)s 156.6 (NHCOO), 137.3 (ArC), 
128.5-128.2 (ArCH), 70.0 (CH2Ph), 63.7 (C-3), 57.7 (C-2), 51.8 (CH30), 38.8 (C-6), 
26.2 (C-5), 22.8 (C-7), 22.5 (C-4); NIS (ES) mlz 327 [M+Naý] (3 0), 305 [M+H+j (100), 
91 (100%); HRMS (ES) calculated for C16H21N204 305.1496 [M+H+], found 305.1496. 
95a and b (129 mg, 21%); Rf 0.18 (20% ethyl acetate in petroleum ether); vrnax 
(neat)/cm" 3334,2951,1731,1498; 8H (400 MHz, CA) 7.22-7.15 (2H, m, ArH), 7.11- 
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7.00 (3H, m, ArH), 5.87 (0.75H, d, J=8.5 Hz, NH), 5.73 (0.25H, d, J=8.0 Hz, NH), 
5.14-4.98 (2H, m, CH2Ph), 4.48 (0.25H, dd, J= 8.5,3.8 Hz, H-2), 4.40-4.33 (0.75H, m, 
H-2), 3.41 (0.25H, dd, J 8.5,3.5 Hz, H-3), 3.33 (0.75H, s, CH30), 3.29 (2.25H, s, 
CH30), 2.95 (0.75H, t, J 7.5 Hz, H-3), 2.02-1.98 (0.75H, m, H-6), 1.91-1.85 (0.25H, 
m, H-6), 1.61-1.43 (3H, m, 2x H-5, H-4), 1.31 (0.75H, d, J=5.2 Hz, H-7e, ý), 1.29 
(0.25H, d, J=5.5 Hz, H-7e, ý), 1.18-0.88 (IH, m, H-4), 0.56 (0.75H, d, J=3.3 Hz, H- 
7endo), 0.53 (0.25H, d, J=3.5 Hz, H-7endo); 8c (100 MHz, C6D6) 172.0 (CH30CO)) 171.4 
(CH30CM 157.0 (NHCOO), 156.2 (NHCOO), 137.2 (ArC), 128.5-128.4 (ArCH), 67.1 
(CH2Ph), 67.0 (CH2Ph), 66.9 (C-3), 66.0 (C-3), 59.9 (C-2), 58.1 (C-2), 51.9 (CH30)5 
51.7 (CH30)141.0 (C-6), 40.0 (C-6), 28.2 (C-7), 28.0 (C-7), 26.1 (C-5), 25.0 (C-5), 24.3 
(C-4), 22.6 (C-4); LRMS (ES) m1z 327 [M+Na+] (10), 305 [M+H+] (25), 91 (100%); 
HRMS (ES) calculated for C16H21N204 305.1496 [M+H+], found 305.1493. 
Spectroscopic data were in accordance with the reported values of Paurnier. 55 
55 2-(Trimethylsilyl)ethyl (d ieth oxyphos pho ryl) acetate (106). 
00 
2 Ho 0 
---ýO-P, 1-0--ý "-ýOllpllýl 0-1ý 0 
106 
To a stirred solution of diethylphosphonoacetic acid (7.84 g, 39.90 mmol) in dry 
tetrahydrofuran (150 mL) was added 2-trimethylsilylethanol. (8.00 mL, 55.90 mmol) 
followed by a solution of DCC (13.17 g, 63.90 mmol) and DMAP (635 mg, 5.19 mmol) 
in dry tetrahydrofuran (150 mL). The reaction mixture was stirred for 2 days at room 
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temperature, after which the precipitate was collected by filtration and washed with cold 
diethyl ether (50 mL). The filtrate was concentrated in vacuo and the resulting yellow oil 
purified by silica gel column chromatography (50 --+ 100% ethyl acetate in petroleum 
ether) to give 106 (11.75 g; 99%) as a colourless oil. Rf 0.54 (ethyl acetate, 100%); vma" 
(neat)/cm" 2955,1733,1249,1100,834 (Si(CH3)3); 5H (400 MHz, CDC13) 4.15-4.04 
(6H, In. C02CH2,2 x CH3CH20), 2.85 (2H, d, J2. p = 21.6 Hz, H-2), 1.25 (6H, t, Jme-CH2 
= 7.2 Hz, 2x CH3CH20), 0.93 (2H, t) JSiCH-HCO = 8.5 Hz, CH2Si), 0.00 (9H, s, Si(CH3)3); 
5c (100 MHz, CDC13) 165.7 (d, Jcl-p 5.7 Hz, C-1), 63.1 (SiCH2CH2), 62.4 (d, Jc. p = 
6.5 Hz, 2x OCH2CHA 34.3 (d, JC2-P 133.8 Hz, C-2), 17.1 (SiCH2)t 16.1 (d, JC-p = 6.5 
Hz, 2x CH3CH20). -1.8 (Si(CH3)3)- 
1H NMR data were in accordance with the reported 
55 values of Paurnier. 
2-(Trimethylsilyl)ethyl d iazo(d iethoxyp hos pho ryl) acetate (101). 55 
1 
a 1 
--ýO- piý-o-ý 
N2 
»U 2f 
101 
To a stirred mixture of 106 (1.18 g, 4.00 mmol) and cesium carbonate (1.30 g, 4.00 
mmol) in dry tetrahydrofuran (7.50 mL) was added dropwise a solution of 4- 
acetamidobenzensulfonyl azide (950 mg, 4.00 mmol) in dry tetrahydrofuran (3.74 mL). 
The reaction mixture was stirred for 4h at room temperature, filtered, concentrated in 
vacuo, and the resulting residue was partitioned between water (5 mL) and ethyl acetate 
(5 mL), the resulting solution was extracted with ethyl acetate (3 x 10 mL). The 
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combined organic fractions were dried over MgS04, filtered and concentrated in vacuo. 
Silica gel column chromatography (20% ethyl acetate in petroleum ether) yielded 101 
(1.18 g, 92%) as a pale yellow oil. Rf 0.05 (20% ethyl acetate in petroleum ether); vmax 
(neat)/cm" 295 5,2122,1703,1445,1274,1112,1017,835; 8H (400 MHz, CDC13) 4.23- 
4.19 (2H, m, SiCH2CH2), 4.13-4.05 (4H, m, 2x CH3CH20), 1.30-1.26 (6H, m, 2x 
CH3CH20). 0.98-0.93 (2H, m, (SiCH2)), 0.00 (9H, s, Si(CH3)3); 5c (100 MHz, CDC13) 
175.5 (C-1), 163.3 (d, Jc-p =1 1.4 Hz, C-2), 63.9 (SiCH2CH2), 63.4 (d, Jc. p = 5.7 Hz, 2x 
CH3CH20). 17.4 (SiCHA 15.9 (d, JC-p = 6.9 Hz, 2x CH3CH20). -1.7 (Si(CH3)3)- 
Spectroscopic data were in accordance with the reported values of Paumier. 55 
55 (2S)-3-Methyl-2-[2-(trimethylsilyl)ethoxycarbonylaminolbutyrate (103). 
0 'ýNH2. HCI 0"fl": 
H 
00 
103 
To a stirred solution of L-valine methyl ester hydrochloride (5.00 g, 29.80 mmol) in 
water (25 mL) was added a solution of triethylamine (5.95 mL, 42.70 mmol) in dioxane 
(25 mL) followed by 1-[2-(trimethylsilyl)ethoxycarbonyloxy]pyrrolidin-2,5-dione (8.42 
g, 32.50 mmol). The reaction mixture was stirred at room temperature overnight, then 
diluted with water (125 mL), acidified to pH -2 with aqueous saturated potassium 
hydrogen sulfate solution (50 mL) and extracted with diethyl ether (3 x 200 mL). The 
combined organic layers were dried over MgS04, filtered and concentrated in vacuo to 
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yield, without further purification, to yield 103 (7.17 g, 87%) as a colourless oil. vma" 
(neat)/cm" 3346,2955,1717,1347,1090,833; 51-1 (400 MHz, CDC13) 5.17 (IH, d, JNH-2 
= 8.5 Hz, NH), 4.21 (1 H, dd, J2-NH = 8.5, J2,3 = 4.8 Hz, H-2), 4.09 (2H, dd, 
JH'-H = 9.5, 
JH-2H = 8.5 Hz, SiCH2CHY), 3.66 (3H, s, CH30), 2.10-2.05 (IH, m, H-3), 0.94-0.92 
(2H, m, (SiCH2), 0.89 (3H, d, Jme-3 = 6.8 Hz, CHO, 0.82 (3H, d, Jme-3 = 6.8 Hz, 
CHO, 
0.00 (9H, s, (CH3)3Si); 5c (100 MHz, CDC13) 172.6 (CO), 156.5 (CO), 63.2 
(SiCH2CH2), 58.7 (C-2), 52.0 (CH30), 31.1 (C-3), 18.8 (CHA 17.6 (CH2Si)q 17.4 
(CHA 
-1.7 
(SiCH3)3)- Spectroscopic data were in accordance with the reported values 
55 
of Paumier. 
61 (2S)-3-Methyl-2-[2-(trimethylsilyl)ethoxycarbonylaminolbutyric acid (104). 
00 
liý bý HO N Y`ýýH 'i-'7-H 
00 
104 
To a stirred solution of 103 (7.17 g, 26.0 mmol) in tetrahydrofuran (48 mL) was added 
sodium hydroxide solution (2M, 25.5 mL). The reaction mixture was stirred for 3h at 
room temperature, diluted with ethyl acetate (50 mL) and acidified with aqueous 
hydrochloric acid (37 %, 4.50 mL). The aqueous layer was extracted with ethyl acetate 
(3 x 100 mL). The combined organic layers were dried over MgS04, filtered and 
concentrated in vacuo to afford 104 (7.26 g, 100%) as a colourless oil. [a]" -2.7 D 
(CHC13, C 11.7), ref [a] "-4.5 (CHC13, C 11.4)60; Vmax (neat)/cm" 2960,1715,1249, D 
834; ÖH (400 MHz, DMSO) 12.49 (IH, br. s, OH), 7.18 (IH, d, JNH-2 = 8.5 Hz, NH), 
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4.09-4.01 (2H, m, CH2CH2Si), 3.83 (IH, dd, J2-NH ý 8.5, J2-3 = 6.5 Hz, H-2), 2.02 (IH, 
m, H-3), 0.95-0.91 (2H, m, CH2Si), 0.87 (6H, t) JMe-3 = 6.7 Hz, 2x CHA 0.02 (9H, s, 
Si(CH3)3); 5c (100 MHz, DMSO) 173.4 (CO), 156.5 (CO), 61.7 (CH2CH2Si), 59.4 (C- 
2), 29.5 (C-3), 19.2 (CHA 18.0 (CHA 17.4 (CH2Si)9 -1.5 (Si(CH3)3). Spectroscopic 
data were in accordance with the reported values of Shute et al. 
61 
(2S)-3-Methyl-2-[2-(trimethylsilyl)ethoxycarbonylaminolbutyric amide (100). 55 
o0 
HO, 
lr 
H2N 
N0N lk 0 
HH 
00 
100 
To a stirred solution of 104 (440 mg, 1.70 mmol) in tetrahydrofuran (4 mL) at 0 *C was 
added triethylamine (225 VL, 1.70 mmol) followed by fast addition of ethyl 
chloroformate (157 pL, 1.70 mmol). The resulting solution was stirred at 0 *C for lh, 
followed by the addition of aqueous ammonia (28%, 512 pL) in tetrahydrofuran (185 
RL). After stirring for Ih at 0 'C, the mixture was diluted with ethyl acetate (10 mL) and 
water (5 mL). The aqueous layer was extracted with ethyl acetate (3 x8 mL) and the 
combined organic layers were washed with a saturated aqueous solution of NaHC03 (15 
mL), brine (15 mL), IM aqueous hydrochloric acid (15 mL) and water (15 mL). The 
organic layer was then dried over Na2SO4. filtered and concentrated in vacuo to provide 
a colourless gel, which crystallised on addition of petroleum ether to give 100 (298 mg, 
67%) as a colourless solid; mp 148-149 'C (Ref. mp 147 'C)55; [(X] 24 - 7.0 (CHC13, C D 
8.3), ref. [Ct] 
28 
- 7.1 (CHC13, c 
0.08))55; v..,, (neat)/cm" 3335,2955,1655,1244,831; D 
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5H (400 MHz, CDC13) 6.02 (IH, s, NH), 5.66 (IH, s, NH), 5.20 (IH, d, JNH-2 = 8.5 Hz, 
NH), 4.17-4.12 (2H, M, C02CHA 4.00 (1 H, app. t, J3-2 = 6.6 Hz, H-3), 2.13 (1 H, app. 
sextet, J2-3 = 6.6 Hz, H-2), 0.98-0.92 (8H, m, 2x CH3,2 x CH2Si(CH3)A 0.02 (9H, S, 
Si(CH3)3); 8c (100 MHz, CDC13) 174.0 (CO), 156.9 (CO), 63.5 (C02CH2)p 59.8 (C-2), 
30.7 (C-3), 19.2 (CHA 17.7 (CHA 17.6 (CH2Si)i -1.5 (Si(CHOO; LRMS (FAB) m1Z: 
261 [MH+], 136 (83%); HRMS (FAB): calcd. for CIIH25N203Si 261.163346, found 
261.163441. Spectroscopic data were in accordance with the reported values of Paurnier 
et al. 
55 
(2S)-(Diethoxy-phosphoryl)-[3-methyl-2-(2-trimethylsilanyl-ethoxycarbonylamino)- 
butyrylaminol acetic acid 2-trimethylsilanyl ethyl ester (99). 55 
0 H 
N2 Z, 1 , ýýI 0 --ly 02N Y ýrH 
, --ýO- P, ý-0--- 
0 
10 
99 
To a stirred solution of 100 (150 mg, 0.57 mmol) and 101 (260 mg, 0.81 mmol) in 
toluene (2 mL) was added rhodium(II) octanoate dimer (10 mg, 2 mol%). The resulting 
mixture was heated for 24 h at 80 T and concentrated in vacuo. The resulting residue 
was purified by silica gel column chromatography (ethyl acetate/petroleum ether; 40%) 
to provide 99 (251 mg, 79%) as a colourless solid; mp 107-109 'C (Ref. mp 109 'C); Rf 
0.4 (40% ethyl acetate in petroleum ether); [a] "- 10.7 (CHC13, c 9.7), ref. [a] 21 - 18.7 DD 
(CHC13, c 9.7) 
54; 
Vmax (neat)/cm" 3326,2954,1738,1715,1685,1295,1050,833; 5H 
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(400 MHz, CDC13) 7.33-7.22 (IH, dd, J= 35.7, J=7.4 Hz, NH), 6.70-6.68 (IH, m, 
NH), 5.14 (0.5H, dd, J2-NH = 9.0 Hz, H-2), 5.08 (0.5H, dd, J2-NH = 9.0 Hz, H-2), 4.30- 
4.11 (9H, m, CHCH(CH3)2,2 x C02CH2,2 x CH3CH20P), 2.21-2.13 (IH, m, 
CH(CH3)2), 1.35-1.28 (6H, m, 2x CH3CH20P), 1.06-0.91 (10H, m, 2x CH2Si, 2x 
CHA 0.02 (18H, s, Si(CH3)3); 8c (100 MHz, CDC13) 171.0 (d, J= 10.8 Hz, C-1), 166.5 
(CO), 156.6 (NHCO(CH)2(CH3)2), 65.0 (C02CH2), 64.9 (C02CH2)9 63.8 (d, Jc-p = 6.5 
Hz, CH3CH20), 63.5 (d, Jc-p = 6.9 Hz, CH3CH20), 59.9 (CHCH(CH3)2), 50.7 (d2 Jc. p = 
146.6 Hz, C-2). 31.2 (CH(CHOA 19.2 (CHA 19.1 (CHA 17.6 (CH2SO) 17.4 (d, Jc. p 
=CH3CH20), 17.3 (CH2SO) 16.3 (d, Jc-p = 5.7, CH3CH20), -1.5 (Si(CH3)A -1.6 
(Si(CH3)3); LRMS (FAB) m1z 555 [MH+I, 188 (37), 144 (35), 137 (20%); HRMS 
(FAB+): calcd. for C22H48N208PSi2 555.2686 [MH+]; found 555.2687. Anal. calcd. for 
C22H47N208PSi2: C, 47.63; H, 8.54; N, 5.05%. Found: C, 47.64; H, 8.54; N, 4.85%. 
55 Spectroscopic data were in accordance with the reported values of Paurnier. 
(2Z)-2-(Trimethylsilyl)ethylacetyl-2-[(trimethylsilyl)ethoxycarbonylamino-(2S)-iso- 
propylcarbonylaminolhex-2-ene (213) 
0 
TMSEO --Iy N )rNHTeoc 
(EtO)20P 0 
0 
H 
TMSEO NHTeoc 
0 
4 
213 
To a stirred solution of 99 (40 mg, 0.072 mmol) in dichloromethane (I mL) at -10 "C, 
was added dropwise DBN (8.60 pL, 0.072 mmol), and the resulting mixture was stirred 
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for 10 minutes. n-Butanal (6.70 ýtL, 0.072 mmol) was added dropwise keeping the 
internal temperature below 10 'C. The reaction mixture was stirred at 10 I'C for Ih and 
allowed to warm to room temperature with further stirring overnight. The mixture was 
concentrated in vacuo to yield a colourless oil, which after purification by silica gel 
column chromatography (30% ethyl acetate in petroleum ether; 30%) yielded (Z)-213 as 
a colourless oil (28 mg, 76%). Rf 0.64 (50% ethyl acetate in petroleum ether); 
Vmax(neat)/cm-1 3294,2956,2898,2875,1719,1669,1514,830; 8f, (300 MHz, Acetone- 
8.44 (1 H, s, =CNH-CO), 6.55 (I H, app. t, J=7.4Hz, H-3), 6.11 (IH, d, JNH-CH=8.3 
Hz, NH), 4.24-4.09 (5H, m, (CH3)2CHCH +2X C02CH2), 2.14 (3H, app. q, J4-s = 7.3 
Hz, H-4 + (CH3)2CHCH), 1.46 (2H, app. sext. J5-4 = 7.3 Hz, H-5), 1.06-0.88 (13H, 
H-6 +2x CH3 +2x CH2SO, 0.06 (9H, s, 3x CHA 0.04 (9H, s, 3x CH3); 8c (75 MHz, 
Acetone-d6) 171.0 (CO), 170.0 (CO), 164.8 (CO), 137.6 (C-3), 127.5 (C-2), 63.3 
(C02CH2), 63.0 (C02CHA 60.8 (COCHCH(CH3)2), 31.6 (CH(CH3)2), 30.0 (C-4), 22.0 
(C-5), 19.7 (C-6), 18.0 (SiCHA 18.0 (CHA 17.7 (SiCHA 14.0 (CHA -1.5 (Si(CHOA' 
1.6 (Si(CH3)3); LRMS (FAB) m1z 495 [M+Na+], 473 [M+H+], 417 (20), 188 (60), 144 
(45 %); HRMS (FAB) calculated for C22H45N205Si2,473.2867 [M+H+]; found 
473.2860. 
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(2S)-[3-Methyl-2-(2-trimethylsilylethoxycarbonylamino)-butyrylaminol-3-propyl_ 
acrylic acid 2-trimethylsilyl ethyl ester (213) 
0 
N)r = 
TMSEO --Iy ý'NHTeoc 
(EtO)20P 0 
0H 
TMSEO NWeoc 
4 
(Z)- and (E)-213 
To a stirred suspension of lithium chloride (9 mg, 0.22 mmol) in dry acetonitrile (0.5 
mL) was added 99 (40 mg, 0.072 mmol) followed by DIPEA (12.5 [tL, 0.072 mmol). To 
the clear solution was added n-butyraldehyde (6.70 gL, 0.072 mmol) in acetonitrile (0.5 
mL), then the reaction mixture was stirred overnight at room temperature. Water (I mL) 
was added and the solution extracted with dichloromethane (3 xI mL). The combined 
organic layers were dried over MgS04, filtered and concentrated in vacuo to give a 
colourless oil which was purified by silica gel column chromatography (30% ethyl 
acetate in petroleum ether) to yield 213 as a colourless oil: 
(Z)-213 (20 mg, 59%), data as previously described, and (E)-213 (5 mg, 15%): Rf 0.58 
(50% ethyl acetate in petroleum ether) 5H (300 MHz, Acetone-d6) 8.68 (0.2H, s, 
=CNHCO), 8.43 (0.8H, s, =CNHCO), 6.55 (0.8H, app. t, J=7.5 Hz, H-3), 6.45 (0.2H, 
app. t, J=7.7 Hz, H-3), 6.18 (0.2H, d, J=7.4 Hz, NH), 6.10 (0.8H, d, J=8.5 Hz, NH), 
4.29-4.09 (6H, m, CHCH(CH3)2 +2X C02CH2), 2.44 (OAH, app. q, J=7.5 Hz, H-4 + 
CHCH(CH3)2), 2.16 (1.6H, app. sept. J=6.8 Hz, H-4 + CHCH(CH3)2), 1.46 (2H, app. 
sext, J=7.4 Hz, H-5), 1.07-0.88 (13H, m, H-6 +2x CH3 +2x CH2Si), 0.06 (9H, s, 
Si(CH3)3)2 0,04 (9H, s, Si(CH3)3); Sc (75 MHz, Acetone-d6) 170.9 (CO), 170.7 (CO), 
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164.8 (CO), 137.6 (C-3), 128.0 (C-2), 63.3 (C02CH2), 62.9 (C02CH2)9 60.4 
(CHCH(CH3)2), 31.6 (CHCH(CH3)2), 30.0 (C-4), 22.0 (C-5), 22.7 (C-5) 19.7(C-6), 19.5 
(C-6), 18.2 (SiCH2), 18.0 (SiCH2)3 17.7 (SiCH2)2 14.3 (CH3)9 14.0 (CH3)2 13.9 (CH3)9 - 
1.5 (Si(CH3)3)9 -1.6 (Si(CH3)3). 
1,2-5,6-Diisopropylidene-D-mannitol. 86 
OH OH -1-0 OH 
HO 
ýýOH 
bo 0 
OH OH OH 0-lý 
D-Mannitol (100.00 g, 549 mmol) and 2,2-dimethoxypropane (160 mL, 1.30 mol) were 
mechanically stirred in freshly distilled 1,2-dimethoxyethane (240 mL) at room 
temperature. Stannous chloride (100 mg, 0.66 mmol) was added and the reaction was 
warmed up to reflux for 90 min. The heat was removed and once the reaction had ceased 
to reflux, pyridine (240 ýQ was added. The mixture was allowed to cool to room 
temperature and the solvent removed in vacuo. The resulting crude 'Was redissolved in 
dichloromethane (600 mL) and mechanically stirred under reflux until most of the solids 
had dissolved. The heat was removed and once reflux had ceased, celite (20 g) was 
added. The mixture was cooled to room temperature, the slurry was filtered through 
celite, and the filtrate was washed with dichloromethane (2 x 100 mL). The organic 
washings were combined and concentrated, to provide 1,2-5,6-diisopropylidene-D- 
mannitol (144 g, 100%), which was used without further purification; mp 120-122 *C 
(Lit. mp 118-120 *C)85; [CC] 11 + 1.5 (CH30H, c 20), lit. [a] 20 + 1.9 (CH30H, c 20)85; VM"' DD 
127 
Chapter Four: Experimental Section Maria Garcia 
(neat)/cm-1 3394-3273,2978,1157; 8H (400 MHz, CDC13) 4.18 (2H, dd, J1.1, = 12.3, JI-2 
= 6.2 Hz, H- 1), 4.11 (2H, dd, J3-3' = 8.5, J3-2 = 6.2 Hz, H-3), 3.96 (2H, dd, 
JV. 3 = 8.51 J3-2 
= 6.2 Hz, H-3'), 3.74 (2H, d, J2-3 = 6.2 Hz, H-2), 2.56 (2H, bs, OH), 1.41 (6H, s, 
CHA 
1.35 (6H, s, CH3); 8c (100 MHz, CDC13) 109.4 (2 x (CH3)2C), 76.3 (2 x C-1), 71.2 (2 x 
C-2), 66.7 (2 x C-3), 26.7 (2 x CHA 25.2 (2 x CH3)- Spectroscopic data were in 
accordance with the reported values of Schmid et al. 
86 
2,3-0-isopropylidene-D-glyceraldehyde ((R)-158). 86 
ý_O 
OH 
0-i0 
OH 0--ý 
O)fr.. H 
(R)-158 
1,2-5,6-Diisopropylidene-D-mannitoI (100.00 g, 381.00 mmol) was mechanically stirred 
in dichloromethane (I L) at 0T with saturated NaHC03 solution (40 mL). Sodium 
metaperiodate (163.1 g, 762.0 mmol) was added in portions, maintaining the internal 
temperature below 35 T. Once addition was complete, the reaction was stirred for 20 
min at 0T and for 2h at room temperature. MgS04 (90-0 g) was added and after 
stirring for 20 min, the reaction was filtered. The residue was washed with 
dichloromethane (2 x 600 mL) and the solvent from the filtrate was removed by 
distillation. The remaining oil was distilled at 30 mmHg and the fraction collected 
between 67-73 'C provided (R)-158 (72.23 g, 73%). [a]'9 + 60 (C6H69 C 1.7)9 lit. [a] 23 + DD 
70-80 (C6H6i C 1.0_1.5)85; vmax (neat)/cm" 2989,2938,17349 13749 1149; 5H(400 MHz, 
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CDC13) 9.63 (IH, app. t, JI-2 =-- 1.5 Hz, CHO), 4.30 (IH, ddd, 
J2-3 = 7.6, J2-3' = 4.8, J2-1 = 
1.5 Hz, H-2), 4.09 (IH, app. t. J3-2 = 7.6 Hz, H-3), 4.02 (IH, dd, 
JY-3 = 8.8, JV-2 = 4.8 
Hz, H-3'), 1.40 (3H, s, CHA 1.33 (3H, s, CH3); 5c (100 MHz, CDC13) 201.6 (CHO), 
I 11.1 ((CH3)2Q, 79.7 (C-3), 65.4 (C-2), 26.1 (CHA 25.0 (CH3)- Spectroscopic data 
86 
were in accordance with the reported values of Schmid et al. 
(Z)-Methyl 3-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)acrylate (160). 88 
0 
olýI 
160 
To a stirred solution of (R)-158 (3.74 g, 28.70 mmol) in methanol (120 mL) at -10 'C 
was added methyl (trimethylphosphoranylidene)acetate (11.52 g, 34.40 mmol) then the 
mixture was stirred at -10 'C for 20 h. The reaction mixture was concentrated in vacuo, 
diethyl ether (20 mL) was added and the mixture filtered. The filtrate was concentrated 
in vacuo to give a colourless oil that after purification by silica gel column 
chromatography (10% diethyl ether in petroleum ether) afforded (Z)-160 (4.05 g; 76%) 
as a colourless oil. Rf 0.08 (10% diethyl ether in petroleum ether); v (neat)/cm" 
2988-2878,1723,714; 8H (400 MHz, CDC13) 6.33 (IH, dd, J3-2 = 11.7, J3-4 = 6.7 Hz, H- 
3), 5.82 (1 H, dd, J2-3 11.7, J2-4 = 1.4 Hz, H-2), 5.46 (1 H, qd, J4-3 = 6.7, J4-2 = 1.4 Hz, 
H-4), 4.34 (IH, app. Js-s, = 7.6 Hz, H-5), 3.68 (3H, s, CH302C), 3.58 (IH, app. t, Js-. s 
= 7.6 Hz, H-5'), 1.41 (3H, s, CHA 1.35 (3H, s, CHO; 8c (100 MHz, CDC13) 166.0 (CO), 
149.5 (C-3), 120.2 (C-2), 109.7 (C(CH3)2), 73.5 (C-4), 69.3 (C-5), 51.4 (CH302C), 26.5 
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(CHA 25.3 (CH3); further elution provided (E)-160 (532 mg; 10%) was also isolated as 
a colourless oil. Rf 0.03 (10% diethyl ether in petroleum ether); 
8H (400 MHz, CDC13) 
6.8 8 (1 H, dd, J2-3 -"= 15.7, J2-4 = 5.7 Hz, H-2), 6.10 (1 H, dd, J3-2 = 15.7, 
J3-4 = 1.5 Hz, H- 
3), 4.68-4.63 (1H, m, H-4), 4.17 (IH, dd, J5-5' = 8.3, Js4 = 6.6 Hz, H-5), 3.74 (3H, s, 
CH302Q? 3.66 (IH, dd, Js-. s = 8.3, Js. -4 = 7.0 Hz, 
H-5'), 1.43 (3H, s, CHO, 1.39 (3H, s, 
CH3). Spectroscopic data were in accordance with the reported values of Sugisaki et 
al. 
88 
(5S)-(Hydroxymethyl)furan-2(5H)-one (156). 88 
ý_o 01-1 
313 
0 
4 
156 
To a stirred solution of (Z)-160 (195 mg, 0.373 mmol) in ethanol (26 mL) was added 
DOWEX 5OW-X8 (614 mg) and the suspension stirred for 8 h. The mixture was filtered 
and the solvent removed in vacuo. The crude product was dissolved in dichloromethane 
(10 mL), dried over MgS04, filtered and concentrated in vacuo. Silica gel colum 
chromatography (80% diethyl ether in petroleum ether; 80%) provided 156 (84 mg, 
99%) as a colourless gel. Rf 0.41 (5% methanol in ethyl acetate); [a] 
28-1 
- 132.7 (water, c D 
1.1), Lit. [a] 21 - 143 (water, c 1.135); v., (neat)/cm*l 3388,2968-2942,1714,1596, D 
1385,1333,1110,1048,717-683; 5H (400 MHz, CDC13) 7.48 (IH, dd, J3-4 = 5.8, J3-5 = 
1.5 Hz, H-3), 6.16 (1 H, dd, J4-3 = 5.8, J4-5 = 2.0 Hz, H-4), 5.14 (1 H, ddd, J5-6, = 5.0, JS-6 
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= 3.8, Js4 = 2.0 Hz, H-5), 3.95 (1 H, A J6-6, = 12.3, J6-s = 3.8 Hz, H-6), 3.76 (1 H, dd, 
J6--6 = 12.3, J6, -5 = 
5.0 Hz, H-6'), 2.95 (IH, s, OH); 5c (100 MHz, CDC13) 173.4 (C-2), 
153.8 (C-3), 122.9 (C-4), 84.2 (C-5), 62.2 (C-6); LRMS (EI+) m1z: 115 [M+H+], 97 (10), 
84 (100), 83 (35%); HRMS (EI+): calculated for C5H703 115.0395 [M+H+], found 
115.0398. Spectroscopic data were in accordance with the reported values of Sugisaki et 
al. 88 
(4S, 5S)-4-Benzylamino-4-[(tert-butyldiphenyisilyl)oxymethyl]dihydro-2(3H)-furan- 
one (169). 91 
0 
0 
TBDPSO 0 
54 
NH 
169 
To a stirred solution of 156 (500 mg, 4.39 mmol) in dry methanol (3.4 mL) at 0 "C was 
added dropwise benzylamine (480 gL, 4.39 mmol) and the mixture stirred for 36 h at 0 
T. It was then concentrated in vacuo and the residue dissolved in N, Y- 
dimethylformamide (10 mL). To the resulting solution was added tert-butyldiphenyisilyl 
chloride (1.5 mL, 6.45 mmol) and imidazole (470 mg, 6.90 mmol). The reaction mixture 
was stirred for 48 h at room temperature, was then partitioned between water (30 mL) 
and diethyl ether (30 mL) and the aqueous phase extracted with diethyl ether (3 x 20 
mL). The organic layers were combined, dried over MgS04, filtered and concentrated in 
vacuo. Silica get column chromatography (50% diethyl ether in petroleum ether) 
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provided 169 (0.789 g, 39%) as a yellow oil. Rf 0.1 (60% diethyl ether in light 
petroleum); [a]" + 20.3 (CHC13, C 1.1)ý 
lit. [Ct]20 + 15.3 (CHC13, c 1.08)90; DD 
Vmax(neat)/cm" 3072,2931,2858,1774,1361,1111; 
5H (400 MHz, CDC13) 7.69-7.64 
(4H, m, Affl), 7.49-7.41 (6H, m, ArH), 7.36-7.29 (5H, m, ArH), 4.38 (IH, app. q, 
J54 = 
3.4 Hz, H-5), 3.90-3.86 (2H, dd, JCH-Ar ý 11.3, JCH-NH= 3.8 Hz, PhCH2). 3.80 (2H, d, 
JCH-5 =5.5 Hz, OCHA 3.67 (1 H, app. q, 
J4-3' = 3.7 Hz, H-4), 2.98-2.91 (1 H, dd, J3-3' = 
17.8, J3-4= 7.8 Hz, H-3), 2.46-2.40 (IH, dd, J3'-3 = 17.8, J3,. 4= 4.0 Hz, H-3% 1.07 (9H, 
s, Si(CH3)3); 5c (100 MHz, CDC13) 175.8 (CO), 139.1 (ArC), 135.6 (2 x ArCH), 135.5 
(2 x ArCH), 132.6 (ArC), 132.4 (ArC), 129.9 (2 x ArCH), 128.6 (2 x ArCH), 128.0 (2 x 
ArCH), 127.8 (3 x ArCH), 127.4 (2 x ArCH), 85.1 (C-5), 64.2 (CH2), 55.7 (C-4), 51.6 
(CH20), 36.5 (C-3), 26.7 (SiC(CHDA 19-1 (SiC(CH3)3)- Spectroscopic data were in 
accordance with the reported values of Collis et al. 91 
(5S)- [(Tri ph enyl methoxy) m ethyl] -2 (5H)-fu ra none (17 1). 
92 
LC bl 
171 
To a stirred solution of 156 (1.00 g, 8.77 mmol) in dry pyridine (50 mL) was added trityl 
chloride (2.90 g, 10.50 mmol) and the resulting solution heated at 70 *C for 16 h. On 
cooling to room temperature, it was poured onto ice-water (20 mL) and extracted with 
diethyl ether (3 x 15 mL). The combined organic layer was washed with 0.1 M HCI to 
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acidic pH, then washed with saturated aqueous NaHC03 solution (20 mL) and water (20 
mL), it was then dried over Na2SO4, filtered and concentrated in vacuo to give a 
colourless oil. Purification by silica gel column chromatography (50% ethyl acetate in 
petroleum ether) gave 171 (2.31 g, 74%) as a white crystalline solid. mp 152-155 T 
(Lit. mp 152-154 `Q91; Rf 0.28 (100% ethyl acetate); [a]" - 82.6 (c 3.5 1, CHCIA Lit. D 
[cc] "- 95.1 (c 3.42, CHC13)91; Vinax (neat)/cm"l 3092,2927,1751,1607,1489,1450; 5H D 
(400 MHz, CDC13) 6.84-6.78 (6H, m, ArH + H-3), 6.64-6.62 (10H, m, ArH), 5.59 (IH, 
dd, J=5.6, J=2.1 Hz, H-4), 4.49 (1 H, tt, J=6.7, J5-6 = 4.9, J=1.7, H-5), 2.79 (2H, dd, 
J6-5 = 4.9, J= 2.5 Hz, H-6); 5C (100 MHz, CDC13) 172.8 (C-2), 154.2 (C-4), 143.3 (3 x 
ArQ, 128.6 (6 x ArCH), 128.0 (6 x ArCH), 127.3 (3 x ArCH), 122.5 (C-3), 87.0 (CphA 
82.1 (C-5), 63.4 (C-6); LRMS (FAB) m1z 356 [M+H+], 259 (5), 243 (100), 154 (56%); 
HRMS (FAB+): calcd. for C24H2103 356.141 [M+H+], found 356.140. Spectroscopic 
data were in accordance with the reported values of Garcia et al. 92 
(4S, 5S)-4-Azido-5-[(triphenylmethoxy)methylI -2(5H)-fu ra none (174). 
C 
174 
To a stirred solution of 171 (100 mg, 0.28 mmol) in water (100 ýtL), tetrahydrofuran 
(150 RL), and glacial acetic acid (17.4 M; 496 ýtL, 8.63 mmol), was added sodium azide 
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(CAUTION) (200 mg, 3.07 mmol) and the reaction mixture stirred at room temperature 
for three days. Water (I mL) was then added, and the crude reaction mixture extracted 
with ethyl acetate (3 xI mL). The combined organic layers were washed with water (2 
mL), dried over MgS04, filtered and concentrated in vacuo to give an oil, which was 
purified by silica gel column chromatography (40% ethyl acetate in petroleum ether) to 
give 174 (59 mg, 52%) as a colourless oil. Rf 0.45 (40% ethyl acetate in petroleum 
ether); Vmax (neat)/cm" 3059,2929,2101,1781,1597,1490,1448; 8H (400 MHz, 
CDC13) 7.50-7.27 (15 H, m, ArH), 4.60-4.57 (1 H, m, H-4), 4.55 (IH, br. q, J5-6= 3.2 Hz, 
H-5), 3.5 7-3.5 3 (1 H, dd, J6-6' -ý 10.8, J6-s = 3.2 Hz, H-6), 3.3 5 -3.3 2 (1 H, dd, 
J6'-6 = 10.8, 
J6--5 = 3.5 Hz, H-6'), 3.21-3.14 (1 H, dd, J3-3'= 18.0, J3-4 = 7.7 Hz, H-3), 2.64 (1 H, dd, 
JV-3 = 18.01 JY-4 = 3.6 Hz, H-3'); 8c (100 MHz, CDC13) 173.9 (C-2), 142.9 (3 x ArC), 
128.4 (5 x ArCH), 128.1 (5 x ArCH), 127.4 (5 x ArCH), 87.5 (Ph3CO)v 83.3 (C-5), 63.1 
(C-6), 58.8 (C-4), 35.1 (C-3); LRMS (ES) mlz: 423 [MH+Ne], 243 (100), 165 (40%); 
HRMS (FAB): calculated for C24H2jN303Na 422.1475 [M+Ne], found 422.1477. 
(5S)-[(tert-Butyldiphenylsilyl)oxymethyl]-2(5H)-furanone (168). 93 
0 
-0 HO 0 
0-si-O 
042 
b5 
168 
To a stirred solution of 156 (17.70 g, 155.00 mmol) and imidazole (20.70 g, 304.00 
mmol) in N, N-dimethylformamide (200 mL) at 0 T, was added tert-butyldiphenylsilyl 
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chloride (32.37 mL, 185.00 mmol). The mixture was stirred at room temperature for 16 
h then water (200 mL) was added, and the mixture was extracted with diethyl ether (3 x 
200 mL). The combined organic layers were washed with water (200 mQ and brine 
(200 mL), dried over MgS04, filtered and concentrated in vacuo to give a pale yellow 
oil, which was purified by silica gel column chromatography (10% ethyl acetate in 
petroleum ether) to give 168 (52.77 g, 96%) as a white solid. mp 80-81 'C (Lit. mp 79- 
80 oC)92 ; Rf 0.22 (20% ethyl acetate in petroleum ether); [a]" - 80.7 (c 1.05, CHCIA D 
Lit. [Cq 25 
- 81.8 (c 1.05, 
CHC13)92; Vinax (neat)/cm-1 3070,2935-2858,1749,1604,1330, D 
1099; 5H (400 MHz, CDC13) 7.64-7.61 (4H, m, ArH), 7.46-7.37 (7H, m, ArH + H-3), 
6.17 (IH, dd, J= 5.6 Hz, H-4), 5.06 (IH, app. hept, J= 1.8 Hz, H-5), 3.90 (IH, dd, J= 
10.9, J= 4.3 Hz, SiOCIIH), 3.86 (IH, dd, J= 10.9, J= 4.9 Hz, SiOCHH), 1.03 (9H, s, 
C(CH3)3); 5c (100 MHz, CDC13) 172.9 (CO), 153.9 (C-3), 135.6 (2 x ArCH), 132.7 
(ArC), 132.5 (ArC), 130.0 (2 x ArCH), 129.9 (2 x ArCH), 127.9 (2 x ArCH), 127.8 (2 x 
ArCH), 122.7 (C-4), 83.2 (C-5), 63.3 (CH2), 26.7 (C(CH3)3)) 19.2 (C(CH3)3); LRMS 
(ES) m1z: 353 [M+H+], 327 (100 %); HRMS (FABý: calcd. for C21H2503Si 353.157 
[M+H+], found 353.156. Spectroscopic data were in accordance with the reported 
values of Jeong et al. 93 
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4-(S)-Azido-5(S)-[[(tert-butyldiphenylsilyl)oxyI methyll-3,4-dihydro-(5H)-fu ran-2- 
one (17 . 
93 
, 
--Y 0 O-si-Rý 
b 
0 » 
O-Si-0 
02 
N3 
173 
To a vigorously stirred suspension of 168 (10.00 g, 0.28 mmol) in glacial acetic acid (50 
mQ, water (20 mQ and tetrahydrofuran (15 mQ, was added portionwise sodium azide 
(CAUTION) (20 g) over 4 days (8 portions), after which time the reaction mixture was 
stirred for an additional day. Water (20 mQ was added and the mixture was extracted 
with ethyl acetate (3 x 20 mL). The combined organic layers were washed with water 
(30 mQ, then the organic phase was transferred to a beaker and neutralised with a 
saturated solution of NaHC03. The combined organic layers were then washed with 
water (20 mL), then brine (20 mQ, dried over MgS04, filtered and concentrated in 
vacuo to give a colourless oil. Purification by silica gel column chromatography (5% 
ethyl acetate in petroleum ether) gave 173 (8.90 g, 79%) as a white crystalline solid: mp 
74-77 T (Lit. mp 72-74 *C)92 ; Rf 0.25 (10% ethyl acetate in petroleum ether); [a]'9 D 
19.8 (CHC13, C 1.53), lit. [a]" + 19.0 (CHC13, C 1.53)92; Vmax (neat)/cm*l 2932,2860, D 
2112,1787,1260,1111; ÖH (400 MHz, CDC13) 8.65-7.61 (4H, m, ArH), 7.49-7.37 (6H, 
m, ArH), 4.41-4.38 (2H, m, H-4 + H-5), 3.89 (IH, dd, Jg = 11.7, JCHi-5= 3.0 Hz, 
SiOCHH), 3.77 (IH, dd, Joý.. = 11.7, JciH-s 2.3 Hz, SiOCHB), 3.04 (IH, dd, J3-3' = 
18.0, J3-4 = 7.6 Hz, H-3), 2.57 (IH, dd, JY-3 18.0, J3, -4 = 
3.0 Hz, H-3'), 1.05 (9H, s, 
C(CH3)3); Öc (100 MHz, CDC13) 173.8 (CO), 135.6 (2 x ArCH), 135.4 (2 x ArCH), 
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134.6 (ArCH), 132.4 (ArC), 131.8 (ArC), 130.2 (2 x ArCH), 128.0 (2 x ArCH), 127.5 
(ArCH), 84.2 (C-5), 63.6 (CHA 58.6 (C-4), 35.2 (C-3), 26.7 (C(CHDA 19-1 (C(CH3)3); 
LRMS (CI+) m1z: 413 [M+NH4+1,370 (70), 274 (60%); FIRMS (ES+): calcd. for 
C2jH29N403Si 413.2003 [M+NH4+1, found 413.2002. Anal. calcd. for C2jH25N303Si: C, 
63.77; H, 6.37; N, 10.62%. Found: C, 63.75; H, 6.39; N, 10.48%. 
1H NMR data were in accordance with the reported values of Jeong et al. 93 
(4S, 5S)-4-Azido-5-0-(tert-butyldiphenylsilyl)-2,3-dideoxy-a, P-D-erythropento- 
furanose (182). 93 
0 si-o 
lý3 
OH 
02 
N3 
182 
To a stirred solution of 173 (1.00 g, 2.53 mmol) in dichloromethane (60 mL) at -78 *C, 
was added dropwise a solution of DIBAL-H (IM in hexanes; 37.90 mL, 38.00 mmol). 
The mixture was stirred at -78 'C for 4h and then quenched by addition of a solution of 
methanol in chloroform (1: 5, v/v; 60 mL). The solution was warmed to room 
I 
temperature, then aqueous sodium potassium tartrate (30 mL) was added. The resulting 
solution was further stirred for 1 h, then extracted with chloroform (3 x 60 mQ. The 
combined organic layers were dried over MgS04, filtered and concentrated in vacuo to 
yield a colourless oil which was purified by silica gel column chromatography (15% 
]21 + ethyl acetate in petroleum ether) to give 182 (804 mg, 80%) as a colourless oil; [aD 
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17.9 (c 1.42, CHC13); lit, [a]" + 11.5 (c 1.41, CHC13)92 ; Rf 0.40 (30% ethyl acetate in D 
light petroleum); Vmax (neat)/cm-1 3418,3072-2858,2101,1260,1111; 8H (400 MHz, 
CDC13) 7.72-7.58 (4H, m, ArH), 7.48-7.40 (6H, m, ArH), 5.58-5.53 (IH, m, H-2), 4.30- 
4.24 (1 H, m, H-4), 4.19 (0.5 H, dt, J=7.8, J=2.8 Hz, H-5), 4.04 (0.5 H, app. q, J=4.3 
Hz, H-5), 3.86-3.64 (2H, m, H-6), 3.41 (0.5H, d, JOH-2 = 6.3 Hz, OH), 3.20 (0.5H, d, JOH- 
2=6.3 Hz, OH), 2.38-2.29 (1 H, m, H-3), 21.7-2.11 (0.5H, m, H-3'), 2.06 (0.5H, dd, JV-3 
= 14.0, J=1.7 Hz, H-3'), 1.12 (4.5H, s, 3x CHA 1.09 (4.5H, s, 3x CH3); 5c (100 MHz, 
CDC13) 135.6 (ArCH), 135.5 (ArCH), 135.4 (ArCH), 132.9 (ArC), 132.8 (ArC), 132.5 
(ArC), 130.0 (ArCH), 129.9 (ArCH), 129.8 (3 x ArCH), 127.9 (ArCH), 127.. 8 (ArCH), 
127.7 (ArCH), 98.7 (C-2), 98.5 (C-2), 85.2 (C-5), 84.0 (C-5), 64.7 (C-6), 64.0 (C-6), 
61.5 (C-4), 60.9 (C-4), 40.4 (C-3), 39.1 (C-3), 26.8 (3 x CHA 26.7 (3 x CHA 19.2 
(C(CH3)3); LRMS (CI) m1z 397 [M+H+], 372 (20), 89 (100%); HRMS (ESý: calculated 
for C2jH3jN403Si 415.2160 [M+NH41, found 415.2162. Spectroscopic data were in 
accordance with the reported values of Jeong et al. 93 
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(4S, 5S)-4-(tert-B u ty loxyca rbonyla m ino)-5- [(tert-(b u tyld ip henyls ilyl)oxym ethyl] 
dihydro-2-(5H)furanone (199). 
-si-o 
Z 
lý3 
-lý C-Si-o 02 
HN y0 
ollýK 
199 
To a stirred suspension of palladium on carbon (10% w/w; 278 mg) in ethyl acetate (15 
mL), was added a mixture of 173 (2.77 g, 7.00 mmol) and di-tert-butyl dicarbonate (1.83 
g, 8.40 mmol) in ethyl acetate (13 mL). This suspension was stirred under an atmosphere 
of hydrogen for 16 h. After which time it was filtered through a celite pad, and the 
filtrate concentrated in vacuo to give a colourless oil. Purification by silica gel column 
chromatography (10% ethyl acetate in dichloromethane) gave 199 (2.38 g, 72%) as a 
white powder; mp 148-150 'C; [CC] 29,5 + 8.4 (CHC13, C 1.0); Rf 0.4 (20% ethyl acetate in D 
dichloromethane); v.,,. (neat)/cm" 3329,2960,2930,2930,2857,1778,1683,1530; 8H 
(400 MHz, Acetone-d6) 7.76-7.71 (4H, m, ArH), 7.51-7.43 (6H, m, ArH), 6.63 (1 H, s, 
NH), 4.50 (2H, br. s, H-4, H-5), 3.95 (I H, dd, J6-6"= 11.6, J6-5=2.2 Hz, H-6), 3.90 (I H, 
dd, J6-6' = 11.6, J6,. 5 = 2.9 Hz, H-6'), 2.99 (1 H, dd, J3-3' = 17.7, J3-4 = 8.8 Hz, H-3), 2.5 8 
(IH, dd, JY-3 = 17.7, J3, -4 = 
4.6 Hz, H-3% 1.41 (9H, s, OC(CH3)3), 1.05 (9H, s, 
SiC(CH3)3); 8c (100 MHz, Acetone-d6) 175.2 (C-2), 156.1 (CO), 136.2 (3 x ArCH), 
133.6 (ArC), 133.4 (ArC), 130.7 (ArCH), 128.7 (3 x ArCH), 128.6 (3 x ArCH), 86.3 (C- 
5), 79.4 (C(CH3)3), 64.9 (C-6), 49.5 (C-4), 35.7 (C-3), 28.4 (3 x CHA 26.9 (3 x CHA 
19.6 (SiC(CH3)3); LRMS (FAB) m1z 492 [M+Ne], 470 (100), 460 (60%); HRMS 
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(FAB+): calculated for C26H36NO5Si 470.236 [M+H+], found 470.235. Anal. calcd. for 
C26H35NO5Si: C, 66.49; H, 7.5 1; N, 2.98%. Found: C, 66.44; H, 7.54; N, 2.96%. 
(4S, 5S)-4-Amino-5-(tert-butyldiphenylsilyl)oxymethyldihydro-2-(5H)furanone 
(175 . 
91 
0 -si-o 
Z, 
lý3 
0 bo 0-Si-0 02 
H2N 
175 
A suspension of 173 (3.40 g, 8.60 mmol) and palladium on carbon (340 mg; 10% w/w) 
in ethyl acetate (33 mL) was stirred under an atmosphere of hydrogen for 4 h. The 
suspension was filtered through a pad of celite and concentrated in vacuo, to give a 
yellow oil that was purified by silica gel column chromatography (0 -> 10% methanol in 
ethyl acetate) to give 175 (3.05 g, 90%) as a colourless oil. Rf 0.18 (10% methanol in 
ethyl acetate, 10%); [a] "+ 10.7 (CHC13, C 0.72), Lit. [ct] 'o + 19.4 (CHC13, C 0.72)90; DD 
Vmax (neat)lcm" 3372,2932-2858,1770,1589,1259,1175,1111; 5H (400 MHz, CDC13) 
7.68-7.64 (4H, m, ArH), 7.48-7.39 (6H, m, ArH), 4.18 (IH, app. q, J=3.5 Hz, H-5), 
3.89-3.79 (3H, m, CH2+H-4), 2.97 (I H, dd, J3-3'= 17.6, J= 7.6 Hz, H-3), 2.30 (IH, dd, 
JY-3 = 17.6, J=4.9 Hz, H-3'), 1.06 (9H, s, C(CH3)3); 8c (100 MHz, CDC13) 175.6 (C-2), 
135.5 (2 x ArCH), 135.4 (2 x ArCH), 135.4 (2 x ArCH), 132.7 (ArC), 132.2 (ArC), 
129.9 (2 x ArCH), 127.8 (2 x ArCH), 87.6 (C-5), 63.7 (CHA 50-1 (C-4), 38.9 (C-3), 
26.7 (C(CH3)A 19.1 (C(CH3)3); LRMS (Cl) m1z 387 [M+NH4+1 (90), 370 [M+H+], 
140 
Chapter Four: Experimental Section Maria Garcia 
(50), 274 (20), 250 (20), 72 (60), 70 (100%); HRMS (ES) calculatcd for C2jH28NO3Si 
370.1833 [M+H+]; found 370.1833. Spectroscopic data were in accordance with the 
reported values of Collis et al. 91 
(4S, 5S)-4-Benzyloxyca rbonylam ino-5- [(tert-b utyld ip h enylsilyl)oxy m ethyl] d ihyd ro- 
2(5H)furanone (176). 91 
0 
H21ý 
, _lý 0 
0-Si- 
02 
HN 
\r 0 
Bn0 
176 
To a stirred solution of 175 (1.35 g, 3.65 mmol) in tetrahydrofuran/water (1: 1, v/v; 30 
mL) was added sodium carbonate (774 mg, 7.3 mmol) then the mixture was cooled to 0 
*C. Benzyloxycarbonyl chloride (584 ýtL, 4.09 mmol) was added dropwise. After lh, the 
mixture was allowed to warm to room temperature and stirring continued for a further 
2.5 h. The mixture was diluted with diethyl ether (15 mL), washed with water (10 mL) 
and the aqueous phase back extracted with diethyl ether (3 x 15 mL). The combined 
organic fractions were dried over Na2SO4, filtered and concentrated in vacuo to give an 
oil. Purification by silica gel column chromatography (10% ethyl acetate in petroleum 
ether) gave 176 (1.76g, 98%) as a white foam. Rf 0.31 (30% ethyl acetate in petroleum 
ether); [a]21 + 17.1 (CHC13, C 0.693); lit. [a]20 + 18.9 (CHC13, C 0.695)90; vm., DD 
(neat)/cm" 3326,3032-2859,1777,1699,14889 1528; SH (400 MHz, Acetone-d6) 7.76- 
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7.71 (5H, m, ArH), 7.50-7.42 (5H, m, ArH), 7.38-7.29 (5H, m, ArH), 7.00 (IH, br. d, J 
NH4 = 4.0 Hz, NH), 5.09 (2H, s, CH2Ph), 4.63-4.57 (IH, m, H-4), 4.54 (IH, app. q, 
J= 
2.8 Hz, H-5), 3.97-3.91 (2H, br. m, H-6), 3.03 (1 H, dd, J3-3' = 17.8, J3-4 = 9.0 Hz, H-3), 
2.61 (1 H, dd, JY-3 = 17.8, J V-4 = 4.8 Hz, H-3'), 1.06 (9H, s, 3x CH3); 8c (100 MHz, 
Acetone-d6) 175.1 (CO), 156.7 (CO), 137.9 (ArC), 136.2 (3 x ArCH), 133.5 (ArC), 
133.3 (ArC), 130.7 (3 x ArCH), 129.1 (3 x ArCH), 128.7 (6 x ArCH), 86.1 (C-5), 66.7 
(OCH2Ph), 64.9 (C-6), 49.9 (C-4), 35.7 (C-3), 26.9 (3 x CHA 19.6 (C(CH3)3); LRMS 
(FAB) m1z 504.0 [M+H+] (44), 445.9 (100), 426.0 (25), 336.0 (26), 197.0 (30), 135.0 
(77%); HRMS (FAB) calculated for C29H34NO5Si, 504.220 [M+H+]; found 504.219. 
Spectroscopic data were in accordance with the reported values of Collis et al. 91 
(4S, 5S)-4-Benzy loxyca rbonylam ino-5-0- [(tert-b u tyld imethyls ilyl)oxy m ethyl] -2,3- 
dideoxy-a, P-D-eryth ropento fu ra nose (177). 
0 %,. -j -si-o 
0C 
HN 0 
Bn0 
OH 
si-o 0, 
HN 
\r 0 
Bn0 
177 
To a stirred solution of 176 (1.74 g, 3.54 mmol) in toluene (13 mL) at -78 *C was added 
di-iso-butyl alurninium hydride (IM in hexanes; 5.32 mL, 5.32 mmol) dropwise and the 
mixture stirred for 2h at -78 'C. The reaction was quenched by the addition of methanol 
(13 mL) at -78 'C and allowed to warm to room temperature. A concentrated aqueous 
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solution of Rochelle's salt (10 mL) was added and the mixture stirred for a further 2 h, 
then this solution was extracted with ethyl acetate (3 x 10 mQ. The combined organic 
phases washed with sodium hydrogen carbonate (10 mL) and brine (10 mL), dried over 
MgS04, filtered and concentrated in vacuo to give a colourless oil. Purification by silica 
gel column chromatography (10% ethyl acetate in dichloromethane) gave 177 (1.54 g, 
89%) as a colourless oil. Rf 0.31 (30% ethyl acetate in light petroleum); [a]'9 + 27.7 D 
(CHC13, C 1.0); v.,,, (neat)/cm"l 3409,3070,2931,2857,1698,1513,1111; 8H (400 
MHz, Acetone-d6) 7.76-7.74 (5H, m, ArH), 7.47-7.30 (IOH, m, ArH), 6.55 (0.3H, d, J= 
7.5 Hz, NH), 6.3 9 (0.7H, d, J=8.3 Hz, NH), 5.5 8 (OAH, app. t, J=3.7 Hz, H-2), 5.50- 
5.46 (0.6H, m, H-2), 5.09 (3H, s, CH2 + OH), 4.48 (0.3H, app. quin., J=7.6 Hz, H-4), 
4.35 (0.7H, app. sept., J=3.8 Hz, H-4), 4.14 (0.7H, app. q, J=4.1 Hz, H-5), 3.97 
(0.3H, app. q, J=5.0 Hz, H-5), 3.89-3.81 (0.6H, m, H-6), 3.79 (IAH, d, J=3.5 Hz, H- 
6), 2.41-2.36 (0.7H, m, H-3), 2.21-2.16 (0.3H, ddd, J= 12.5, J=7.6, J=1.7 Hz, H-3), 
1.87-1.82 (IH, ddd, J= 13.3, J= 3.5, J= 1.5 Hz, H-3'), 1.05 (9H, s, (CH3)3); 8C (100 
MHz, Acetone-d6) 156.6 (CO), 138.1 (ArC), 136.2 (3 x ArCH), 134.1 (2 x ArC), 130.4 
(3 x ArCH), 129.1 (3 x ArCH), 128.5 (6 x ArCH), 98.9 (C-2), 98.5 (C-2), 85.0 (C-5), 
84.6 (C-5), 66.9 (CHA 66.5 (C-6), 64.5 (CHA 52.6 (C-4), 4 1.1 (C-3), 40.8 (C-3), 27.0 
(3 x CHA 19.6 (SiC(CH3)3); LRMS (FAB) m1z 528 [M+Na+] (30), 488 (55), 448 (35), 
269 (100%); HRMS (FAB) calculated for C28H3sNO5NaSi, 528.218 [M+Ne]; found 
528.219. 
143 
Chapter Four: Experimental Section Maria Garcia 
(4S, 5S)-4-(Iert-Bu tyloxycarbonylamino)-5-0- [(tert-bu tyld i phenyls ilyl)oxy m ethyl] -2, 
3-dideoxy-a, P-D-eryth ropentofu ra nose (183). 
OH 0-Si-0 
01 
HN y0 
OBn 
OH 
02 
0 
5c 
HN y0 
OSU 
183 
A suspension of 177 (300 mg, 0.60 mmol), di-tert-butyl dicarbonate (170 mg, 13.80 
mmol) and 10% palladium on carbon (60 mg) in methanol (15 mL) was stirred at room 
temperature under an atmosphere of hydrogen for 3 h. The suspension was filtered 
through celite to remove the catalyst and concentrated in vacuo to give a colourless oil. 
Purification by silica gel column chromatography (10% ethyl acetate in 
dichloromethane) gave 183 (217 mg, 79%) as a colourless oil: [(x] "+ 69.2 (CHC13, C D 
1.0); Rf 0.46 (10% ethyl acetate in dichloromethane); vma, (neat)/cm" 3409,3070,2931, 
2857,1698,1111; 8H (400 MHz, Acetone-d6) 7.76-7.74 (4H, m, ArH), 7.47-7.30 (6H, 
m, ArH), 6.55 (0.3H, d, J=7.5 Hz, NH), 6.39 (0.7H, d, J=8.3 Hz, NH), 5.58 (OAH, 
app. t, J= 3.7 Hz, H-2), 5.50-5.46 (0.6H, m, H-2), 4.48 (03H, app. quin, J= 7.6 Hz, H- 
4), 4.3 5 (0.7H, app. sep., J=3.8 Hz, H-4), 4.14 (1 H, app. q, J=4.1 Hz, H-5), 3.77 (2H, 
d, J=4.0 Hz, H-6), 2.41-2.36 (IH, m, H-3), 2.21-2.16 (0.5H, ddd, J= 12.5, J= 7.6, J= 
IYHz, OH), 2.03-1.96 (0.5H, m, OH), 1.87-1.82 (IH, ddd, J= 13.3, J=3.5, J= 1.5 Hz, 
H-3'), 1.42 (6H, s, 2x CHA 1.40 (3H, s, CHA 1.06 (3H, s, CHA 1.05 (6H, s, 2x CH3); 
5c (100 MHz, Acetone-46) 146.8 (CO), 138.1 (ArC), 136.4 (3 x ArCH minor), 136.2 (3 
x ArCH), 134.1 (ArC), 130.5 (2 x ArCH minor), 130.4 (2 x ArCH), 128.5 (4 x ArCH 
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minor), 128.4 (5 x ArCH), 98.9 (C-2 major), 98.5 (C-2 minor), 85.0 (C-5 major), 84.6 
(C-5 minor), 78.9 (C(CH3)3), 66.9 (C-6 minor), 65.6 (C-6 major), 52.1 (C-4 major), 51.9 
(C-4 minor), 41.1 (C-3 minor), 40.8 (C-3 major), 28.5 (C(CHOA 27.1 (3 x CH3 minor), 
27.0 (3 x CHA 19.7 (SiC(CH3)3); LRMS (FAB) m1z: 494 [M+Ne], 472 (30), 460 (60), 
454 (100%); HRMS (ES): calculated for C26H37N5OsNaSi 494.233 [M+Na+], found 
494.235. 
(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-hydroxy-5-[(tert- 
butyldiphenylsilyl)oxyl- 
N, 0-dimethylpentanamide (201). 
0 
TBDPSO\,. 
__C 
BocHN 0 
TBDPSO"'ý5 
HN 
0 
OH 
'Buo 
201 
To a stirred suspension of N, O-dimethylhydroxylamine hydrochloride (1.38 g, 14.20 
mmol) in dichloromethane (60 mL) was slowly added trimethylalurninium (2M in 
hexanes; 7.08 mL, 14.20 mmol) at 0 "C. The mixture was allowed to warm to room 
temperature, then stirred at this temperature for a further 30 minutes. A solution of 199 
(1.33 g, 2.83 mmol) in dichloromethane (14 mL) was added and the mixture, stirred 
overnight at room temperature. Hydrochloric acid (0.5 M; 30 mL, 60 mmol) was added 
then the mixture diluted with dichloromethane (30 mL). The aqueous layer was re- 
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extracted with dichloromethane (3 x 40 mL), and the combined organic phases were 
dried over MgS04, filtered and concentrated in vacuo to give a colourless oil. 
Purification by silica gel column chromatography (40% ethyl acetate in iso-hexane) to 
yield 201 (1.00 g, 67%) as a colourless oil. Rf 0.38 (50% ethyl acetate in petroleum 
ether); [a] 29*7 + 9.3 (CHC13, C 1.0); vm (neat)/cm-1 3423,2932,2858,1710,1645,1110; D 
5H (300 MHz, Acetone-d6) 7.77-7.74 (4H, m, ArH), 7.49-7.39 (6H, m, ArH), 6.02 (IH, 
d, JNH4 ý 8.5 Hz, NH), 4.3 0 (1 H, d, JOH-5: -- 5.6 Hz, OH), 4.16-4.17 (1 H, m, H-4), 3.87 
(I H, quin., J=5.6 Hz, H-5), 3.81-3.76 (1 H, dd, J6-6- = 10.6, J6-5 = 4.2 Hz, H-6), 3.75- 
3.69 (IH, dd, J6'-6 ý 10.6, J6'. 5 = 4.2, H-6'), 3.70 (3H, s, OCHA 3.11 (3H, s, NCH3), 
2.91 (1 H, dd, J3-3' ý 16.2, J3-4 = 6.2 Hz, H-3), 2.71 (1 H, dd, JY-3 =- 16.2, J3-. 4 = 4.7 Hz, H- 
3'), 1.35 (9H, s, OC(CH3)3). 1.06 (9H, s, SiC(CH3)3); 8c (75 MHz, Acetone-d6) 172.4 
(CO), 155.9 (CO), 136.1 (4 x ArCH), 134.0 (2 x ArC), 130.3 (4 x ArCH), 128.4 (2 x 
ArCH), 78.6 (C(CH3)3)2 74.0 (C-5), 66.6 (C-6), 61.3 (CHA 50.5 (C-4), 32.9 (C-3), 32.5 
(CHA28.4 (3 x CHA27.0 (3 x CHA 19.6 (C(CH3)3); LRMS (FAB) m1z 531 [M+H+] 
(50), 431 (100), 373 (20), 154 (35%); FIRMS (FAB) calculated for C28H43N206Si, 
531.2890 [M+H+]; found 531.2906. 
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k 
(3S, 4R)-3-tert-Butyloxycarbonylamino-4-methanesulfonyloxy-5-tert-butyldiphenyl- 
silyl)oxy)-N, 0-dimethylpentanamide (204). 
BocHN 0 BocHN 0 
TBDPSO ýýN'O"' 10 TBDPSO"ý5-ýl N'O"' 
6ms 
204 
To a stirred solution of 201 (1.00 g, 1.89 mmol) in dry dichloromethane (20 mL) at 0 "C 
was added portionwise triethylamine (789 gL, 5.66 mmol) and methanesulfonyl chloride 
(379 gL, 4.90 mmol). The reaction mixture was stirred at 0 'C for 30 minutes, then 
warmed to room temperature and stirred for a further 16 h. The mixture was 
concentrated in vacuo, then the residue re-dissolved in ethyl acetate (20 mL) and washed 
with saturated aqueous ammonium chloride (10 mL). The aqueous phase was re- 
extracted with ethyl acetate (3 x 10 mL) then the combined organic phases washed with 
water (10 mL), brine (10 mL), dried over MgS04, filtered and concentrated in vacuo. 
Purification by silica gel column chromatography (20 -> 100% ethyl acetate in iso- 
hexane) gave 204 (1.04 g, 90%) as a white solid; mp 180 -I 10 *C; Rf 0.25 (40% ethyl 
acetate in iso-hexane); [(, 1 
30,3 
- 17.4 (CHC13, C 
1-0); Vrnax (neat)/cm" 2933-2858,1754, D 
1653,1472,1427,1315,1111,1040; 8H (400 MHz, Acetone-d6) 7.78-7.74 (4H, m, 
ArH), 7.51-7.43 (6H, m, ArH), 6.20 (1 H, d, J=8.0 Hz, NH), 5.01 (1 H, app. q, J=5.0 
Hz, H-4), 4.48-4.41 (IH, m, H-3), 4.02-3.94 (2H, m, H-6), 3.69 (3H, s, OCHA 3.12 
(3H, s, NCHA 3.92 (3H, s, SCHA 2.88 (IH, dd, J2-3 = 6.8, J2-2' = 16.8 Hz, H-3), 2.75 
(IH, dd, J2'-3 = 4.4, J2'-2 = 16.8 Hz, H-2'), 1.37 (9H, s, OC(CH3)3). 1.08 (9H, S, 
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SiC(CH3)3); 8c (75 MHz, Acetone-d6) 172.0 (CO), 155.7 (CO), 136.2 (ArCH), 136.1 
(ArCH), 133.5 (ArC), 133.3 (ArC), 130.6 (4 x ArCH), 128.6 (4 x ArCH), 83.4 (C-4), 
79.1 (C(CH3)3), 64.2 (C-5), 61.4 (CHA 48.4 (C-3), 38.5 (2 x CHA 32.7 (C-2), 28.4 (3 x 
CHA 27.0 (3 x CHA 19.6 (SiC(CH3)3); LRMS (ES) m1z 631 [M+Na+] (100), 609 
[M+H+] (74), 509 (26%); HRMS (ES) calculated for C28H44N208SSi, 609.2660 
[M+H+]; found 609.2660. 
(4S, 5R)-4-1(tert-butyldiphenylsilyl)oxymethyll-5-(N, O-Dimethylaminoethyl)-l, 3- 
oxazolidin-2-one (206). 
0 
BocHN 0A 02 NH 
T13DPSO"'-ýN'O"' Im 
TBDPSO- oms 
N-0 
206 
To a stirred solution of 204 (288 mg, 0.47 mmol) in N, N-dimethylformamide (9 mL) 
was added sodium azide (307 mg, 4.7 mmol). The mixture was heated for Ih at 95 *C. 
On cooling to room temperature, the mixture was diluted with diethyl ether (5 mL) and 
water (5 mL), then extracted with diethyl ether (3 x5 mL). The combined organic 
fractions were washed with brine (5 mQ, dried over M9SO4, filtered and concentrated in 
vacuo to give an oil, which after silica gel column chromatography (40% ethyl acetate in 
dichloromethane) gave 206 (30 mg, 14%) as a colourless oil. Rf 0.40 (100% ethyl 
acetate); [a] 22 + 2.1 (CHC13, C 1.0); vm,, ý (neat)/cm" 3294,3072,2932,2857,1754, D 
1655,1427,1111; 8H (300 MHz, Acetone-d6) 7.76-7.73 (4H, m, ArH), 7.50-7.40 (6H, 
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m, ArH), 6.5 5 (1 H, s, NH), 4.40 (1 H, dt, J4.5 = 5.1, J4-8 = 3.5 Hz, H-4), 4.25 -4.18 (1 H, 
m, H-5), 3.94 (2H, app. d, J8-4 = 3.5 Hz, H-8), 3.73 (3H, s, OCHA 3.12 (3H, s, CHA 
2.86 (2H, m, H-6), 1.05 (9H, s, C(CH3)); 5c (75 MHz, Acetone-d6) 170.4 (CO), 158.4 
(CO), 136.3 (2 x ArCH), 136.2 (2 x ArCH), 133.9 (ArC), 133.7 (ArC), 130.6 (2 x 
ArCH), 128.5 (2 x ArCH), 128.5 (2 x ArCH), 81.8 (C-4), 65.2 (C-8), 61.5 (OCHA 50.7 
(C-5), 3 8.5 (C-6), 27.0 (3 x CHA 20.5 (NCH3)ý 14.3 (SiC(CH3)3); LRMS (FAB) m1Z 
457 [M+H+] (70), 399 (40), 307 (25), 154 (100%); HRMS (FAB) calculated for 
C24H33N205Si, 457.2157 [M+H+]; found 457.2157. 
(4S, 5R)-4-tert-Butyloxycarbonylamino-5-hydroxymethyl-2(5H)furan-2-one (185). 
ýý+ 00 si-%4ý HO\, O. 02 
HN 
\r 0 
HN 
\r 0 
00r 
185 
To a stirred solution of 199 (5.16 g, 10.90 mmol) in tetrahydrofuran (150 mL) at 0 'C, 
was added n-tetrabutylammonium fluoride (IM in THF; 16.50 mL, 16.50 mmol) 
dropwise and the resulting mixture stirred for 4h at 0 'C. The mixture was concentrated 
in vacuo, re-dissolved in ethyl acetate (100 mL) then washed with saturated aqueous 
ammonium chloride solution (30 mL), water (30 mL) and finally brine (30 mL). The 
organic phase was dried over MgS04, filtered and concentrated in vacuo to give a 
colourless oil, which after purification by silica gel column chromatography (40% ethyl 
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acetate in petroleum ether) gave 185 (2.30 g, 91%) as a white solid; mp 127-130 'C; 
21.2 
D-2.0 (CHC13, C 1.0); Rf 0.42 (100% ethyl acetate); v. a. 
(neat)/cm" 3410,3354, 
2980,1764,1682; 8H (300 MHz, Acetone-d6) 6.62 (IH, s, OH), 4.39 (IH, q, J54 = 6.9, 
JS-6 = 3.7 Hz, H-5), 4.34-4.25 (2H, m, H-4 + NH), 3.86-3.79 (IH, ddd, J". = 5.8, J6--5 = 
2.9, J=2.9 Hz, H-6), 3.78-3.70 (1 H, ddd, J6, -6 = 
5.8, J6,. 5 = 3.7, J=3.6 Hz, H-6'), 2.91 
(I H, dd, J3-3' = 17.9, J=8.9 Hz, H-3), 2.49 (1 H, dd, J3'-3= 17.9, J=4.9 Hz, H-3'), 1.41 
(9H, s, 3x CH3); 5c (75 MHz, Acetone-d6) 175.1 (CO), 156.8 (CO), 86.5 (C-5), 79.1 
(C(CH3)3), 62.4 (C-6), 49.1 (C-4), 35.1 (C-3), 28.0 (3 x CH3); LRMS (ES) m1z 485 
[2M+Na+] (100), 254 [M+Na+] (16); HRMS (ES+) calculated for CloH2lN205,249.1445 
[M+NH4+1; found 249.1449. Anal. calcd. for CIOH17NO5: C, 51.94; H, 7.41; N, 6.06 %. 
Found: C, 52.07; H, 7.40; N, 5.99%. 
(4S, 5R)-4-1(tert-Butyloxycarbonylamino)-5-azidomethyll-2(5H)furan-2-one (186). 
00 
HO N3 02 
H14 HDý 
\r 0 
00 
Nr 
186 
To a stirred solution of 185 (2.10 g, 9.08 mmol) in dichloromethane (40 mL) at 0 'C was 
added triethylamine (1.77 mL, 1.40 mmol) and methanesulfonyl chloride (914 gL, 1.30 
mmol). The mixture was stirred for 16 h at room temperature. It was then concentrated 
in vacuo. The residue was re-dissolved in ethyl acetate (20 mL), washed with aqueous 
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saturated ammonium chloride solution (10 mL), water (10 mL) and finally brine (10 
mQ. The organic phase was dried over MgS04, filtered and concentrated in vacuo to 
give the crude mesylate (3.10 g) as a yellow solid which was used without further 
purification; mp 117-118 'C; Rf 0.67 (100% ethyl acetate); vinax (neat)lctW' 3335,2981, 
2942,1766,1680,1529,1358,1180; 5H (300 MHz, Acetone-d6) 6.69 (IH, s, NH), 4.65- 
4.62 (IH, hr. m, H-5), 4.57 (IH, dd, J6-6, = 11-5, J6-5 = 2.5 Hz, H-6), 4.47 (IH, dd, J6'-6 = 
11.5, J6--5 = 5.0 Hz, H-6'), 4.35 (1 H, hr. quin, J=7.0 Hz, H-4), 3.18 (3H, s, CH3SO2), 
2.94 (IH, dd, J3-3'= 17.9, J3-4 = 9.1 Hz, H-2), 2.65 (IH, dd, JY-3 = 17.9, J3.4 = 6.5 Hz, H- 
Y), 1.42 (9H, s, 3x CH3); 5c (75 MHz, Acetone-d6) 173.9 (CO), 155.8 (CO), 82.7 (C-5), 
79.5 (C(CH3)3), 69.6 (C-6), 48.8 (C-4), 36.9 (CH3SO2)) 34.2 (C-3), 28.0 (3 x CHO; 
LRMS (ES) m1z 332 [M+Na+] (100), 276 (19), 254 (35%). 
To a stirred solution of this mesylate (3.10 g) in N, N-dimethylformamide (24 mQ was 
added sodium azide (1.63 g, 25.00 mmol). The mixture was warmed to 70 *C and stirred 
for 2 h. On cooling to room temperature, water (25 mL) was added, and the mixture 
extracted with diethyl ether (3 x 10 ml). The combined organic fractions were washed 
with sodium bicarbonate (10 mQ, brine (10 mQ, then dried over MgS04, filtered and 
concentrated in vacuo. Purification by silica gel column chromatography (60% ethyl 
acetate in petroleum ether) gave 186 (1.95 g, 84% over two steps) as a white solid; mp 
84-86 *C; [cc] '9 + 30.9 (CHC13, C 1.0); Rf 0.58 (60% ethyl acetate in petroleum ether); D 
vmax (neat)/cm*l 3353,2983,2937,2096,1777,1678; 5H (300 MHz, Acetone-d6) 6.63 
(IH, s, NH), 4.52-4.48 (IH, m, H-5), 4.31-4.22 (IH, m, H-4), 3.77 (IH, dd, J6-6, = 13.6, 
J=3.2 Hz, H-6), 3.68 (1 Hq dd, J6. -6= 13.6, J=5.6 Hz, H-6% 2.94 (1 H, dd, J3-3' = 17.8, 
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J=8.9 Hz, H-3), 2.61 (1 H, dd, JY-3 = 17.8, J=6.6 Hz, H-3'), 1.41 (9H, s, 3x CH3); 8C 
(75 MHz, Acetone-d6) 174.1 (CO), 155.9 (CO), 84.0 (C-5), 79.4 (C(CH3)3)) 53.0 (C-6), 
49.8 (C-4), 34.5 (C-3), 28.1 (3 x CH3); LRMS (ES+) m1z 535 [2M+Na+] (22), 279 
[M+Naý] (100), 129 (25), 122 (42%); HRMS (ES) calculated for ClOH2ON504,274.1510 
[M+NH4+1; found 274.15 10. Anal. calcd. for CIOH16N404: C, 46.87; H, 6.29; N, 21.86%. 
Found: C, 46.89; H, 6.23; N, 21.47%. 
(4S, 5R)-4-[(Iert-Butyloxycarbonylamino)-4-azido]-2, 3-dideoxy-a, P-D- 
crythropento-furanose (184). 
0 
N3 0 
0 
0r 
OH 
N3 02 U- 
HN 0 
0 
184 
To a stirred solution of 186 (100 mg, 0.39 mmol) in dry dichloromethane (5 mL) at -78 
T was added a solution of di-iso-butylaluminium hydride (IM in hexanes; 590 [tL, 0.59 
mmol) dropwise. The reaction mixture was stirred at -78 'C for 3 h, then saturated 
aqueous potassium sodium tartrate (5 mL) was added, and the solution stirred for a 
further 2 h. The mixture was extracted with dichloromethane (3 x5 mL), then the 
combined organic phases washed with brine (5 mQ, dried over MgS04, filtered and 
concentrated in vacuo. Purification by silica gel column chromatography (80% ethyl 
acetate in petroleum ether) gave 184 (96 mg, 95%)as a white amorphous solid; mp = 74- 
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75 'C; [al 21 + 69.2 (CHC13, C 1.0); Rf 0.58 (80% ethyl acetate in petroleum ether); v,, a,, D 
(neat)/cm-1 3348,2975,2933,2098,1683; 8H(400 MHz, CD2CI2) 5.51 (0.78H, br. s, H- 
2), 5.46 (0.22H, app. t, J= 3.9 Hz, H-2), 5.39 (IH, d, J= 8.3 Hz, NH), 4.81 (0.25 Hz, s, 
OH), 4.43 (0.75H, s, OH), 4.23-4.15 (0.17H, m, H-5), 4.11 (0.83H, dt, J=5.5, J=3.7 
Hz, H-5), 3.92-3.81 (0.7H, m, H-4), 3.80-3.78 (0.3H, m, H-4), 3.49-3.37 (1.2H, m, H-6), 
3.23 (0.8H, dd, J= 12.8, J=5.2 Hz, H-6), 2.28-2.16 (1 H, m, H-3), 1.89-1.84 (0.1 H, m, 
H-3% 1.78 (0.9H, dd, J= 13.8, J=2.1 Hz, H-3'), 1.3 5 (9H, 3x CH3); 5c (100 MHz, 
CD2CI2) 155.8 (CO), 99.1 (C-2 major), 98.6 (C-2 minor), 84.1 (C-5 minor), 83.9 (C-5 
major), 80.1 (C(CH3)3)) 53.6 (C-6 major), 53.5 (C-6 minor), 52.5 (C-4 major), 52.5 (C-4 
minor), 40.4 (C-3 minor), 39.9 (C-3 major), 28.4 (3 x CH3 major), 28.4 (3 x CH3 minor); 
LRMS (Cl+) mlz 259 [M+H+] (10), 241 (60), 202 (100), 159 (15%); HRMS (ES) 
calculated for CIOH19N404,259.140 [M+H+]; found 259.139. Anal. calcd. for 
CIOH18N504: C, 46.50; H, 7.02; N, 21.69%. Found: C, 46.72; H, 7.04; N, 21.14%. 
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(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-hydroxy-5-azido-N, 0-dimethylpentan- 
amide (107). 
00 
N3 
. - 
c 
'Bu0--1-NH 0 
Z b. 101*-ý 
HN N3---5 N 
\ro ÖH 
113u0 
107 
To a stirred solution of N, O-dimethylhydroxylamine hydrochloride (1.89 g, 19.50 
mmol) in dry tetrahydrofuran (35 mL) at 0 'C was added droPwise trimethylaluminiurn 
(2M in hexanes; 9.80 mL, 19.50 mmol). The mixture was stirred for 30 min at room 
temperature and a solution of 186 (1.00 g, 3.90 mmol) in dichloromethane (35 mL) was 
then added. The mixture was stirred for 4 h, then quenched by the addition of a saturated 
aqueous solution of potassium sodium tartrate (70 mL) and stirred for 2 h. It was then 
extracted with dichloromethane (3 x 40 mL), washed with brine (40 mL), dried over 
MgS04, filtered and concentrated in vacuo to give a colourless oil that after purification 
by silica gel column chromatography (60% ethyl acetate in petroleum ether) afforded 
207 as a white foam (1.14 g, 92%); [a]" + 14.6 (CHC13, C 1.0); Rf 0.26 (60% ethyl D 
acetate in petroleum ether); v. a,, (neat)/cm" 3354,2977,2937,2097,1687,1641; 5tj 
(400 MHz, Acetone-d6) 6.05 (1 H, d, J=7.5 Hz, NH), 4.71 (1 H, d, J=6.0 Hz, OH), 
3.98-3.85 (2H, m, H-4 + H-3), 3.73 (3H, s, CHA 3.36 (IH, dd, J5-5, = 12.9, J=2.7 Hz, 
H-5), 3.30 (IH, dd, J5, -s= 12.9, J= 7. OHz, H-5'), 3.12 (3H, s, CHA2.89 (I H, dd, J2-2- = 
16.0, J=5.8 Hz, H-2), 2.75 (IH, dd, J2-. 2 = 16.0, J=4.3 Hz, H-2'), 1.39 (9H, s, 3x 
CH3); 8c (100 MHz, Acetone-d6) 169.8 (CO), 156.0 (CO), 78.9 (C(CH3)3), 73.2 (C-3), 
61.3 (CHA 55.0 (C-5), 50.9 (C-6), 33.0 (C-2), 31.9 (CHA 28.3 (3 x CHO; LRMS 
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(FAB) m1z 318 [M+H+l (100), 262 (35), 218 (50), 201 (15), 154 (30), 136 (20%); 
HRMS (FAB) calculated for C12H24N50s, 318.177 [M+H+]; found 318.176. 
(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-methanesulfonyloxy-5-azido-N, O-dime- 
thylpentanamide (208). 
0 
1-ýO NH 0 
N 1-1,1ý 3N 
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N3 N' 
0, 
s 
6 ý'01 
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To a stirred solution of 207 (1.00 g, 3.15 mmol) in dry dichloromethane (20 mL) at 0 'C 
was added triethylamine (1.32 mL, 9.45 mmol) then methanesulfonyl chloride (634 gL, 
8.19 mmol) dropwise. The mixture was allowed to warm to room temperature, then 
stirred for 4 h. The mixture was concentrated in vacuo, re-dissolved in ethyl acetate (20 
mL), then washed with saturated aqueous ammonium chloride (5 mL), water (5 mL) and 
brine (5 mL). The organic layer was dried over MgS04, filtered and concentrated in 
vacuo to give a yellow oil. Purification by silica gel column chromatography (60% ethyl 
acetate in petroleum ether) gave 208 (939 mg, 75%) as a white foam; [a] 24 - 23.7 D 
(CHC13, C 1.0); Rf 0.45 (60% ethyl acetate in petroleum ether); v,,,,, (neat)/cm-1 3338, 
2978,2938,2105,1705,1650,1497,1391,1344; 8H (400 MHz, Acetone-46) 4.97 (IH, 
dt, J4-5 = 10-02 J4-3 = 6.3 Hz, H-4), 4.29 (IH, dd, J3-2 = 11-5, J3-4 = 6.3 Hz, H-3), 3.84 
(IH, dd, Js-5- = 13.7, J54 = 3.8 Hz, H-5), 3.73 (3H, s, CHA3.64 (IH, dd, J5-. 5 = 13.7, J5-. 
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4=6.3 Hz, H-5% 3.23 (3H, s, CH3), 3.12 (3H, s, CHA 2.88 
(1 H, dd, J2-2' = 16.7, J2-3 = 
6.8 Hz, H-2), 2.79 (IH, dd, J2'-2 = 16.7, J2'-3 = 4.5 Hz, H-2% 1.40 (9H, s, 3x CH3); 8C 
(100 MHz, Acetone-d6) 171.7 (CO), 155.6 (CO), 81.0 (C-4), 79.1 (C(CH3)3), 61.3 
(CHA 51.9 (C-5), 48.7 (C-3), 38.4 (CHA 32.4 (C-2), 31.9 (CHA 28.2 (3 x CHD ; 
LRMS (ES+) m1z 813 [2M+Ne] (6), 435 [M+" (15), 418 [M+Ne] (100), 396 [M+H] 
(13), 340 (31), 296 (15%); HRMS (ES) calculated for C13H26N507S. 396.1547 [M+H]; 
found 396.1547. 
(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-methanesulfonyloxy-5-azido-pentanaI 
(209). 
0 
0 
)ý 
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To a stirred solution of 208 (100 mg, 0.25 mmol) in dry tetrahydrofuran (5 mL) at -78 T 
was added a solution of di-iso-butylaluminium hydride (IM in hexanes; 375 [tL, 0.36 
mmol) dropwise. The mixture was stirred at -78 'C for 4 h, then transferred via canula to 
a stirred mixture of ethyl acetate (5 mL) and saturated aqueous potassium sodium 
tartrate (5 mL) at 0 'C. After stirring overnight at room temperature, the mixture was 
extracted with ethyl acetate (3 x5 mL). The combined organic layers washed with brine 
(5 mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by silica gel 
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column chromatography (30% ethyl acetate in petroleum ether) gave 209 (46 mg, 55%) 
as a colourless oil; [a] "- 44.0 (CHC13, C 1.0); Rf 0.56 (60% ethyl acetate in petroleum D 
ether); vn. (neat)/cm" 3381,2979,2939,2106,1699,1513,1392,1336; 811 (400 MHz, 
Acetone-d6) 9.71 (1 H, d, JI -2= 2.1 Hz, CHO), 6.32 (IH, d, 
JNE-3= 8.3 Hz, NH), 4.90 
(I H, app. dt, J4-5, = 6.0, J=4.0 Hz, H-4), 4.44 (1 H, dddd, J3-2 =9.4, 
J3-NIj = 8.3, 
J3-2' = 
4.2, J3-4= 4.1 Hz, H-3), 3.8 3 (1 H, dd, J5-5' = 13.6, J5-4= 3.8 Hz, H-5), 3.66 (1 H, dd, J5-5' 
= 13.6, 
J5,. 4= 6.3 Hz, H-5'), 3.23 (3H, s, CH3S), 2.88 (IH, 
ddd, J2-2. = 17.2, J2-3= 9.4, 
J2-1 = 2.1 Hz, H-2), 2.74 (IH, br. 
dd, J2'-2 = 17.2, J2'-3= 4.2 Hz, H-2'), 1.40 (9H, s, 3x 
CH3); 5c (100 MHz, Acetone-46) 200.1 (CHO), 155.7 (CO), 80.4 (C-4), 79.4 (QCH3)A 
51.8 (C-5), 47.4 (C-3), 44.1 (C-2), 38.5 (CH3S), 28.2 (3 x CH3); LRMS (ES+) mlz 359 
[M+Naý] (100), 281 (20%); HRMS (ES) calculated for CIIH2oN4NaO6S, 359.0996 
[M+Na+]; found 359.0992. 
(4S, 5R)-4-(tert-Butyloxycarbonylamino)-5-azidomethyl-2,3-dihydrofuran (210). 
0 
'Bu0 lýI NH 0 
Ni""ýH 37 
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To a stirred solution of 209 (90 mg, 0.27 mmol) in dry N, A"-dimethylformamide (I 
mL), was added potassium carbonate (37 mg, 0.27 mmol). After 6 h, water (I mL) was 
added, and the mixture extracted with diethyl ether (3 xI mL). The combined organic 
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layers were dried over MgS04, filtered and concentrated in vacuo. Purification by silica 
gel column chromatography (30% ethyl acetate in petroleum ether) afforded 210 (18 mg, 
28%) as a colourless oil. Rf 0.72 (60% ethyl acetate in petroleum ether); [a]'9 - 11.2 D 
(CHC132 C 1-0); Vmax (neat)/cm-1 3346,2978,2932,29322 2098,1702,1615; 5H (400 
MHz, Acetone-d6) 7.16 (1 H, d, JNH4 = 8.8 Hz, NH), 6.41 (1 H, dd, J2-3 = 3.0, J2-5 = 1.9 
Hz, H-2), 5.70 (1 H, dd, J4-NH = 8.8 Hz, J4-5 = 4.6 Hz, H-4), 4.92 (1 H, tq J3-2 = 2.9 Hz, H- 
3), 3.48-3.44 (IH, dd, J6-6, = 12.3, J6-s = 5.8 Hz, H-6), 3.39 (IH, dd, J6,6 = 12.3, J6'. 5 = 
7.1 Hz, H-6'), 3.07-3.01 (1 H, m, H-5), 1.42 (9H, s, 3x CH3); 5c (100 MHz, Acetone-d6) 
155.34 (CO), 146.7 (C-2), 100.5 (C-3), 87.5 (C-4), 79.5 (C(CH3)3)9 54.0 (C-6), 48.4 (C- 
5), 28.2 (3 X CH3); LRMS (ESý mlz 503 (100) [2M+Naý], 263 (28%) [M+Naý]; HRMS 
(ES) calculated for CjoH20N503p 258.1561 [M+NH4+1; found 258.1560. 
(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-acetyloxy-5-azido-N, 0-dimethylpentan- 
amide (211). 
40 MH 0 
--- - --------- »- 
ÖH 1 
ýOINH 0 
N3 N' 
OY 1 
211 
To a stirred solution of 207 (1.00 g, 3.15 mmol) in dry dichloromethane (20 mL) at 0 'C 
were added dry pyridine (2.55 mL, 31.50 mmol), 4-dimethylaminopyridine (231 mg, 
1.89 mmol) and acetic anhydride (1.84 mL, 19.50 mmol). The mixture was stirred at 
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room for 4 h, then concentrated in vacuo. Purification by silica gel column 
chromatography (20% ethyl acetate in petroleum ether) gave 211 (1.06 g, 94%) as a 
white amorphous solid; mp 74-76 IC; [a] 21 + 9.9 (CHC13, C 1.0); Rf 0.37 (40% ethyl D 
acetate in petroleum ether); v. (neat)/cm-1 3334,2977,2103,1739,1681,1657,1532; 
8H (400 MHz, Acetone-d6) 5.81 (1 H, d, J NH-3 = 9.0 Hz, NH), 5.11-5.06 (1 H, m, H-4), 
4.08 (1 H, app. sept., J= 4.7 Hz, H-3), 3.58 (3H, s, CH3), 3.46 (IH, dd, Js-s- = 13.3, Js4= 
3.0 Hz, H-5), 3.34 (IH, dd, J5'-5 = 13.3, J5.. 4 = 6.3 Hz, H-5'), 3.07 (3H, s, CHA 2.81 
(I H, hr. d, J2-2- = 16.6 Hz, H-2), 2.45 (1 H, dd, J2'-2 = 16.6, J=4.3 Hz, H-2'), 2.00 (3H, s, 
CH3C02)y 1.33 (9H, s, 3x CH3); 5c (100 MHz, Acetone-d6) 171.8 (CO), 169.7 (CO), 
155.1 (CO), 79.4 (C(CH3)3), 72.7 (C-4), 6 1.1 (CHA 51.3 (C-5), 47.6 (C-3)o 31.8 (CHO) 
31.5 (C-2), 28.1 (3 x CHA 20.6 (CH3CO2); LRMS (ES) m1z 3 82 [M+Ne] (100), 326 
(12), 282 (40%); HRMS (ES) calculated for C14H26N506,360.1878 [M+H+]; found 
360.1877. Anal. calcd. for C14H25N506: C, 46.79 ; H, 7.01; N, 19.49%. Found: C, 46.78; 
H, 7.0 1; N, 19.19%. 
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(3S, 4R)-3-(tert-Butyloxycarbonylamino)-4-acetyloxy-5-azido-pentanaI (212). 
40 
0 lýI NH 0 
N -'-ýN , 
01--ý 
oir 
0 
0 
ljý -ýOýNH 0 
, 'A N3" 5H 
OY 
0 
212 
To a stirred solution of 211 (50 mg, 0.14 mmol) in dry tetrahydrofuran (I mL) at -50 'C 
was added di-iso-butylaluminium hydride (IM in hexanes; 153 gL, 0.15 mmol) 
dropwise. The mixture was stirred at -50 *C for 4 h, then transferred via canula to a 
stirred solution of ethyl acetate (I mL) and saturated aqueous of potassium sodium 
tartrate (2 mL) at 0 *C. After sitrring overnight at room temperature, the mixture was 
extracted with ethyl acetate (3 x. 2 mL). The combined organic layers washed with brine 
(2 mQ, dried over Na2SO4, filtered and concentrated in vacuo. Purification by silica gel 
column chromatography (30% diethyl ether in petroleum ether) gave 212 (33 mg, 79%) 
as a colourless oil; [a] "+1.2 (CHC13, C 1.02); Rf 0.45 (40% diethyl ether in D 
dichloromethane); vmýý (neat)/cm-1 3353,2979,2099,1712,1517; 8H (400 MHz, 
CD2CI2) 9.71 (1 H, hr. t, JI-2 = 1.3 Hz, H- 1), 5.19 (1 H, d, JNH-3 = 8.8 Hz, NH), 5.07 (1 H, 
app. sext., J=3.0 Hz, H-4), 4.31 (1 H, app. quin., J=6.8 Hz, H-3), 3.5 5 (1 H, dd, J5-5, = 
13.4, J54 = 3.8 Hz, H-5), 3.46 (1 H, dd, J5, -5 = 
13.4, J5-. 4 = 5.8 Hz, H-5'), 2.68 (1 H, d, J2. 
2' = 6.0, J2-1 = 1.2 Hz, H-2), 2.67 (1 H, d, J2'-2 = 6.0, J2.., = 1.3 Hz, H-2') , 2.10 (3 H, s, 
CHA 1.43 (9H, s, 3x CH3); 8c (100 MHz, CD2CI2) 200.3 (C-1), 170.4 (CO), 155.4 
(CO)2 80.3 (C(CH3)3)2 73.4 (C-4), 51.5 (C-5), 47.0 (C-3), 44.8 (C-2), 28.3 (3 x CHA 
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20.9 (CH3); LRMS (ES) mlz 623 [2M+Naý] (36), 323 [M+Naý] (100), 217 (48%); 
HRMS (ES) calculated for C, 21120N40sNa, 323.1326 [M+Na+]; found 323.1324. 
(5S, 6R, 2Z)-1(2S)-3-Methyl-2-(2-trimethylsilylethoxycarbonylamino)butyrylaminoI 
-5-(Iert-butyloxycarbonylamino)-6-acetyloxy-7-azido-heptyl-2-ene-2-trimethyl-silyI 
ethyl ester (214). 
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MethodA: 
(E)-214 
To a stirred suspension of lithium chloride (13 mg, 0.31 mmol) in dry acetonitrile (I 
mL) were added 99 (170 mg, 0.31 mmol) in acetonitrile (2 mL), then d Wso-propyl ethyl 
amine (53 gL, 0.31 mmol). After 10 min, 212 (92 mg, 0.31 mmol) in acetonitrile (1 mL) 
was added. The mixture was stirred for 16 h at room temperature, then concentrated in 
vacuo. The residue was re-dissolved in ether (4 mQ, washed with water (I mL) then 
brine (I mL), dried over MgS04, filtered and concentrated in vacuo. Purification by 
silica gel column chromatography (20% diethyl ether in dichloromethane) gave (E)-214 
(24 mg, I I%); [a]2' - 38.3 (CHC13, C 1.0); Rf 0.35 (20% diethyl ether in D 
dichloromethane); vma. (neat)/cm-1 3307,2957,2100,1713,1683,1515; 5H (500 MHz, 
Acetone-d6) 8.74 (1 H, s, =CNHCO), 6.50 (IH, app. t, J34 = 7.8 Hz, H-3), 6.17 (I H, br. 
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s, NHB oc), 6.13 (1 H, d, JNH-8 ý 9.4 Hz, NHTeoc), 5.10 (1 H, app. sept., J6-7 = 3.4 Hz, H- 
6), 4.31-4.26 (2H, m, C02CH2), 4.15-4.09 (2H, M, C02CH2), 4.05 (1 H, app. t, J8-9 = 7.1 
Hz, NHCHCH(CH3)2), 3.93-3.89 (1 H, m, H-5), 3.5 8 (1 H, dd, J7-7' = 13.3, J7-6 = 3.4 Hz, 
H-7), 3.52 (IH, dd, JT-7 = 13.3, J=7.5 Hz, H-T), 2.68-2.60 (2H, m, H-4), 2.16 (1 H, q, 
j9-10 = 6.7 Hz, NHCHCH(CH3)21 2.07 (3H, s, CH3C0), 1.39 (9H, s, 3x CH3), 0.99-0.96 
(4H, dd, J=8.5, J=5.0 Hz, 2x CH2Si), 0.94 (6H, d, Jlo-g = 6.7 Hz, 2x CH3), 0.07 (9H, 
s, Si(CH3)3), 0.04 (9H, s, Si(CH3)3); 8c (125 MHz, Acetone-d6) 170.9 (CO), 170.3 (CO), 
164.5 (CO), 157.2 (CO), 156.3 (CO), 129.1 (C-2), 126.4 (C-3), 79.0 (C(CH3)3» 74.3 (C- 
6), 63.9 (C02CH2), 63.0 (CO2CH2), 61.2 (C-9), 52.0 (C-5), 51.6 (C-7), 31.4 (C-8), 30.5 
(C-4), 28.4 (3 x CH3), 20.8 (CH3C0), 19.5 (CH3» 18.2 (CH2Si)9 18.0 (CH3)p 17.8 
(CH2Si) 
-1.6 (Si(CH3)3)2 -1.7 
(Si(CH3)3); LRMS (ES+) mlz 723 [M+Naý] (46), 701 
[M+H+] (29), 601 (100%); HRMS (ES+) calýulated fOr C30H57N6O9Si29 701.3720 
[M+H+]; found 701.3721. 
Further elution provided (Z)-214a (106 mg, 51%) as a colourless glassy solid; mp 74-75 
'C; [a] "+3.9 (CHC13, C 1.0); Rf 0.32 (20% diethyl ether in dichloromethane); D Vmax 
(neat)/cm-1 3320,2956,2100,1715,1685,1518; 8H (400 MHz, Acetone-d6) 8.47 (IH, s, 
=CNHCO), 6.59 (IH, app. t, J=7.0 Hz, H-3), 6.45 (IH, d, JNH-S = 8.5 Hz, NHBoc), 
6.18 (IH, d, J= 7.5 Hz, NHTeoc), 5.13-5.09 (IH, m, H-6), 4.21 (4H, app. t, J= 8.4 Hz, 
2x C02CH2), 4.16-4.06 (1 H, m, NHCHCH(CH3)2), 3.97 (1 H, app. sep, J=5.0 Hz, H- 
5), 3.50-3.41 (2H, m, H-7), 2.50-2.33 (2H, m, H-4), 2.19 (IH, app. sext, J=6.8 Hz, 
(CH3)2CHCHNH), 2.06 (3H, s, CH3CO), 1.40 (9H, s, 3x CHA 1.04-0.99 (10H, m, 2x 
CH2Si + NHCHCH(CH3)2), 0.05 (9H, br. s, C(CHDA 0.04 (9H. br. s, C(CH3)3); 5C (100 
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MHz, Acetone-d6) 171.1 (CO), 170.3 (CO), 164.6 (CO), 157.4 (CO), 156.4 (CO), 133.7 
(C-3), 128.7 (C-2), 79.1 (C(CH3)3), 74.3 (C-6), 63.7 (C02CH2), 63.1 (C02CH2)9 61.2 
(NHCH), 51.7 (C-7), 51.2 (C-5), 31.5 (CH3)2CHCHNH), 28.6 (C-4), 28.5 (3 x CH3), 
20.9 (CH3C0)i 19.7 «CH3CH3)CHCHNH), 18.2 «CH3CH3)CHCHNH), 17.8 (2 x 
CH2Si)e 
-1.5 (Si(CH3)3)9 -1.6 (Si(CH3)3); LRMS (ES+) mlz 723 [M+Na+] (18), 601 
(100%); HRMS (ESI calculated for C3oH56N6Na09Si2,723.3540 [M+W]; found 
723.3539. Anal. ealed. for C30H56N6O9Si2: C, 51.40; H, 8.05; N, 11.99%. Found: C, 
51.61; H, 8.05; N, 11.39%. 
Method B: 
To a stirred solution of 99 (185 mg, 0.33 mmol) in dichloromethane (2 mL) at 10 *C was 
added DBN (40 gL, 0.33 mmol) dropwise. After 10 min, to this mixture was added 212 
(100 mg, 0.33 mmol) in dichloromethane (I mL) at 10 T. After stirring overnight at 
room ptemperature, the solution was concentrated in vacuo. Purification by silica gel 
column chromatography (10% diethyl ether in dichloromethane) gave (Z)-214 (181 mg, 
81 %) as a colourless glassy solid. Data as previously described. 
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(2R, 4SI, 5R', 2S")- and (2S, 4S', 5R', 2S")-(5'-Acetoxy-4'-tert- 
butyloxycarbonylamino-piperidin-21-yl)-[(2"-trimethylsilylethoxycarbonylamino) 
butyrylaminol -acetic acid trim ethyls ilylethyl ester (220). 
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MelhodA: A suspension of (Z)-214 (160 mg, 0.235 mmol) and palladium on carbon (16 
mg; 10% w/w) in ethyl acetate (I mL) was stirred under an atmosphere of hydrogen for 
4 h. The mixture was filtered through celite to remove the catalyst, then concentrated in 
vacuo. Purification by column chromatography (20% diethyl ether in dichloromethane) 
gave 220 (106 mg, 69%) as a white glassy solid and as an inseparable 1: 1.2 mixture of 
epimers at C-2 as judged by 1H NMR spectroscopy; Rf 0.30 (20% diethyl ether in 
dichloromethane); Vmax (neat)/cm" 3319,2955,1712,1510; 811 (500 MHz, CD2CI2) 6.82 
(0.45H, br. s, C-NHCO), 6.77 (0.55H, d, JNH-2-= 7.3 Hz, C-NHCO), 5.22 (IH, br. s, 
NHVal), 4.86 (IH, br. s, H-5'), 4.73 (IH, br. s, NHBoc), 4.51 (0.39H, br. dd, J2. Nj = 
7.2, J 2-2' = 5.4 Hz, H-2), 4.47 (0.6 1 H, dd, J2-NH = 7.3, J2-2, = 3.5 Hz, H-2), 4.26 (2H, dd, 
J=9.7, J=6.6 Hz, CH2CO2), 4.20-4.15 (2H, m, CH2CO2), 4.07-3.99 (1 H, m, H-2"), 
3.82 (1 H, hr. s, H-4'), 3.25 (1 H, dd, J6'-6'a = 15, J6-. 5- = 2.2 Hz, H-6'), 3.17 (0.54H, app. 
d, J= 11.3 Hz, H-2'), 2.99 (0.46H, app. d, J= 13.5 Hz, H-2'), 2.77 (1 H, app. t, J= 12.9 
Hz, H-6'a), 2.16 (IH, app. sext., J=6.6 Hz, H-3"), 2.11 (1.17H, s, CH3CO), 2.10 
(1.83H, s, CH3CO), 1.79 (1 H, app. td, J=9.4, J=2.0 Hz, H-3'), 1.44 (11 H, hr. s, 
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C(CH3)3 + H-4'a + NHpip) 1.09-0.93 (10H, m, 2x CH2Si +2x CHA 0.09 (3.51H, s, 
Si(CH3)3)9 0.08 (5.49H, s, Si(CH3)A 0.07 (9H, s, Si(CH3)3); 8C (125 MHz, CD2C12) 
172.1 (CO), 171.9 (CO major), 171.6 (CO), 171.1 (CO major), 171.0 (CO), 170.7 (CO 
major), 170.5 (CO), 170.4 (CO major), 156.9 (CO), 155.0 (CO major), 79.7 (C(CHDA 
70.1 (C-5'), 69.9 (C-5' major), 64.6 (CH2CO2 major), 64.5 (CH2CO2 major), 64.4 
(CH2CO2), 63.7 (CH2C02)) 60.6 (C-2"), 60.4 (C-2' major), 57.3 (C-2'), 56.9 (C-2' 
major), 56.5 (C-2 major), 56.2 (C-2), 49.7 (C-4'), 49.6 (C-4' major), 48.6 (C-6'), 48.4 
(C-6' major), 31.9 (C-3' major), 31.5 (C-3"), 31.0 (C-3'), 30.5 (C-3" major), 28.4 Qx 
CHA21.4 (CH3CO major), 21.3 (CH3CM 19.5 (C-4" major), 19.3 (C-4"), 19.2 (C-4"), 
18.0 (2 x CH2Si major), 17.9 (C-10 major), 17.6 (2 x CH2Si), -1.4 (2 x Si(CH3)3 major), 
-1.5 (2 x Si(CH3)3); LRMS (ES) mlz 697 [M+Ne] (12), 675 [M+H+] (100%); HRMS 
(ES+) calculated for C3oH59N409Si2,675.3815 [M+H+]; found 675.3819. 
Method B: A suspension of (Z)-214 (100 mg, 0.143 mmol) and Lindlar's catalyst (20 
mg; 20 % w/w) in ethanol (I mL) was stirred under an atmosphere of hydrogen for 20 h. 
The mixture was filtered through celite to remove the catalyst, then concentrated in 
vacuo. Purification by column chromatography (20% diethyl ether in dichloromethane) 
gave 220 (86 mg, 89%) as a white glassy solid and as an inseparable 1: 5 mixture of 
epimers at C-2 as judged by lH NMR spectroscopy; 5H (500 MHz, CD2CI2) 6.83 (0.16H, 
d, J=7.8 Hz, CRNHCO), 6.76 (0.84H, d, JNH-2 = 7.3 Hz, CHNHCO), 5.22 (1 H, br. s, 
NHVal), 4.87 (1 H, s, H-5'), 4.72 (1 H, d, JNH4'= 7.8 Hz, NHBoc), 4.52-4.48 (0.16H, br. 
m, H-2), 4.46 (0.84H, dd, J2-NH = 7.3, J=3.5 Hz, H-2), 4.28-4.25 (2H, m, C02CH2), 
4.22-4.11 (2H, M. C02CH2), 4.08-4.01 (1 H, m, H-2"), 3.82 (1 H, br. s, H-4'), 3.25 (1 H, 
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dd, J6, 
-6-,, = 
14.2, J=2.3 Hz, H-6'), 3.16 (0.87H, app. br. d, J= 11.6 Hz, H-2'), 2.98 
(0.13H, app. br. d, J= 11.6 Hz, H-2'), 2.78 (1 H, br. d, J6, -6.,, = 
14.2 Hz, H-6'a), 2.19- 
2.14 (IH, m, H-3"), 2.12 (0.48H, s, CH3CO), 2.11 (2.52H, s, CH3CO), 1.80 (IH, app. dt, 
JY-Va == 12.6, J=3.2 Hz, H-3'), 1.44 (11 H, br. s, NHpip + H-3'a +3x CHA 1.09-0.94 
(10H, m, 2x SiCH2 +2x CHA 0.087 (1.44H, S, SiC(CH3)3), 0.08 (7.56H, s, 
SiC(CH3)3). 0.07 (9H, s, SiC(CH3)3). 
(3S, 4R)-3-(Di-tert-butyloxycarbonyl)amino-4-acetyloxy-5-azido-N, O-dimethyl- 
pentanamide (231). 
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To a stirred solution of 211 (760 mg, 1.65 mmol) in dry acetonitrile (10 mL) were added 
di-tert-butyldicarbonate (1.80 g, 8.27 mmol) and 4-dimethylaminopyridine (404 mg, 
3.31 mmol) in dry acetonitrile (5 mL). The mixture was heated at 60 "C overnight. On 
cooling, the orange solution was concentrated in vacuo. Purification by silica gel column 
chromatography (100% dichloromethane) afforded 231 (859 mg, 93%) as a yellow oil; 
[CC] 30 - 2.8 (CHC13, C 1.0); Rf 0.39 (20% ethyl acetate in d ichloro methane); v,,,,,, D 
(neat)/cm" 2980,2938,2099,1744,1701,1667,1349,1368,1221; 5H (400 MHz, 
CD2CI2) 5.53-5.48 (IH, m, H-4), 4.80 (IH, td, J3-2 = 8.9, J34 = 4.8 Hz, H-3), 3.68 (3H, s, 
CH30), 3.54 (IH, dd, J5-5, = 13.4, J5-4 = 3.0, H-5), 3.39 (IH, dd, J5,. s = 13.4, J5, -4 = 
6.0, 
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H-5'), 3.15 (3 H, s, CHR, 3.02 (1 H, dd, J2-2' = 15.8, J2-3 = 8.9 Hz, H-2), 2.70 (1 H, dd, 
J2, 
-2 = 
15.8, J2'-3 = 4.5 Hz, H-2'), 2.10 (3H, s, CH3CO), 1.52 (18H, s, 3x CH3); 8C (100 
MHz, CD2CI2) 171.3 (CO), 170.0 (CO), 152.4 (2 x CO), 83.0 (2 x C(CH3)3), 72.6 (C-4), 
61.1 (CH30)2 53.6 (C-3), 51.5 (C-5), 33.9 (C-2), 32.2 (CHN, 27.9 (6 x CHA 20.9 
(CH3CO); LRMS (ES+) m1z 482 [M+Ne] (100), 360 (37), 304 (49%); HRMS (ES) 
calculated for CjqH33N5NaO8,482.2221 [M+Na+]; found 482.2222. Anal. calcd. for 
C19H33N508: C, 49.66; H, 7.24; N, 15.24%. Found: C, 49.61; H, 7.25; N, 14.93%. 
(3S, 4R)-3-Di-(tert-butyloxycarbonylamino)-4-acetyloxy-5-azido-pentanaI (232). 
Boc2N 0 
N3 5 N' 
OY 
0 
Boc2N 0 
N3 ZI 
6y 
0 
232 
To a stirred solution of 231 (318 mg, 0.57 mmol) in dry tetrahydrofuran (3 mL) at -78 T 
was added di-iso-butylaluminium hydride (IM in hexanes; 850 ýtL, 0.85 mmol) 
dropwise. The mixture was stirred at -78 'C for 8 h, then transferred via cannula to a 
mixture of ethyl acetate (3 mL) and saturated aqueous potassium sodium tartrate (5 mL) 
at 0 'C. After stirring overnight whith warming to room temperature, the mixture was 
extracted with ethyl acetate (3 x3 mL). The combined organic layers washed with brine 
(I mL), dried over Na2SO4, filtered and concentrated in vacuo. Purification by silica gel 
column chromatography (10% ethyl -acetate in dichloromethane) gave 232 (211 mg, 
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93%) as a colourless oil; [(X] 
28 + 11.1 (CHC13, C 1.0); Rr 0.70 (20% ethyl acetate in D 
dichloromethane); Vmax (neat)/cm-1 2980,2934,2101,1729,1701,1369,1350,1219; 8H 
(400 MHz, CD2CI2)9.70 (IH, t, JI-2= 2.0 Hz, H- I)q 5.49-5.45 (1 H, ddd, J=9.59 J4-3 ý-- 
5.2, J4.5= 3.2 Hz, H-4), 4.86 (1 H, app. td, J3-2= 8.5, J3-2' 5.3 9J=5.2 Hz, H-3), 3.5 8 
(I H9 dd, J5-5- = 13.6, J5-4= 3.2 Hz, H-5), 3.3 8 (1 H, dd, J5,. 5 13.6, J5'4= 5.2 Hz, H-5'), 
2.92 (1 H, ddd, J2-2' =16.9, J2-3= 8.5, J2.1 = 2.1 Hz, H-2), 2.72 (1 H, ddd, J2'-2 = 16.9, J2'-3 
= 5.3, J2, -j = 
1.9 Hz, H-2'), 2.07 (3H, s, CHA 1.51 (18H, s, 6x CH3); 8c (100 MHz, 
CD2C12) 199.5 (C-1), 170.1 (CO), 153.0 (2 x CO), 83.8 (2 x C(CH3)3), 72.8 (C-4), 51.8 
(C-3), 51.6 (C-5), 44.6 (C-2), 28.0 (6 x CHA 20.9 (CH3); LRMS (ES) m1z 439 [M+K+l 
(15), 423 [M+Na+] (100), 217 (31%); HRMS (ES+) calculated for C17H28N4NaO7, 
423.1850 [M+Na+]; found 423.1853. Anal. calcd. for C17H28N407: C, 50.99; H, 7.05; N, 
13.99%. Found: C, 50.80; H, 7.09; N, 13.75%. 
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(5S, 6R, 2Z)-[(2S)-3-Methyl-2-(2-trimethylsilylethoxycarbonylamino)butyrylaminoI 
-(5-d i-(tert-bu tyloxyca rbonyl)a m ino)-6-acetyloxy-7-azido-h eptyl-2-ene-2-tri m ethyl- 
silylethyl ester (230). 
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Method A. To a stirred solution of 99 (1.08 g, 1.96 mmol) in dichloromethane (10 mL) 
at 10 'C was added DBN (212 ýiL, 1.78 mmol) dropwise. After 30 min, 232 (712 mg, 
1.78 mmol) in dichloromethane (10 mL) was added and the mixture was stirred 
overnight at room temperature. Concentration in vacuo followed by purification by silica 
gel column chromatography (10% ethyl acetate in dichloromethane) gave (Z)-230 (1.02 
g, 72%) as a colourless oil. [a] 29 + 3.5 (CHC13, C 1.0); Rf 0.4 (20% ethyl acetate in D 
dichloromethane); vm (neat)/cm" 3313,2957,2101,1745,1702; 8" (500 MHz, CDC13) 
7.52 (1 H, s, =CNH), 6.49 (IH, app. t, J3-4 = 7.3 Hz, H-3), 5.37 (I H, ddd, J6-5 = 9.3, J= 
4.7, J=3.1, H-6), 5.20 (1 H, br. d, JNH-8 = 7.9 Hz, NHTeoc), 4.40 (1 H, td, J5-6 = 9.3, J= 
5.7 Hz, H-5), 4.23-4.13 (5H, m, 2X C02CH2+H-8), 3.56 (I H, dd, J7-7'-= 13.6, J7-6=2.8 
Hz, H-7), 3.29 (1 H, dd, JT-7 -= 13.6, J7, -6 = 4.7 Hz, H-T), 2.64 (1 H, app. sext., J=7.9 
Hz, H-4), 2.55-2.47 (IH, m, H-4'), 2.21 (lH, app. sept. J=6.3 Hz, H-9), 2.07 (3H, s, 
CH3C0)2 1.48 (9H, s, (CH3)3), 1.47 (9H, s, (CH3)3), 1.00-0.93 (1 OH, m, 2x CH2Si +2x 
CH3)2 0.02 (I8H, s, 2x Si(CH3)3); Sc (125 MHz, CDC13) 170.0 (CO), 169.9 (CO), 169.8 
(CO), 164.0 (CO), 156.6 (CO), 152.9 (CO), 131.9 (C-3), 127.9 (C-2), 83.4 (C(CH3)3)e 
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83.3 (C(CH3)3), 73.3 (C-6), 63.9 (C02CH2), 63.5 (C02CH2), 60.1 (C-8), 55.4 (C-5), 51.3 
(C-7), 31.2 (CH(CH3)2). 29.5 (C-4), 27.9 (2 x (CH3)3), 20.9 (CH3CO)) 19.3 (CHA 17.6 
(CH2Si)i 17.4 (CHA 17.3 (CH2Si)s -1.5 (SiCH3)3)9 -1.6 (Si(CH3)3); LRMS (ES) m1z 
823 [M+Ne] (80), 701 (36), 601 (100%); HRMS (ES) calculated for 
C35H64N601jSi2Na, 823.4064 [M+Na+]; found 823.4161. Anal. calcd. for 
C35H64N601ISi2: C, 52.48; H, 8.05; N, 10.49%. Found: C, 52.40; H, 8.10; N, 10.18%. 
Method B. To a stirred suspension of lithium chloride (5 mg, 0.12 mmol) in dry 
acetonitrile (0.5 mL) was added 99 (69 mg, 0.12 mmol) in acetonitrile (I mL), then di- 
iso-propylethyl amine (22 RL, 0.12 mmol). After 10 min, 232 (50 mg, 0.12 mmol) in 
acetonitrile (0.5 mL) was added, then the mixture stirred for 16 h at room temperature. 
The mixture was concentrated in vacuo, re-dissolved in ether (2 mL), washed with water 
(I mL) then brine (I mL). The organic phase was dried over MgS04, filtered and 
concentrated in vacuo. Purification by silica gel column chromatography (50% diethyl 
ether in petroleum ether) gave (E)-230 (5.3 mg, 5%) as a colourless oil; Rf 0.29 (50% 
diethyl ether in petroleum ether); [a]" + 10.6 (CHC13, C 1.0); v,,,,, (neat)/cm" 3266, D 
2979,2934,2101,1797,1761,1520; 8H (500 MHz, Acetone-d6) 7.80 (1 H, s, =CNHCO), 
7.18 (1 H, app. t, J34 = 7.5 Hz, H-3), 5.52 (1 H, ddd, J=9.1 J=7.8, J=2.8 Hz, H-6), 
5.13 (IH, d, J= 6.9 Hz, NHTeoc), 4.45 (IH, dt, J= 9.4, J= 5.5 Hz, H-5), 4.28 (2H, app. 
q, J=9.1 Hz, C02CHA 4.16 (2H, app. t, J=8.8 Hz, C02CH2), 3.99 (1 H, hr. s, H-8), 
3.57 (1 H, dd, J= 13.4, J=2.8Hz, H-7), 3.33 (IH, dd, J= 13.4, J= 5. OHz, H-7'), 3.07 
(I H, td, J= 16.3, J=8.5 Hz, H-4), 3.00-2.94 (1 H, m, H-4'), 2.18-2.14 (1 H, m, H-9), 
2.08 (3H, s, CH3CO), 1.48 (18H, s, 2x (CH3)A 1.09 (2H, app. t, J=8.9 Hz, CH2Si), 
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0.99-0.95 (5H, m, CH2Si + CHA 0-91 (3H, d, J= 6.9 Hz, CH2Si), 0-01 (9H, s, SiCH3). 
0.03 (9H, s, SiCH3); Öc (125 MHz, Acetone-d6) 170.0 (CO), 169.6 (CO), 163.8 (CO), 
156.7 (CO), 152.7 (CO), 151.8 (CO), 127.1 (C-3), 126.1 (C-2), 83.0 (2 x C(CH3)3), 73.7 
(C-6), 64.5 (C02CH2), 60.9 (C-8), 60.4 (C02CHA 56.5 (C-5), 51.4 (C-7), 31.0 - 
(CH(CH3)2), 28.7 (C-4), 27.9 (6 x CHA 2 1.0 (CH3CO)q 19.3 (CHA 17.7 (CH2Si)) 17.5 
(C142SOý 14.2 (CHA -1.5 (Si(CH3)3)9 -1.6 (Si(CH3)3); LRMS (ES) m1z 823 [M+Na+1 
(80), 701 (36), 601 (100%); HRMS (ES) calculated for C35H64N601jSi2Na, 823.4064 
[M+Na+]; found 823.4067. 
Further elution gave (Z)-230 (54 mg; 54%) as a colourless oil. Data as previously 
described. 
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(2R, 4S', 5RI, 2S")- and (2S, 4SI, 5R', 2Sl)-(51-Acetoxy-4'-di-lerl- 
butyloxycarbonylamino-piperidin-2'-yl)-1(2"-trimethylsilylethoxycarbonylamino) 
butyrylaminol -acetic acid trimethylsilylethyl ester (235). 
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A suspension of 230 (500 mg, 0.625 mmol) and Lindlar's catalyst (100 mg; 20 % w/w) 
in ethanol (7 mL) was stirred under an atmosphere of hydrogen for 20 h. The mixture 
was filtered through celite to remove the catalyst, then concentrated in vacuo. 
Purification by column chromatography (50% diethyl ether in dichloromethane) gave 
235 (387 mg, 80%) as a white glassy solid and as a 6: 1 mixture of epimers at C-2, as 
judged by 1H NMR spectroscopy, mp 74-75 "C; [a] 31 -2.7 (CHC13, C 1.0); Rf 0.4 D 
(diethyl ether/dichloromethane, 60%); vma., (neat)/cm" 3321,2956,1745,1707,1526; 
8H (500 MHz, CD3CN) 7.04 (0.15H, d, J=7.0 Hz, CHNHCO), 6.97 (0.85H, d, J=6.9 
Hz, CHNHCO), 5.63 (1 H, hr. d, J=8.5 Hz, NHTeoc), 5.02 (1 H, hr. s, H-5'), 4.44 
(0.1 8H, dd, J=7.8, J=4.0 Hz, H-2), 4.40 (0.82H, dd, J=7.5,1 = 4.0 Hz, H-2), 4.26- 
4.11 (4H, m, 2x CH2CO2), 4.08 (1 H, dt, J= 13.2, J=2.9 Hz, H-4'), 4.01 (1 H, hr. t, J= 
7.0 Hz, H-2"), 3.09 (1 H, dt, J= 11.6, J=3.1 Hz, H-2'), 3.01 (1 H, dd, J7-7' = 14.8, J= 
2.5 Hz, H-6'), 2.76 (IH, hr. d, JT-7 = 14.8 Hz, H-6'a), 2.11-2.04 (IH, m, H-3"), 2.02 
(3H, hr. s, CH3CO), 1.66 (1 H, dt, J= 12.2, J=3.1 Hz, H-3'), 1.46 (3H, s, CH3), 1.45 
(I 7H, s, 5x C(CH3)3 + H-3'a + NHpip), 1.07-0.87 (1 OH, m, 2x CH2Si +2x CH3), 0.05 
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(9H, br. s, SiC(CH3)A 0.03 (9H, br. s, SiC(CH3)3); 8c (125 MHz, CD3CN) 172.6 (CO), 
172.4 (CO), 172.4 (CO), 171.4 (CO), 171.3 (2 x CO), 171.0 (2 x CO), 157.5 (CO), 153.5 
(CO), 153.5 (CO), 153.4 (CO), 83.1 (2 x C(CH3)3 minor), 83.0 (2 x C(CH3)3 major), 
69.0 (C-5' major), 68.9 (C-5' minor), 64.4 (CH2CO2 major), 64.2 (2 x CH2C02 minor), 
63.6 (CH2CO2 major), 61.1 (C-4' major), 60.9 (C-4' minor), 58.3 (C-2" minor), 58.1 (C- 
2" major), 57.3 (C-2' major), 57.1 (C-2' minor), 56.8 (C-2 major), 56.7 (C-2 minor), 
49.4 (C-6' minor), 49.3 (C-6' major), 31.7 (C-3" major), 31.6 (C-3" minor), 29.5 (C-3' 
major), 29.4 (C-3' minor), 28.0 (2 x C(CH3)3 major + minor), 21.6 (CH3COmajor + 
minor), 19.7 (CH3 major), 19.6 (CH3 minor), 19.5 (CH3 minor), 18.2 (SiCH2 major + 
minor), 18.0 (CH3 major), 17.8 (SiCH2 major + minor), -1.5 (Si(CH3)3 major + minor), - 
1.6 (Si(CH3)3 major + minor); LRMS (ES) m1z 797 [M+Na+] (14), 775 [M+H+ ](100), 
391 (6), 167 (12%); HRMS (ES) calculated for C35H67N401ISi2,775.4339 [M+H+ ]; 
found 775.4339. Anal. calcd. for C35H66N401ISi2: C, 54.24; H, 8.58; N, 7.23%. Found: 
C, 54.06; H, 8.60; N, 6.97%. 
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(2R, 4S', 5R', 2S")- and (2S, 4S', 5R', 2S")-(5'-Hydroxy-4'-di-tert-butyloxycarbonyI 
amino-piperidin-2'-yl)-[(2"-trimethylsilylethoxycarbonylamino)butyrylaminoI 
acetic acid (239). 
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To a stirred solution of 235 (100 mg, 0.129 mmol) in methanol (5 mL) was added 
potassium carbonate (17.8 mg, 0.129 mmol). After 2 h, the mixture was concentrated in 
vacuo then purified by column chromatography (20% methanol in dichloromethane; 1% 
ammonia) to give 239 (69 mg, 74%) as a white powder; mp 195-196 *C; Rf 0.29 (20% 
methanol in d ichloro methane); v. a,, (neat)/cm" 3333,2960,1663,1619,1530; 811 (400 
MHz, MeOD-d4) 4.49 (0.6H, app. d, J=3.5 Hz, H-2), 4.42 (OAH, d, J=5.8 Hz, 11-2), 
4.29-4.22 (1.2H, M. C02CHA 4.19-4.11 (0.8H2 M. C02CH2), 4.06 (IH, d, J2-. 3" = 6.5 
Hz, H-2"), 4.02 (1 H, hr. s, H-5'), 3.77-3.67 (1 H, m, H-4), 3.59 (1 H, app. d, J= 12.3 
Hz, H-2'), 3.44-3.40 (1 H, m, H-6'), 3.19 (1 H, t, J6,. -6- = 12.3 Hz, H-6'a), 2.19 (1 H, app. 
sext. J3,! -2- = 6.5 Hz, H-P), 1.99-1.56 (2H, m, H-3% 1.47 (9H, s, 3x CHA 1.08-0.97 
(8H, m, CH2Si +2x CHA 0.09 (9H, s, Si(CH3)3); 8c (100 MHz, MeOD-d4) 174.1 (CO), 
173.9 (CO), 159.0 (CO), 157.3 (CO), 80.4 (C(CH3)3» 64.9 (C-5'), 64.8 (CO2CH2), 64.3 
(C02CH2), 62.1 (C-2"), 62.0 (C-2"), 59.3 (C-4'), 57.0 (C-2), 56.1 (C-2'), 55.6 (C-2), 
49.9 (C-6), 49.8 (C-6'), 31.7 (C-3"), 28.7 (3 x CHA 25.6 (C-3'), 19.9 (CH3)9 18.6 
(CH2Sil 18.3 (CH3)2 -1.3 (Si(CH3)3)2 -1.4 (Si(CH3)3); LRMS (ES) mlz 555 [M+Nä+] 
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(47), 533 [M+H+] (100), 391 (8%); HRMS (ES) calculated for C23H45N40SSi, 533.3001 
[M+H+]; found 533.3002. 
(4S, 5R)-4-(l, 3-Dibenzylhexahydro-2-oxo-1, 
2(5H)furanone (224). 
0 
N3 0 
HN 
-)" 
0 
3,5-triazin-5-yl)-5-azido- 
0 
N3 02 
r-N 
BnN rNBn 
0 
224 
To a stirred solution of trifluoroacetic acid (7.5 mL) and dichloromethane (205 mL) at 0 
*C was added 186 (3.00 g, 11.70 mmol) in dichloromethane (50 mL). The mixture was 
stirred at 0 'C for 6 h, then concentrated in vacuo, to give the free amine. This material 
was stirred with formaldehyde (30% in water; 8.8 mL, 117.0 mmol) and di-iso- 
propylethyl amine (2.04 mL, 11.70 mmol) for 10 min. The mixture was concentrated in 
vacuo, azeotroped with toluene (2 x 50 mL), then concentrated in vacuo to constant 
weight. This amine-formaldehyde adduct was dissolved in ethyl acetate (50 mL) and N, 
A"-dibenzylurea (2.81 g, 11.7 mmol) added. The mixture was heated at reflux for I h. 
On cooling to room temperature, the mixture was diluted with ethyl acetate (50 mL), 
washed with water (50 mQ, and the organic phase dried over MgS04, filtered and 
concentrated in vacuo. Purification by silica gel column chromatography (10% ethyl 
acetate in dichloromethane) gave 224 (2.24 g, 46% over three steps) as a colourless 
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amorphous solid; mp 128-129 T; 
[(X] 25 + 25.8 (CHC13, C 1.02); Rf 0.26 (20% ethyl D 
acetate in dichloromethane); vmax (neat)/cm" 3030,2919,2101,1783,1634,1354; 8H 
(400 MHz, CD2CI2) 7.44-7.34 (1 OH, m, ArH), 4.57 (2H, d, J= 15.0 Hz, 2x CH), 4.46 
(2H, d, J= 15.0 Hz, 2x CH), 4.22-4.13 (5H, m, H-4 +2x CH2), 3.36-3.31 (IH, ddd, J= 
6.2, J=4.8, J=4.5 Hz, H-4), 3.14 (1 H, dd, J", = 13.6, J6-5 = 3.0 Hz, H-6), 2.68 (1 H, 
dd, J6. 
-6 = 
13.6, J6-. 5 = 4.8 Hz, H-6'), 2.16 (2H, ddd, J= 18.1, J=8.0, J=6.0 Hz, H-3); 
5c (100 MHz, CD2CI2) 173.8 (CO), 155.7 (C-2), 138.5 (2 x ArC), 129.1 (4 x ArCH), 
128.8 (4 x ArCH), 128.1 (2 x ArCH), 81.5 (C-5), 63.7 (2 x CH2), 56.6 (C-4), 52.8 (C-6), 
48.5 (2 x CHA 32.9 (C-3); LRMS (ES) m1z 460 [M+K+] (8), 443 [M+Na+] (38), 421 
[M+H+] (100), 391 (7%); HRMS (ES) calculated for C22H25N603,421.1983 [M+11+]; 
found 421.1983. 
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(3S, 4R)-3-(l, 3-Dibenzylhexahydro-2-oxo-1,3,5-triazin-5-yl)-4-acetyloxy-5-azido- 
N, 0-dimethylpentanamide (226). 
0 
BnN liý NBn 
/, N N0 
BnN 
NBn Nr5 N 101. % y 
ÖAc 
0 
226 
To a stirred solution of N, O-dimethylhydroxylarnine hydrochloride (2.55 g, 26.10 
mmol) in dichloromethane (60 mL) at 0 'C was added trimethylaluminium (2M in 
hexane; 13.08 mL, 26.10 mmol). After 30 min at room temperature, 224 (2.20 g, 5.25 
mmol) in dichloromethane (60 mL) was added. The mixture was stirred for 4 h, then 
quenched by the addition of saturated aqueous potassium sodium tartrate (100 mL). 
After 2 h, the mixture was extracted with dichloromethane (3 x 40 mQ, then the 
combined organic phase washed with brine (40 mQ, dried over MgS04, filtered and 
concentrated in vacuo. This gave 225 (2.69 g) as a white foam that was used without 
further purification; Rf 0.2 (60% ethyl acetate in petroleum ether); v,,,. (neat)/cm*l 3357, 
2919,2098,1622; 51-1 (400 MHz, CD2CI2) 7.39-7.20 (1 OH, m, ArH), 4.56 (2H, d, J= 15 
Hz, 2x CH), 4.47 (2H, d, J= 15 Hz, 2x CH), 4.22 (4H, br. d, J= 2.8 Hz, 2x CH20.73 
(IH, d, JOH-4 = 7.0 Hz, OH), 3.61 (4H, m, CH3 + H-4), 3.28-3.22 (3H, m, H-5 + H-3), 
3.16 (3H, s, CHA 2.74 (IH, dd, J2-2- = 16.7, J2-3 = 3.0 Hz, H-2), 2.57 (IH, dd, J2, -2 = 
16.7, J2'-3 = 6.5 Hz, H-2'); 8C (100 MHz, CD202) 172.9 (CO), 156.1 (CO), 138.6 (2 x 
ArQ, 128.8 (4 x ArCH), 128.3 (4 x ArCH), 127.5 (2 x ArCH), 72.0 (C-4), 64.6 (2 x 
CHA 61.5 (CHA 59.8 (C-3), 55.4 (C-5), 48.8 (2 x CH2), 32.3 (CHA 30.9 (C-2); LRMS 
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(ES) m1z 504 [M+Na+] (100), 421 (30), 242 (64%); HRMS (ES) calculated for 
C24H32N704,482.25 10 [M+H+]; found 482.2508. 
This free alcohol was dissolved in dichloromethane (45 mL) at 0 'C. To this solution 
were added dry pyridine (4.23 mL, 52.3 mmol), 4-dimethylaminopyridine (383 mg, 3.14 
mmol) and acetic anhydride (3.06 mL, 32.4 mmol). After stirring at room temperature 
overnight, the mixture was concentrated in vacuo. Purification by silica gel column 
chromatography (10% ethyl acetate in dichloromethane) gave 226 (2.04 g, 74% over 
two steps) as a white foam; [a]" - 13.3 (CHC13, C 1.2); Rf 0.13 (50% ethyl acetate in D 
petroleum ether); Vmax (neat)/cm" 2938,2098,1743,1639; 5H (400 MHz, CDC13) 7.40- 
7.35 (7H, m, ArH), 7.34-7.29 (3H, m, ArH), 4.97 (IH, app. sept., J= 3.4 Hz, H-4), 4.63 
(2H, d, J= 15.1 Hz, 2x CH), 4.51 (2H, d, J= 15.1 Hz, 2x CH), 4.23 (2H, d, J= 11.4 
Hz, 2x CH), 4.18 (2H, d, J= 11.4 Hz, 2x CH), 3.84 (1 H, app. dt, J=8.8, J=5.8 f Iz, 
H-3)9 3.64 (3H, s, CHA 3.44 (1149 dd, J5-5, = 13.2, J5-4 = 3.4 Hz, H-5), 3.39 (IH, dd, J5'. 5 
= 13.2, J5,4 = 5.4 Hz, H-5'), 3.22 (3H, s, CHA 2.77 (1 H, dd, J2-2'= 17.6, J2-3 = 6.0 Hz, 
H-2), 2.50 (1 H, dd, J2'-2 "= 16.6, J2'-3 = 4.0 Hz, H-2'), 2.07 (3H, s, CH3); 5C 0 00 MHZ9 
CD2C1) 171.1 (CO), 170.1 (CO), 155.5 (CO), 137.6 (2 x ArC), 128.4 (4 x ArCH), 128.0 
(4 x ArCH), 127.2 (2 x ArCH), 72.9 (C-4), 64.1 (2 x CH2), 61 -0 (CH3)2 5 8.4 (C-3), 51.8 
(C-5), 48.6 (2 x CH2), 32.0 (CH3), 30.9 (C-2), 20.7 (CH3); LRMS (ESý mlz 524 [M+H+] 
(100 %); HRMS (ESý calculated fOr C2A4N705,524.2616 [M+H+]; found 524.2622. 
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(4S, 5R)-4-[(N, AI-b is-(tert-B u tyloxyca rbo nylam in o)gu an id in e-5-azid om ethyl] - 
2(5H) furan-2-one (189). 
0 
N3 0 
HN y0 
-), " 
0 
0 
N3 02 
oc 
BocHN 
189 
To a stirred solution of trifluoroacetic acid (2.6 mL) and dichloromethane (7.4 mL) at 0 
T was added 186 (189 mg, 0.740 mmol) in dichloromethane (7.4 mL). After 6h, the 
mixture was warmed to room temperature and the residue was re-dissolved in 
dichloromethane (7 mL), triethylamine (205 ItL, 1.48 mmol) was added dropwise, 
followed by N, N-bis-(tert-butyloxycarbonylamino)guanidine triflate (289 mg, 0.74 
mmol). The mixture was stirred overnight at room temperature, then concentrated in 
vacuo. Purification by silica column chromatography (20% diethyl ether in petroleum 
[(j] 24 ether) gave 189 (268 mg, 91%) as a white solid; mp 97-99 'C; D+ 11.9 (CHC13, C 
1.0); v. ý,, (neat)/cm-1; Rf 0.27 (20% diethyl ether in petroleum ether); vmax (neat)/cm" 
3314,2982,2936,2105,1788,1726,1610; 8H (400 MHz, Acetone-d6) 11.51 (IH, s, 
NHBoc), 8.55 (1 H, d, JNH-4 ý 6.5 Hz, NHC=N), 4.80-4.73 (1 H, m, H-4), 4.69 (1 H, app. 
td, J5-6- = 5.2, J5-6 = 3.0 Hz, H-5), 3.89-3.85 (IH, dd, J"- = 13.4, J6-5 = 3.0 Hz, H-6), 
3.82-3.77 (IH, dd, J6, 
-6 = 
13.4, J6-. 5 = 5.2 Hz, H-6'), 3.05-3.00 (IH, dd, J3-3'= 18-09 J3-4 
= 9.5, H-3), 2.86-2.79 (IH, dd, JY-3 = 18.0, J3.. 4 = 6.5 Hz, H-3'), 1.51 (9H, s, 3x CH3), 
1.44 (9H, s, 3x CH3); 5c (100 MHz, Acetone-d6) 173.9 (CO), 163.7 (CO), 156.3 (CO), 
153.0 (C=N), 122.0 (C(CH3)3» 118.8 (C(CH3)3,83.8 (C-5), 53.3 (C-6), 49.5 (C-4), 34.7 
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(C-3), 2 8.1 (3 x CH3), 27.8 (3 x CH3); LRMS (ES+) 8 19 [2M+Nä+] (7), 617 (24), 421 
[M+Na+] (38), 399 [M+H+] (100%); HRMS (ES) calculated for C16H27N604,399.1987 
[M+H+]; found 399.1983. 
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173 
C2, H25 N3 03 Si 
395.53 
293(2)K 
1.54178 A 
Orthorhombic 
P2(1)2(1)2(l) 
a=9.8190(3) A 
b= 10.2558(3) A 
c= 21.7107(7) A 
2029.6 (3) A32 
1.202 Mg/m3 
1.154 mm-1 
840 
Table 1. Crystal data and structure refinement for 173. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume, Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 23.26" 
Absorption correction 
Maria Garcia 
90.00 (2)*. 
90.00 (2)0. 
90.00 (2)*. 
0.20 x 0.10 x 0.02 MM3 
1.74 to 70.56'. 
-10/ 11, -12/ 12, -24/ 26. 
14036 
4020 [Ri,, t = 0.0696] 
99.3% 
Semi-empirical from equivalents 
198 
Appendix Two Maria Garcia 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(l)] 
Extinction coefficient 
Absolute structure parameter 
Largest diff. peak and hole 
Detector 
0.7966 to 0.9773. 
Full-matrix least-squares on F2 
4020/12/257 
1.042 
Rl = 0.0448, wR2 = 0.1121 
0.0039(4) 
x= -0.05(3). 
0.219 and -0.13 9 e. A-3 
Siemens SMART (Siemens, 1994) three- 
circle system with CCD area detector 
H-atoms were given isotropic displacement parameters equal to 1.2 (or 1.5 for methyl 
hydrogen atoms) times the equivalent isotropic displacement parameter of the atom to 
which the H-atorn is attached. 
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Table 2. Atomic coordinates (x 10^4) and equivalent isotropic displacement 
parameters (A 
A2x JOA 3) for 173. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
x y z U (eq) 
N(l) 4416(5) . 2552(6) 11861(2) 174(2) 
N(2) 3905(4) -1796(5) 11559.2(17) 120(l) 
N(3) 3298(4) -985(4) 11299.7(16) 125(l) 
C(4) 3615(3) -792(3) 10639.8(13) 72(l) 
C(5) 3034(3) -1862(3) 10250.4(17) 79(l) 
C(6) 1689(4) -1360(4) 10048.2(19) 91(l) 
0(6) 811(3) -1952(3) 9791.9(18) 151(l) 
0(7) 1571(2) -103(3) 10184.7(12) 89(l) 
C(8) 2803(4) 384(3) 10431.2(14) 74(l) 
C(q) 3500(4) 1219(3) 9956.8(14) 79(l) 
0(10) 3815(2) 439.0(16) 9439.7(8) 62(l) 
Si(i 1) 4382.3(7) 998.4(6) 8773.5(3) 51(l) 
C(12) 6268(3) 1188(2) 8834.6(12) 54(l) 
C(I 3) 7022(3) 1830(3) 8392.6(14) 70(l) 
C(I 4) 8430(4) 1879(4) 8407.6(18) 87(l) 
C(i 5) 9117(3) 1265(4) 8870.9(19) 88(l 
C(I 6) 8416(4) 625(3) 9317.8(17) 79(l) 
C(I 7) 7006(3) 588(3) 9301.8(14) 67(l) 
C(I 8) 3602(3) 2634(2) 8626.2(12) 52(l) 
C(i 9) 4089(3) 3701(2) 8942.9(13) 61(l) 
C(20) 3520(3) 4925(3) 8890.8(15) 73(l) 
C(21) 2441(4) 5121(3) 8517.0(17) 81(l) 
C(22) 1933(4) 4098(4) 8180.9(18) 92(l) 
C(23) 2498(3) 2879(3) 8239.1(15) 77(l) 
C(24) 3973(3) -324(3) 8201.3(13) 66(l) 
C(25) 2462(4) -706(4) 8217.5(17) 93(l) 
C(26) 4368(4) 123(3) 7547.5(13) 85(l) 
C(27) 4814(4) -1530(3) 8372.2(19) 96(l) 
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Table 3. Bond lengths [A] and angles [deg] for 173. 
N(l)-N(2) 1.132(5) N(2)-N(3) 1.168(5) 
N(3)-C(4) 1.479(4) C(4)-C(5) 1.498(5) 
C(4)-C(8) 1.514(4) C(4)-H(4A) 0.9800 
C(5)-C(6) 1.483(5) C(5)-H(5A) 0.9700 
C(5)-H(5B) 0.9700 C(6)-0(6) 1.193(4) 
C(6)-0(7) 1.328(5) 0(7)-C(8) 1.414(4) 
C(8)-C(9) 1.504(4) C(8)-H(8A) 0.9800 
C(9)-0(10) 1.413(3) C(9)-H(9A) 0.9700 
C(9)-H(9B) 0.9700 0(10)-Si(i 1) 1.6527(19) 
S i(I I)-C(I 2) 1.866(3) S i(I I)-C(l 8) 1.871(3) 
Si(I I)-C(24) 1.883(3) C(I 2)-C(I 3) 1.380(4) 
C(12)-C(17) 1.390(4) C(13)-C(14), 1.384(5) 
C(I 3)-H(I 3A) 0.9300 C(14)-C(15) 1.365(5) 
C(14)-H(14A) 0.9300 C(I 5)-C(I 6) 1.359(5) 
C(I 5)-H(I 5A) 0.9300 C(I 6)-C(I 7) 1.385(5) 
C(I 6)-H(I 6A) 0.9300 C(I 7)-H(I 7A) 0.9300 
C(I 8)-C(I 9) 1.379(4) C(I 8)-C(23) 1.394(4) 
C(I 9)-C(20) 1.379(4) C(I 9)-H(I 9A) 0.9300 
C(20)-C(2 1) 1.350(5) C(20)-H(20A) 0.9300 
C(2 I)-C(22) 1.372(5) C(2l)-H(21A) 0.9300 
C(22)-C(23) 1.374(5) C(22)-H(22A) 0.9300 
C(23)-H(23A) 0.9300 C(24)-C(27) 1.533(4) 
C(24)-C(25) 1.535(4) C(24)-C(26) 1.541(4) 
C(25)-H(25A) 0.9600 C(25)-H(25B) 0.9600 
C(25)-H(25C) 0.9600 C(26)-H(26A) 0.9600 
C(26)-H(26B) 0.9600 C(26)-H(26C) 0.9600 
C(27)-H(27A) 0.9600 C(27)-H(27B) 0.9600 
C(27)-H(27C) 0.9600 N(l)-N(2)-N(3) 173.1(5) 
N(2)-N(3)-C(4) 117.1(4) N(3)-C(4)-C(5) 111.6(3) 
N(3)-C(4)-C(8) 106.6(3) C(5)-C(4)-C(8) 102.4(3) 
N(3)-C(4)-H(4A) 111.9 C(5)-C(4)-H(4A) 111.9 
C(8)-C(4)-H(4A) 111.9 C(6)-C(5)-C(4) 104.6(3) 
C(6)-C(5)-H(5A) 110.8 C(4)-C(5)-H(5A) 110.8 
C(6)-C(5)-H(5B) 110.8 C(4)-C(5)-H(5B) 110.8 
H(5A)-C(5)-H(5B) 108.9 0(6)-C(6)-0(7) 122.4(4) 
0(6)-C(6)-C(5) 127.2(4) 0(7)-C(6)-C(5) 110.4(3) 
C(6)-0(7)-C(8) 110.6(3) 0(7)-C(8)-C(9) 109.3(3) 
0(7)-C(8)-C(4) 106.4(3) C(9)-C(8)-C(4) 114.8(3) 
0(7)-C(8)-H(8A) 108.7 C(9)-C(8)-H(8A) 108.7 
C(4)-C(8)-H(8A) 108.7 0(10)-C(9)-C(8) 108.8(2) 
00 0)-C(9)-H(9A) 109.9 C(8)-C(9)-H(9A) 109.9 
0(1 0)-C(9)-H(9B) 109.9 C(8)-C(9)-H(9B) 109.9 
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H(9A)-C(9)-H(9B) 108.3 C(9)-O(l 0)-S i(i 1) 124.95(16) 
0(10)-Si(Il)-C(12) 107.95(11) 0(10)-Si(Il)-C(18) 108.82(11) 
C(12)-Si(Il)-C(18) 108.97(11) 0(10)-Si(Il)-C(24) 104.80(11) 
C(12)-Si(I I)-C(24) 109.50(12) C(I 8)-S i(I I)-C(24) 116.46(13) 
C(13)-C(12)-C(17) 116.0(3) C(13)-C(12)-Si(I 1) 122.2(2) 
C(I 7)-C(I 2)-Si(I 1) 121.6(2) C(12)-C(13)-C(14) 122.5(3) 
C(12)-C(13)-H(13A) 118.8 C(14)-C(13)-H(13A) 118.8 
C(15)-C(14)-C(13) 119.6(3) C(15)-C(14)-H(14A) 120.2 
C(13)-C(14)-H(14A) 120.2 C(16)-C(15)-C(14) 119.9(3) 
C(16)-C(15)-H(15A) 120.0 C(14)-C(15)-H(15A) 120.0 
C(15)-C(16)-C(17) 120.1(3) C(15)-C(16)-H(16A) 119.9 
C(17)-C(16)-H(16A) 119.9 C(16)-C(17)-C(12) 121.8(3) 
C(16)-C(17)-H(17A) 119.1 C(12)-C(17)-H(17A) 119.1 
C(19)-C(18)-C(23) 115.3(2) C(I 9)-C(I 8)-Si(I 1) 119.0(2) 
C(23)-C(I 8)-S i(I 1) 125.7(2) C(18)-C(19)-C(20) 122.8(3) 
C(18)-C(19)-H(19A) 118.6 C(20)-C(I 9)-H(I 9A) 118.6 
C(2l)-C(20)-C(19) 120.2(3) C(2l)-C(20)-H(20A) 119.9 
C(19)-C(20)-H(20A) 119.9 C(20)-C(2 I)-C(22) 119.4(3) 
C(20)-C(2l)-H(21A) 120.3 C(22)-C(2l)-H(21A) 120.0(3) 
C(2l)-C(22)-C(23) 120.0(3) C(2 I)-C(22)-H(22A) 120.0 
C(23)-C(22)-H(22A) 120.0 C(22)-C(23)-C(I 8) 122.3(3) 
C(22)-C(23)-H(23A) 118.9 C(I 8)-C(23)-H(23A) 118.9 
C(27)-C(24)-C(25) 108.0(3) C(27)-C(24)-C(26) 109.1(3) 
C(25)-C(24)-C(26) 109.9(3) C(27)-C(24)-Si(I 1) 107.9(2) 
C(25)-C(24)-Si(I 1) 112.0(2) C(26)-C(24)-Si(I 1) 109.86(19) 
C(24)-C(25)-H(25A) 109.5 C(24)-C(25)-H(25B) 109.5 
H(25A)-C(25)-H(25B) 109.5 C(24)-C(25)-H(25C) 109.5 
H(25A)-C(25)-H(25C) 109.5 H(25B)-C(25)-H(25C) 109.5 
C(24)-C(26)-H(26A) 109.5 C(24)-C(26)-H(26B) 109.5 
H(26A)-C(26)-H(26B) 109.5 C(24)-C(26)-H(26C) 109.5 
H(26A)-C(26)-H(26C) 109.5 H(26B)-C(26)-H(26C) 109.5 
C(24)-C(27)-H(27A) 109.5 C(24)-C(27)-H(27B) 109.5 
H(27A)-C(27)-H(27B) 109.5 C(24)-C(27)-H(27C) 109.5 
H(27A)-C(27)-H(27C) 109.5 H(27B)-C(27)-H(27C) 109.5 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A^2 x. JOA 3) for 173. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a 
*A 2 UI I+... +2hk a* b* U12 
Uli U22 U33 U23 U13 U12 
N(l) 155(3) 241(5) 126(3) 79(3) 17(3) 39(4) 
N(2) 103(3) 182(4) 75(2) 47(3) 10(2) 6(3) 
N(3) 137(3) 163(4) 74(2) 40(2) 28(2) 46(3) 
C(4) 68(2) 92(2) 58(2) 12(2) 15(1) 7(2) 
C(5) 72(2) 66(2) 100(3) 22(2) 12(2) 8(2) 
C(6) 54(2) 102(3) 118(3) 26(2) 4(2) . 23(2) 
0(6) 91(2) 149(3) 212(3) 24(3) -28(2) -49(2) 
0(7) 58(2) 94(2) 116(2) 24(2) 25(l) 20(l) 
C(8) 86(3) 70(2) 67(2) -6(2) 27(2) 11(2) 
C(q) 116(3) 53(2) 68(2) -6(2) 24(2) -1(2) 
0(10) 84(l) 44(l) 58(l) -4(l) 20(l) . 3(l) 
Si(i 1) 61(l) 39(l) 54(l) -2(l) 8(l) -3(l) 
C(I 2) 66(2) 42(l) 54(2) -2(l) 2(l) 5(l) 
C(I 3) 65(2) 74(2) 71(2) 16(2) 4(2) 1(2) 
C(I 4) 66(2) 105(3) 91(2) 7(2) 18(2) . 3(2) 
C(I 5) 54(2) 98(3) 111(3) -13(2) 3(2) 14(2) 
C(I 6) 76(2) 74(2) 86(2) -6(2) -17(2) 23(2) 
C(I 7) 79(2) 57(2) 64(2) 3(2) 3(2) 8(2) 
C(I 8) 48(2) 45(l) 61(2) 2(l) 4(l) . 6(l) 
C(19) 65(2) 45(l) 72(2) 0(1) -13(l) 0(l) 
C(20) 84(2) 45(2) 91(2) -4(2) -5(2) . 3(2) 
C(2 1) 78(2) 54(2) 112(3) 8(2) 5(2) 14(2) 
C(22) 75(2) 73(2) 128(3) 1(2) -39(2) 8(2) 
C(23) 70(2) 59(2) 102(2) -10(2) -24(2) . 6(2) 
C(24) 81(2) 48(2) 68(2) -10(l) 15(2) . 8(2) 
C(25) 97(3) 82(2) 99(2) -29(2) 15(2) . 36(2) 
C(26) 111(3) 78(2) 66(2) -19(2) 15(2) -18(2) 
C(27) 139(4) 45(2) 104(3) -19(2) 11(2) 4(2) 
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Table 5. Hydrogen coordinates (x JOA 4) and isotropic displacement parameters (AA 2x 
IOA3) for 173. 
x y z U(eq) 
H(4A) 4593 -677 10569 87 
H(5A) 3616 -2037 9899 95 
H(5B) 2930 -2657 10488 95 
H(8A) 2593 923 10792 89 
H(9A) 2906 1929 9835 94 
H(9B) 4327 1588 10128 94 
H(l 3A) 6567 2247 8072 84 
H(l 4A) 8906 2327 8104 104 
H(I 5A) 10064 1285 8881 106 
H(l 6A) 8883 211 9635 95 
H(l 7A) 6541 151 9612 80 
H(l 9A) 4834 3591 9203 73 
H(20A) 3881 5618 9114 88 
H(21A) 2045 5942 8488 98 
H(22A) 1206 4230 7913 111 
H(23A) 2132 2194 8012 92 
H(25A) 2318 -1456 7961 139 H(25B) 1921 7 8068 139 
H(25C) 2202 -907 8633 139 
H(26A) 4190 -568 7260 127 H(26B) 5318 340 7538 127 
H(26C) 3840 876 7437 127 
H(27A) 4595 -2232 8097 144 H(27B) 4609 -1785 8787 144 H(27C) 5767 -1329 8339 144 
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Biological Data for 95a and 95b, 142a 
and 142b 
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Table 6. Biological Screening for compounds 95a and 95b, 142a and 142b. 
«a 
f4 
Gram-positive bacteria 
Enterococcus faecium ARC521 2 4 >64 >64 >64 
Staphylococcus aureus ARC516 (MSS) 2 16 >64 >64 >64 
Staphylococcus aureus ARC517 (MRS) 2 64 >64 >64 >64 
Streptococcus pneumoniae ARC509 (PenS) 0.50 2 >64 >64 >64 
Streptococcus pneumoniae ARC548 1 2 >64 >64 >64 
Streptococcus pneumoniae AR556 32 16 >64 >64 >64 
(ARC548LinezR) 
Gram-negative bacteria 
Bacteroides fragilis ARC454 2 2 >64 >64 >64 
Haemophilus influenzae ARC446 8 1 >64 >64 >64 
Haemophilus influenzae ARC713 8 1 >64 >64 >64 
Haemophilus influenzae ARC737 16 1 >64 >64 >64 
Haemophilus influenzae ARC 15 8 (efflux mutant) 4 >64 >64 >64 >64 
Moraxella catarrhalis ARC445 2 0.25 >64 >64 >64 
Escherichia. coli ARC 523 >64 >64 >64 >64 >64 
Escherichia coli ARC 524 (efflux mutant) 8 32 >64 >64 >64 
Yeast 
Candida albicans ARC527 >64 >64 >64 >64 >64 
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